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In this thesis three aspects of the biosynthesis of natural products have 
been considered. In the first case, stable isotope labelling has been used 
in conjunction with nmr spectroscopy to study the biogenesis of 
3_nitropropanoic acid from L-aspartic acid and the post biosynthetic 
cycling of the former compound with 3_nitroacrylic acid. The intermediacy 
of 2_nitrosuCcinc acid has been demonstrated using N labelling. Chiral 
deuterated and 
1 3 c-labelled L-aspartic acids have been prepared and their 
stereochemical fate determined and discussed in terms of the likely 
mechanism of formation of 3_nitropropanoic acid. The use of chiral amide 
derivatives to distinguish pro R and pro S deuter9iofl by deuterium nmr and 
the secondary isotope effect of deuterium on the C nmr resonance of the 
metabolite were used. Finally, the role of 3_nitroacrylic acid was 
determined to be that of a post bi osy
nthetically cycled product rather than 
an intermediate and these findings have been discussed in the context of 
the post biosynthetic cycling of 3_nitropropanoic acid and its unsaturated 
derivative. 
In the second study the biosynthesis of the pyrimidine ring of thiamine 
(Vitamin B 1 ) 
in SaccharOm ces cerevisiae has been studied using stable 
isotopes in conjunction wit M.S. Since the metabolite is only produced in 
microgram amounts, a method has been developed for the cleavage of thiamine 
using the enzyme thiaminase I from Bacillus thiaminolyticus. This method 
was then applied to a stable isotop investigation whichdimonstrated that 
amination of the pyrimidine ring at the 4 position occurs prior to ring 
formation. A precursor which contains all the necessary nitrogen atoms is 
thereby, 
 implicated and.the results have been discussed in terms of 
potential biosynthetic precursors. 
Finally, the cleavage of bNA in a low water environment containing an ionic 
surfactant has been studied. While restriction has been shown to occur 
using a range of restriction enzymes, some apparent increase in specificity 
as evidenced by reproducible cleavage at certain nominally equivalent sites 
and not at others has been observed, preliminary studies on the structure 
of the low water system suggest that the DNA may be constrained and the 
implications for the restriction enzyme cleavage of any modification in DNA 
structure have been considered. The potential of increased specificity for 
isolation of specific DNA fragments and its likely implication for the 
cloning of enzymes has been discussed. 
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The study of the biosynthesis of primary and secondary metabolites is 
crucial to an understanding both of how biologically important 
products are formed and, perhaps more importantly, of how such 
pathways and products can be manipulated in order to facilitate 
improved yields, better growth and even, in some cases, novel product 
formation'. 
Traditional studies of the biosynthetic pathways in both prokaryotes 
and eukaryotes concentrated upon feeding radiolabelled early 
precursors and isolating the required product 2 . A complex 
degradation pathway is then necessary in order to determine the 
precise site of incorporation of labelled atoms in the compound of 
interest. This, essentially chemical approach, yielded a great deal 
of information concerning the biosynthetic interrelationships between 
compounds and groups of compounds. 
The next stage in this strategy was the synthesis of putative 
intermediates containing a radioactive label which could then be fed 
and their incorporation tested as above 3 . By such methods, details 
of the major biosynthetic pathways were elucidated and educated 
estimates made as to likely biosynthetic intermediates. while this 
approach is sensitive, general, powerful and provides substantial 
insight into the route of formation of naturally-occurring compounds, 
a number of limitations - both in a practical sense and inherent in 
the technique - are clearly present. First of all, while 
multiple-labelled compounds can be used, their analysis provides no 
information on the biosynthetic relationship of one atom to another 
throughout the pathway, i.e. there is no way of determining bond 
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formation, bond breaking or bond retention between any two atoms in a 
biosynthetic pathway. For this reason, while a mechanism of 
formation of a compound can often by inferred from the data obtained 
in radiochemical experiments, proof of the proposed mechanism is 
rarely possible except in cases where stereospecific tritium loss or 
retention can be demonstrated. Perhaps more crucially, there are no 
suitable radioisotopes of nitrogen available and it is, to all 
intents and purposes, invisible to radiochemical techniques. On a 
practical level, the synthesis of specifically single- or multiple-
radiolabelled compounds can pose considerable laboratory problems and 
the complex degradation pathways which are necessary in order to 
determine the site of labelling are frequently inconvenient and 
technically demanding. 
The advent of high resolution nuclear magnetic resonance (nut) and 
mass spectrometry (ins) opened up a new potential avenue of research. 
Biosynthetic precursors and intermediates could be prepared which 
contained a non-radioactive isotope ( 13 C, 2 H, ' 5N) and the position 
of the label in the product could then be determined directly4 . 
Furthermore, both nmr and ins can be used to determine multiple 
incorporation directly. The former is particularly powerful for 
determining not only the site of incorporation, but also the 
incorporation (or otherwise) of adjacent atoms. Thus, for example, 
stereospecific deuterium incorporation can be determined directly by 
preparation of suitable chiral analogues 4 and the presence of 2 H, 15N 
or 180  adjacent to 	can be determined directly by consideration of 
the 13 C nmr resonance of the carbon of interest 5 . A considerable 
volume of very valuable and specialised work has been, and continues 
to be carried out using stable isotopes in conjunction, principally, 
with nmr and, to a lesser extent, with ins. In addition, the handling 
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and preparation of precursors and intermediates which, contain a 
stable isotopic label is far easier practically than the 
corresponding radiolabelled compound. 
There are, however, a number of limitations which are principally a 
consequence of the sensitivity of the detection systems used. Nmr is 
basically an insensitive technique which requires milligram amounts 
of material and low dilution of isotopic enrichment in order that the 
effects can be visualised in the spectrum. This precludes the study 
of many important compounds which are produced in only small amounts 
and intermediates which are poorly incorporated either per se or as a 
result of the form in which they are presented to the organism under 
investigation. Ms is substantially more sensitive than nmr with 
microgram amounts of material often sufficient and thus suitable for 
measurements of isotopic enrichments where only small amounts of 
material are available. This is still considerably more than is 
required for radiochemical studies. In addition, despite recent 
advances in soft ionisation techniques such as chemical ionisation 
(CI) and fast atom bombardment (FAB), a significant number of 
compounds are simply not amenable to analysis using ms. A further 
limitation is imposed because ins, unlike nmr, is not a selective 
technique - confining its application to situations where the 
dilution of isotopic species is low. The information provided by ins 
is, even in the best designed experiments, generally much less than 
that available from mar studies. 
In parallel with the chemical approach to the study of biosynthesis, 
a biological approach has also developed. Early studies involved the 
isolation of species which were deficient in sequential parts of 
biosynthetic pathways and which would therefore accumulate certain 
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intermediates. The creation and characterisation of mutants and the 
examination of their accumulated intermediates from incomplete 
biosynthetic pathways, remains a very powerful weapon in bioorganic 
chemistry'. Such studies are largely haphazard in nature, with the 
control 'being exercised at a later stage during the assay and 
selection of mutants. Frequently, however, suitable assay systems 
are difficult to design or the biosynthetic intermediate from an 
incomplete pathway is often not simply accumulated in a convenient 
form. In an ideal situation, the enzyme which carries out a specific 
transformation in a pathway will accumulate - together with its 
product - in the cell. More usually, the enzymes of interest are 
only produced in extremely small amounts. Under these conditions, 
recent advances in molecular biology offer an opportunity to 
investigate the reactions catalysed by these enzymes in detail. The 
gene which codes for the enzyme is isolated then cloned into a 
suitable piece of carrier DNA (vector); This conjugate is then 
introduced into the cell - where in some cases it may be produced in 
multiple copies - and the protein subsequently overproduced 6' '. The 
overproduced enzyme can then be isolated using traditional protein 
purification techniques and its activity, substrate specificity and 
mechanism of action investigated in detail in vitro". There are 
some difficulties in this latter approach. A great deal of 
preliminary work must be done in order to isolate the gene of 
interest. In many cases, simple strategies for cutting and joining 
the appropriate pieces of DNA to a suitable vector do not exist and 
other more complex techniques must be employed9 . The overproduced 
protein may be difficult to isolate in a highly purified state and 
may be unstable to the purification conditions which must be 
employed. Nonetheless, allowing for these disadvantages, the 
possibilities for rapidly increasing knowledge of existing and future 
-5- 
interesting pathways makes this a method which should be considered 
to be essential to the future direction of bioorganic chemistry. 
This thesis investigates three different methodological approaches to 
the study of biosynthetic pathways in prokaryotes, eukaryotes and in 
vitro. The biosynthesis of 3-nitropropanoic acid, a fungal 
metabolite, is investigated using stable isotopes and, principally, 
nmr. The pyrimidine ring of thiamine (vitamin B 1 ) is studied using 
ms. Finally, the in vitro manipulation of DNA in a novel environment 
is considered. 
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1. 3-Nitropropanoic acid - Biosynthesis 
1.1 Introduction 
3-Nitropropanoic acid (1) is a toxic compound found in plants of the 
Fabaceae family' and in certain fungi 2 . It has been shown to inhibit 
mammalian succinate dehydrogenase irreversibly and fumarase 
reversibly 3 ' 4 ' 5 . The principal toxicity appears to occur as a 
result, therefore, of depression of energy metabolism through 
tricarboxylic acid cycle inhibition. Indeed, it has been suggested 
that administration of 3-nitropropanoic acid (1) may serve as a 
useful model of brain damage following energy deficiency. 
In plants, it occurs as a glycoside (hiptagin) from which 
3-nitropropanoic acid (1) can be readily released by hydrolysis 7 . 
The glycoside was first isolated in 1920 from Hiptage mandablota 
Gaertht . and later from Carynocarpus laevigata 9 . Acid hydrolysis of 
the glycoside gave hiptagenic acid (3-nitropropanoic acid), carbon 
dioxide, ammonia and a sugar residue 9 . In contrast to fungi, the 
biosynthesis of 3-nitropropanoic acid in plants has been relatively 
little studied. In indigo (Indigofera spicata, (Jacq.) Forsk.) 
malonic acid was found to be a precursor as was 
malonylmonohydroxamate' ° . The label from [2- 14 C]-malonic acid was 
located in both C-2 and C-3 of the isolated 3-nitropropanoic acid and 
the cycling of malonic acid with oxaloacetic acid in the roots was 
suggested. There was no evidence of incorporation of 
[3-14 C]-L---aspartic acid or of constituents of the tricarboxylic acid 
cycle in 3-nitropropanoic acid (1) in indigo" . 
im 
In fungi, the free acid is produced in large amounts (2.4g per litre 
of medium in the case of Penicillium atrovenetum) 12 . Raistrick and 
Stossl also found that the acid was formed in the earliest stages of 
growth then reached a maximum before subsequent decline 12 . 
3-Nitropropanoic acid (1) may be an intermediate in a fungal 
nitrification process where reduced organic nitrogen compounds are 
oxidised rather than nitration occurring directly' 2 . This is 
analogous to the oxidation of ammonia to nitrite carried out by 
Nitromonas bacteria13 . Ammonium salts were found to stimulate 
production while nitrate appeared to be inhibitory ' 2 . This early 
study was followed by an investigation by Birch et al.' 4 on the 
biosynthetic precursors of 3-nitropropanoic acid (1) in P. 
atrovenetum in which [4-' 4 C]- aspartic acid was implicated as a 
direct precursor. The same workers noted that [l-'4C]--alanine was 
not incorporated while [' 4 C]-sodium bicarbonate was also a precursor 
of the carboxyl carbon atom. Gatenbeck and Forsgren showed' 5 that 
uniform labelled ("C]- aspartic acid was incorporated in a uniform 
fashion and this was suggested to implicate a dicarboxylic acid via 
the tricarboxylic acid cycle. Previously Hylin and Matsumoto t6 , in a 
non-labelled investigation, studied the effectiveness of various 
carboxylic acids as precursors of 3-nitropropanoic acid (1). They 
found that maximal production required the presence of ammonium ion 
and a suitable, four-carbon, carboxylic acid. They implied, from 
these results, that, while aspartic acid (2) may be a..precursor, it 
is effectively deaminated prior to incorporation and the dicarboxylic 
acid thereby formed enters the general acid pool and is subsequently 
incorporated. In addition, iyasggested that hydroxylamine 
(figure 1.7) 
addition to fumaric acid (3)AmaY  be a viable pathway. 
N 
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Such speculation was largely terminated by the double-labelled study 
of Gatenbeck and Forsgren' 5 which showed that [' 5 N, U-' 4 C)-aspartic 
acid was incorporated suggesting that the amino group is oxidised in 
situ. Transamination exchange of the nitrogen of aspartic acid with 
ammonium ions in the medium served to complicate matters, however the 
results were sufficiently unequivocal for the intact incorporation of 
aspartic acid (2) to be generally accepted. This matter was not 
finally settled however until the nmr study of Baxter et al 17  who 
showed that [2-13 C, ' 5N1-aspartic acid was incorporated with 
conservation of the carbon-nitrogen bond. The presence of 
doubly-labelled 3-nitropropanoic acid (1) was determined from the 15 N 
coupled 13 C flint spectrum. These authors also found an upper limit 
for exchange of nitrogen from aspartic acid (2) to the medium of ca 
20%; moreover the lack of enhancement of the C-i and C-2 signals in 
the isolated 3-nitropropanoic acid (1) eliminated the possibility of 
randomisation of the label. Since DL-aspartic acid was fed and the D 
form is incorporated via oxaloacetic acid (with concommitant loss of 
the 15 N label), it is clear that equilibration of the 13 C label into 
C-2 and C-3 of oxaloacetic acid through malate dehydrogenase and 
aspartase activity cannot occur (Fig: 1.1). Similarly, randomisation 
through the tricarboxylic acid cycle is also eliminated as a 
possibility. 
These results substantiate the earlier findings from 14 C labelled 
pyruvic and acetic acid feeding studies' 8 . In this work, [2-' 4 C] 
pyruvic acid was shown to be incorporated equally into C-i and C-3 
with C-2 being about half of this. Such a result is predicted if 
pyruvate is converted to oxaloacetic acid and hence via aspartic acid 
(2) to 3-nitropropanoic acid (1). If a symmetrical, dicarboxylic 
acid was involved then equal labelling of C-2 and C-3 in the, product 
Figure 1.2 	INCORPORATION OF H 	ACETATE INTO 3NITROPROPANOIC ACID (1) 
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would be expected. Examination of the pyruvate-de rived aspartic acid 
in the medium showed that, after subtraction of the contribution from 
C-4, the specific radioactivity and distribution was almost identical 
with that of the isolated 3-nitropropanoic acid (1). Similar results 
with specifically labelled acetic acid (see Fig. 1.2) indicate that 
it too, is incorporated via oxaloacetic acid after metabolism through 
the tricarboxylic acid cycle. 
It should, perhaps, be noted at this juncture, that, in the vast 
majority of cases, feeding of labelled precursors was carried out 
either at the time of innoculation, in the lag phase or early in the 
log phase of growth and isolation of 3-nitropropanoic acid (1) was 
carried out once the stationary phase had been reached. The 
significance of this point will become clear in the later discussion. 
While in situ oxidation of the amino fUnctionality inaspartic acid 
(2) is the biosynthetic route of choice, the nature of the 
intermediates remains unclear. Hydroxylamine has been detected in 
the culture medium", although addition of this compound did not 
promote production of 3-nitropropanoic acid (1) due, presumably, to 
the toxicity of hydroxylamine. Gatenbeck and Forsgren' 5 also 
detected nitrite in the culture medium although neither 
3-nitrososuccinic acid nor -oximinopropionic acid were found to 
stimulate production. Both nitrite and nitrate are produced from 
3-nitropropanoic acid (1.) by an enzyme system isolated from P. 
atrovenetum and production is accompanied by .a loss of the acid in 
the medium in the post-stationary phase of growth". Inorganic, 
oxidised nitrogen compounds appear to be products from the subsequent 
breakdown of 3-nitropropanoic acid (1) rather than biosynthetic 
intermediates. 
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In contrast to the majority of the above results, Shaw and Wang 20 
reported that neither p-alanine (4) nor aspartic acid (2) alone 
stimulated production of 3-nitropropanoic acid (1). These authors 
suggested an inorganic nitrogen precursor was implicated and found 
production to be stimulated both by hydroxylamine and nitrite. It 
should be noted, however, that, in contrast to other studies, these 
workers used shake flasks rather than surface cultures and the 
results were later contradicted by the same author 
21  who suggested 
the composition of the medium to be of prime importance. clearly 
ammonium ion can be incorporated via transamination with oxaloacetic 
acid, but this has been found to occur only to a limited extent. 
A further and related point of interest in the biosynthesis of 
3-nitropropanoic acid (1) is the derivation of the nitro oxygen 
atoms. Shaw and McCloskey have shown" that [1801_  nitrate is not 
incorporated and that exogenous hydroxylamine does not depress the 
incorporation of ( 15 N1- aspartic acid. Lack of incorporation of 
E 18 0]_ nitrate may be due to oxygen exchange of some intermediate 
with water. This question has recently been answered in a further nmr 
study by Baxter and Greenwood22 . In this investigation, cultures of 
P. atroventum were grown in an atmosphere of 18 02/ 6 02 and with 
[ '5 N1- ammonium chloride in the medium. The proton decoupled ' 5N nmr 
spectrum showed three resonances corresponding to 
and 15N1  0
2 indicating that both oxygen atoms of the nitro group 
derive from dioxygen. This suggests involvement of one or two 
dioxygenase enzymes in the biosynthesis23 . 
The isolation of a NADPH-dependent "reductase" enzyme from P. 
atrovenetum which catalyses the conversion of 3-nitroacrylic acid (6) 
to 3-nitropropanoic acid (1)24  implicated the former as a 
Figure 1.3 . PROPOSED BIOSYNTHESIS OF 3 - NITROPROPANOIC ACID (i) 
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biosynthetic precursor (Fig 1.3). While 3-nitroacrylic acid (6) is 
toxic to the culture (being, presumably, an inhibitor of succinate 
dehydrogenase - an activity which 3-nitropropanoic acid (1) itself 
exhibits in vitro), at low levels it reduces the production of 
3-nitropropanoic acid (1) and, furthermore, completely inhibits 
incorporation of [4-14 C]-aspartic acid into (1). In the presence of 
unlabelled aspartic acid, [1-' 4 C]-.3-nitroacrylic acid (6) was 
incorporated by cells of P. atrovenetum (albeit only one third of the 
expected incorporation). The fact that the isolated enzyme, 
11 3-nitroacrylate reductase", is unable to catalyse effectively the 
reverse reaction, oxidation of (ff to. (6)\ has been interpreted as 
evidence of a precursoral relationship. 
The primary precursor of 3-nitropropanoic acid (1) appears, 
therefore, to be L-aspartic acid (2), the nitro oxygen atoms are 
derived from molecular oxygen and the nitrogen is oxidised in situ 
with retention of the carbon-nitrogen bond. Additionally, Shaw et 
24  have shown that 3-nitroacrylic acid (6) may be an intermediate. 
The information available from previous studies, summarised above, 
eliminates a number of possible routes between L-aspartic acid (2) 
and 3-nitropropanoic acid (1). Nonetheless, a number of potential 
pathways and stereochemical possibilities remain viable and some of 
these are outlined in scheme 1.1 
Each of the transformations depicted has some analogy with known 
secondary metabolism pathways. Dehydroamino acids, for example, have 
been reported as fungal metabolites2 25  and intermediates in the 
biosynthesis of certain cyclic and depsipeptides including the 
-16- 
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commercially important antibiotic nisin from Streptococcus lactis and 
the related subtilin from Bacillus subtilis 26 . 
The failure to incorporate fralanine precludes decarboxylation as a 
first step in the sequence however it could occur at a number of 
oxidation levels as shown in scheme 1.1. In addition, several 
different mechanisms of decarboxylation are possible. 
No definitive literature precedent for the decarboxylation of a 
dehydroantino acid is known, however a pyridoxal phosphate mechanism 
analogous to that involved in cr-amino acid decarboxylation is 
possible which would give dehydro3-alanine. Oxidation to the 
corresponding N-hydroxy dehydroamino acid and thence to 
3-nitroacrylic acid (6) would afford a known in vitro precursor. 
A similar oxidative pathway can occur with decarboxylation of 
N-hydroxy aspartic acid or of nitrosuccinic acid and several types of 
decarboxylative mechanism can be envisaged. Decarboxylation could 
occur directly, generating a carbanion intermediate which is then 
quenched by proton abstraction from water. This reaction could 
proceed with either retention or inversion of stereochemistry at the 
position derived from C-2 of L-aspartic acid. An analogy for direct 
decarboxylation can be found in the reversible action of propionyl 
CciA carboxylase which proceeds with overall retention of 
configuration27 . In contrast, decarboxylation of UDP-glucuronate 
occurs with inversion of configuration at G228. 
An alternative mechanism which involves concerted abstraction of a 

























•'  + - Fl R 
xanthocjlljn 
-19- 
involving antiperiplanar elimination of hydrogen and the carboxyl 
functionality is analogous to that involved in the generation of the 
ethylidene side chain in porphyrin biosynthesis where the pro-S 13 
proton is abstracted (Scheme 1.2)29.  Herbert 30  has proposed a 
similar mechanism for the decarboxylation of L-tyrosine in the 
biosynthesis of xanthocillin and tuberin (Scheme 1.2). In the former 
case the 3-pro-S proton is lost while in the latter it is retained 
and the 3-pp-R is lost. 
The work by Shaw2 ' on the in vitro enzymic reduction of 
3-nitroacrylic acid (6) to 3-nitropropanoic acid (1) suggests that a 
concerted decarboxylation mechanism is possible, the reduction of 
3-nitroacrylic acid (6) could also be interpreted as evidence of a 
post-biosynthetic process akin to the metabolism of (1) in mammalian 
tissue in which 3-nitropropanoic acid (1) and its dehydro derivative 
are in equilibrium 3-5 
A strategy was developed for delineating which of the pathways in 
scheme 1.1 was involved and hence which of the mechanisms discussed 
above is implicated. It is essential, in the first instance, to 
determine at which stage decarboxylation of L-aspartic acid occurs. 
The incorporation of 2-nitrosuccinic acid (5) into 3-nitropropanoic 
acid (1) would preclude decarboxylation at a lower oxidation state 
and eliminate a number of possible pathways outlined in scheme 1.1 
therefore this compound was evaluated first. 
1.2 Nitrosuccinic acid (5) 
1.2.1 Synthesis and feeding 
Attempts to synthesise 2-nitrosuccinic acid (5) directly by nitration 
-20- 
of bromosuccinic acid were unsuccessful. Nitrite esters are an 
important side product in the reaction of sodium nitrite with primary 
alkyl bromides and phioroglucinol has been used to minimise ester 
production 31 . Bromosuccinic acid was treated with ethanolic HC1 to 
give the diethylester which was then nitrated with (' 5 N1-sodium 
nitrite in dimethylsulphoxide in the presence of phloroglucinol 
giving [' 5 NJ-DL-nitrosuccinic acid diethylester (20). Attempts to 
hydrolyse the ester gave only a poor yield of the required product. 
The diester (20) was therefore pulse fed to surface cultures of P. 
atrovenetum over 36 hours beginning 48 hours after innoculation. It 
was hoped that by adopting this protocol to obtain maximum 
incorporation with minimum dilution of the label resulting from 
metabolism of 3-nitropropanoic acid (1). 
1.2.2 Results 
The proton decoupled 15 N DEPT (distortionless enhanced polarisation 
transfer) nmr spectrum32 of the isolated 3-nitropropanoic acid (1) 
showed an intense signal at 3.1 ppm with a fourteen fold increase in 
intensity over natural abundance. Incorporation was confirmed by the 
occurrence of 15 N satellites of both methylene signals in the 'H nmr 
of the isolated 3-nitropropanoic acid ( 2 J NH 2.2 Hz, 3  NH 3.7Hz) of 
an intensity corresponding to a twenty-fold dilution of the 15 N 
enrichment from that of the racemic diester. 
1.2.3 Discussion and conclusions 
The incorporation of ( 15 N)_DIL.diethyl nitrosuccinic acid (20) 
suggests that the biosynthesis of 3-nitropropanoic acid (1) involves 
direct oxidation of r-aspartic acid (2). This study does not preclude 
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the possibility that N-hydroxy aspartic acid is also an intermediate 
but it does show that complete oxidation of the amino group of 
L-aspartic acid to a nitro group must occur prior to decarboxylation. 
It has been observed that the C-N bond is conserved in the 
biosynthesis of 3-nitropropanoic acid (1) from L-aspartic acid (2) 
thus the biosynthetic pathway must proceed from L-aspartic acid (2) 
to nitrdsuccinic acid (5) (perhaps via some other oxidised species) 
and thence, after decarbo4d.ation, to 3-nitropropanoic acid (1). 
Furthermore, the non-intermediacy of -alanine is confirmed. 
1.3 Stereochemistry of nitrosuccinic acid incorporation 
While nitrosuccinic acid (5) has been shown to be an intermediate, 
its stereochemistry remains unclear. The incorporation of deuterium 
atoms from L.-[2,3,3- 2 H3 ]-aspartic acid (19) will serve to further 
delineate which of the pathways shown in scheme 1.1 is correct. 
1.3.1 Feeding 
L-[2,3,3-2 H3 ]-Aspartic acid (19) was administered to cultures of 
P. atrovenentum in three equal amounts (8 mg) at 42, 48 and 54 hours 
after inoculation. 3-Nitropropanoic acid (1) was isolated after 72 
hours as described in the experimental section. 
1.3.2 Results and discussion 
The 2 H nmr spectrum of 3-nitropropanoic acid (1) derived from the 
feeding of perdeuterated L-aspartic acid (19) showed two peaks at 
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2.97 ppm and 4.69 ppm due to deuterium incorporation at C-2 and C-3 
respectively. Deuterium is therefore retained at both C-2 and C-3 
positions of 3-nitropropanoic acid (1). If inversion of 
stereochemistry had occurred at the carbon derived from C-2 of 
L-aspartic acid (2) during the course of formation of nitrosuccinic 
acid then no retention of deuterium at the 3 position of the 
metabolite (1) would be expected. It follows, then, that the 
stereochemistry of L-aspartic acid is retained in the oxidation which 
gives nitrosuccinic acid. This, together with the previous result 
from 15 N-nitrosuccinic acid (5), implies that the biosynthetic 
pathway involves oxidation of L-aspartic acid (2) to give 
t.-nitrosuccinic acid prior to decarboxylation. The retention of H-2 
of L.-aspartic acid (2) eliminates the possible intermediacy of 
dehydroaspartic acid derived intermediates (route (a) of Scheme 1.1) 
in the biosynthesis. The mechanism and stereochemistry of the 
decarboxylation however remains unclear. 
1.4 Mechanism of decarboxylation 
To evaluate which of the two plausible decarboxylation mechanisms 
(direct decarboxylation or decarboxylation with loss of a 8-hydrogen 
yielding an acrylate intermediate) is involved, the retention of the 
hydrogen atoms from C-3 of L-aspartic acid (2) in the biosynthetic 
conversion was examined. Measurement of hydrogen retention or loss 
can be determined by snaking use of the 0-isotope shift effect on the 
' 3 c ninr signal caused by deuteration on an adjacent C atom42 . Each 
deuterium atoni shifts the position of resonance of a directly 
attached carbon nucleus by 0.3 to 0.6 ppm upfield. A deuterium which 
is two bonds away has a similar, though smaller (ca 0.01-0.1 ppm per 
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deuterium) effect43 , although variability has been noted especially 
for carbonyl carbon atoms 44 . The multiplicity of carboxyl 13 C 
resonances can thus be used to determine the extent of deuteration at 
C-2. The incorporation of deuterium from L.-[4-' 3 C, 3-2 H2 1-aspartic 
acid would determine whether an acrylate intermediate is involved in 
the biosynthesis of 3.-nitropropanoic acid (1) from L-nitrosuccinic 
acid (5). 
1.4.1 Synthesis and feeding 
DL-[4-'3C,. 3_2  fl2 ]-Aspartic acid (19) was prepared by treatment of the 
of diethyl 
with Na' 3 CN followed by acid hydrolysis in 2 HC1. Acetylation 
followed by methylation of the acid groups afforded DL-[4- 13 C, 
3.-2 }12 J-N-acetyl dimethyl aspartic acid. Examination by nmr suggeted 
a deuterium content of 1.7 per molecule with 85% 2 and 15% 2 i! 
species. 
DL.-[4-'3C, 3_2; ]-aspartic acid (19) (24 mg) was pulse fed to growing 
cultures of P. atrovenetum and 3-nitropropanoic acid (1) isolated 
after 96 hours. 
1.4.2 Results and discussion 
The 13  C nmr resonance of the carboxyl carbon of the isolated 
3-nitropropanoic acid (1) showed two distinct peaks at 175.934 ppm 
and 175.925 ppn - a difference of 0.009 ppm. These correspond to do 
and d1 species. The difference between d0 and d2 at the 2 position 
in [1-' 3 C]-3-nitropropanoic acid was determined elsewhere to be of 
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the order of 0.025 ppm (vide infra). The loss of a single deuterium 
implies a concerted loss of H and the carboxyl group thus suggesting 
that an acrylate intermediate is involved. 
Earlier work on tuberin and xanthocillin biosynthesis discussed 
above 30  has determined that the loss of 0-proton is a stereoselective 
process. A similar mechanism may be involved in this case, and if 
so, we would expect either the 3-p-R or the 3-pro-S proton of 
L-aspartic acid (2) would be lost in the biosynthesis of 
3-nitropropanoic acid (1). This was investigated by preparation and 
feeding of chirally deuterated L-aspartic acid and examination of the 
product using 2 H nmr. 
1.5 Stereochemistry of incorporation of L-aspartic acid (2). 
1.5.1 Introduction 
The lack of chirality of 3-nitropropanoic acid (1) means that 
assignment of the C-2 or C-3 hydrogens requires that a chiral 
derivative is prepared to enable the prochiral methylene hydrogens to 
be distinguished. While any chiral derivative might be expected to 
lead to chiral distinctions, stereochemical assignment is more 
complex. Once approach which was considered was the construction of 
a cyclic derivative based on L-lactic acid (Figure 1.4). 
Model-building suggests that both the diastereotopic 3H,, and 3H and 
2 and 2H. would be sufficiently distinct at 200 MHz in the nrnr 
spectrum. Furthermore, the stereochemistry is locked in the cyclic 
lactic acid derivative and thus the iconformationt might be determined 
by x-ray crystallography. Clearly a significant amount of chemical 
-25- 
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manipulation of the isolated 3-nitropropanoic acid (1) is required. 
The acid (1) must be converted to a suitable form for derivatisation 
with a chiral agent and protection and deprotection steps with 
retention of methylene proton configuration were essential. 
An alternative method makes use of chiral deuterated Ø-alanine (4) 
for conformational studies 33 . This approach has been applied by 
Young et al. 33 who prepared Ø-alanine (4) with stereospecific 
deuterium incorporation from the corresponding deuterated aspartic 
acids. The camphanyl amide of Ø-alanine (16), prepared by reaction 
with camphanyl chloride, showed distinction of the 3R and 35 hydrogen 
atoms in the 1  nmr spectrum. In this case the pro-R hydrogen 
resonated at higher frequency than the pro-S and thus, in the case of 
3-nitropropanoic acid (1), it ought to be possible to determine the 
stereochemistry of deuterium incorporation from feeding deuterated 
aspartic acid at C-3 by conversion of the product to Ø-alanine, 
preparing the caznphanyl amides of the corresponding g-alanines and 
comparing with literature values. Although Gani and Young33 were 
unable to find a suitable derivatising agent for chiral distinction 
at C-2 in fr-alanine (4), it has been shown34 that the methyl valine 
amides of carboxylic acids can give chiral distinction a to the 
carboxyl group. In addition, Brown and Parker 35  have shown that 
chiral distinction of the C-2 methylene protons can be observed in 
the S-methyl mandelate derivatives of simple carboxylic acids. 
Comparison of the methyl valine amide or the methyl mandelate 
derivative of fr-alanine derived from 3-nitropropanoic acid isolated 
after feeding perdeuterated L-aspartic acid to P. atrovenetum with 
the same Ø-alanine derivatives of known conformation prepared 
independently will confirm both the intermediacy or otherwise of 
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3-nitroacrylic acid (6) in the biosynthesis of 3-nitropropanoic acid 
(1) and elucidate the stereochemistry of the biosynthesis at C-2 of 
the product in an absolute fashion. 
1.5.2 Synthesis 
(a) Attempted synthesis of the cyclic derivative 
Attempted reduction of 3-nitropropanoic acid (1) with lithium 
aluminium hydride did not give any of the expected amino alcohol. 
Reduction with tin in hydrochloric acid gave only a small yield of 
-alanine (4) and this route was clearly of no use when dealing with 
labelled material since further reaction was necessary to prepare the 
cyclic derivative. Reaction of (1) with palladium/charcoal and dry 
ammonium formate 36  gave 6-alanine (4) in good yield. 
L-(+)-Lactic acid (13) was chosen as the chiral agent for 
construction of the cyclic derivative. Reaction of this compound 
directly with 3-nitropropanoic acid (1) however gave a mixture of 
products. The corresponding benzyl ester of lactic acid (13) was 
prepared by reaction with benzyl alcohol in tetrahydrofuran in the 
presence of 1,3-dicyclohexylcarbodimide (DCC) but this material could 
not be condensed with 3-nitropropanoic acid (1) under a range of 
conditions. There may be steric reasons for this. L-(+)-Lactic acid 
(13) was protected by reaction with 2,4 1 -dibromoacetophenone37 . This 
protected derivative also failed to react with 3-nitropropanoic acid 
(1) under a range of conditions including the mixed anhydride 
procedure with triflouroacetic anhydride which activates the acid 
prior to esterification38 . In the light of work described below, 
attempts to prepare cyclic derivatives were abandoned. 
190 
(b) Chiral L-aspartic acid 
The difficulties in the cyclisation strategy led to a consideration 
of the two alternative methods of determining the route and 
stereochemistry of the incorporation of deuterated L-aspartic acid 
(2) into 3-nitropropanoic acid (1). These both require distinction 
of the pro-R and pro-S hydrogen atoms at 0-2 in the product by 
preparation of .a suitable chiral derivative which can be compared 
directly with an authentic sample of known stereochemistry. 
fr-Alanine was treated with freshly sublimed (-)- camphanic acid 
chloride in aqueous sodium hydroxide and the product isolated as an 
oil which was used without further purification. The N-camphanyl 
-13-alanine (16) was treated with methyl valine and DCC and the 
diderivatised fr-alanine (17) isolated. This product could not be 
crystallised. Examination by 'H niur showed that the pro-R and pro-S 
hydrogen atoms at C-2 and C-3 of the correspondin 3-nitropropanoic 
acid (1) could be distinguished 
turn confirmed the assignments. 
Decoupling of each resonance in 
Deuterated 3-nitropropanoic acid (1) was prepared by deuterated acid 
hydrolysis of bromopropionitrile followed by nitration (vide infra). 
Unfortunately, treatment with ammonium formate and palladium charcoal 
catalyst led to loss of the deuterium atoms and attempts to carry out 
the reduction by other methods in which the deuterium would be 
retained were unsuccessful. The use of chiral -a1anine derivatives 
was abandoned and a method sought whereby distinction of the pro-R 
and pro-S methylene protons could be made without reduction of the 
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Note: For the sake of clarity, resonances due to C-2H and C-3H only 
are shown; other resonances have been deleted. 
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3-Nitropropanoic acid (1) was converted to the corresponding methyl 
mandelate ester by treatment with trifluoroacetic anhydride then with 
methyl mandelate at room temperature. Esterificatior 11sr?, 
2-ethoxy-l-ethoxy carbonyl-1, 2-dihydroquinoline (EEDQ) or 
dimethylaminopyridine (DIII½P) and dicyclehexylcarbodimide (DCC) gave 
only starting material. Examination by 'H nmr showed that the pro-s 
and pro-S hydrogen atoms at C-3 were distinguishable from one another 
while those at C-2 - remained unresolved (Fig. 1.5). 
The methyl valine amide of 3-nitropropanoic acid was prepared by 
coupling the metabolite with 1.-methyl valine using DCC in THF. The 
'H nmr spectrum showed a complex pattern for the hydrogens at C-2 
characteristic of an AA'BB' system". Decoupling of the resonance 
due to the C-3 hydrogens at 4.72 ppm leads to collapse of the 
virtually symmetrical complex into an AB pattern. A similar pattern 
is obtained for the hydrogen at C-3 and decoupling of the resonance 
due to the hydrogens at C-2 (2.95 ppm) causes a similar collapse. 
(Fig. 1.6). 
Failure to prepare -alanine from 3-nitropropanoic acid (1) with 
retention of deuterium at C-2 of (1) made direct comparison of a 
suitable chiral derivative using 2 H nmr with the same derivative 
prepared with known stereochemistry impossible. Administration of 
chirally deuterated L-aspartic acids and preparation of the 
corresponding methyl valine amides from the isolated 3-nitropropanoic 
acid (1) offered an alternative method of distinguishing 
stereochemistry of the hydrogen atoms at C-2 of (1) derived from 
those at C-3 of L-aspartic acid. 
Figure 1.6  
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Aspartase catalyses the formation of L-aspartic acid from fumaric 
acid. The reaction is stereospecific, therefore using fumaric acid 
as substrate in deuterated water gives 2S, 3R-[3 2 HJ-aspartic acid 
while 2,3-dideutero fumaricacid(27) is converted to 2S, 
• 	.7J,i 
3S-[2,3-2 H2 ] -aspartic ac{' The dideuterated fumaric acid (27) was 
prepared from diacetylene dicarboxylate by reaction with 
triphenylphosphine in the presence of 2 112 0 followed by hydrolysis of 
the diester40 . The chirally deuterated L.-aspartic acids were then 
prepared by incubation with aspartase as described by Field and 
Young 41 (Fig. 1.7). 
The 'H nmr spectrum of the labelled material showed the expected 
resonances, 	73iT[2_3_rH2 )_aSPartic d1 	- ( 14) giving a 
singlet at 2.65 ppm while the monodeuterated derivative, (2S, 3R) - 
[3-2 H) - aspartic acid (15), gave a 111 doublet at 3.50 ppm (11-2 
0=8Hz) and a 111 doublet at 2.30 ppm (11-3 0=8Hz). Incorporation of 211 
was also confirmed by negative ion FAB mass spectral analysis which 
gave a small molecular ion in each case and significant peaks due to 
loss of 00 2 H and showed that a little (<5%) non-'deuterated material 
was also present. 
Each of the labelled L-aspartic acids was fed to cultures of P. 
atrovenetum in 3 equal amounts (8mg/50cm 3 culture) at 42, 48 and 54 
hours after innoculation. The 3-nitropropanoic acid (1) was isolated 
after 72 hours as described in the experimental section. 
The 3-nitropropanoic acid (1) isolated from the stereospecifically 
deuterated-L-aspartic acid feeding experiments was examined by 211  nEw 
then converted to the corresponding methyl valine amides and examined 
-33- 
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once again. A sample of (2sL,3_2Ha1_aspattic  acid (15a 	was 
also fed as described above and the derived 3-nitropropanoic acid 
examined by 2 H nmr. A sample of (2S,3R)- 13- 2 H]-aspartic acid (15) 
was fed to two cultures and the 3-nitropropanoic acid (1) isolated 
after 72 and 96 hours then the methyl valine amides compared by 2 H 
nmr. Finally, [4-' 3 C, 3-2 H2 1-L--aspartic acid (18) was administered 
and the 3-nitropropanoic acid isolated after 72 hours and examined by 
13 C nmr of the carboxyl resonance and FAR ins. 
1.5.3 Results 
Examination of 3-nitropropanoic acid (1) obtained from feeding 
- (19) by 2 H mitt showed two peaks at 
2.97 and 4.69 ppm due to deuterium incorporation at C-2 and c-3 
respectively. The methyl valine amides of this compound gave 
resonances at 2.96 ppm and 3.04 ppm due to the pro-R and pro-S 
deuterium atoms at c-2. The deuterium at C-3 was lost by exchange 
during the preparation of this compound. The proportions of the two 
resonances at C-2 were ca 2:1 (Fig 1.8); that at 3.04ppm being the 
smaller. 
The isolated acid (1) from administered (2S,3S)[2 2 H , 
3-2 H]--L-aspartic acid (14) also showed two resonances in the 2 H nmr 
spectrum at 2.98ppm and 4.70 ppm. The corresponding methyl valine 
amide had a single peak at 3.04 ppm (Fig 1.9). The acid isolated 
after feeding (2S,3R)-[3- 2 H]-L-aspartic acid (15) produced a single 
resonance in the 2 nmr at 2.99 ppm while the corresponding methyl 
valine amide had a peak at 2.94 ppm and a very small resonance at 











In the time course experiments, deuterium was found to be 
incorporated in 3-nitropropanoic acid isolated after 72 and 96 hours 
growth. In the case of the 72 hours isolate, the methyl valine 
amides exhibited a single resonance at 2.94 ppm, and, a very small 
peak at 3.08 ppm (Fig. 1.10). The 96 hours incubation gave 
3-nitropropanoic acid in which the methyl valine amide showed two 
peaks at 2.94 ppm and 3.02 ppm (Fig. 1.10), corresponding to the pro 
R and pro S deuterium atoms at C-2, of approximately equal size. 
These results are summarised in Table 1.1. 




2 H chemical shift of (1) 2 H Chemical shift of 
(ppm) 	 amide derivative 





(25, 35)[2-2H, 3_2 HI 2.98, 4.70 
	
3.04 





(2S, 3R)[3_2  HI(72h) 2.96 
	
2.94 




The 211  nmr spectrum of the methyl valine amide of 3-nitropropanoic 
acid (Fig. 1.8) isolated from feeding [22H, 3_ 2 112 ]-L-aspartic acid 
(19) suggests that, if an unsaturated intermediate is involved, 
either desaturation or reduction is a non-stereospecific process. 
Both the 3 pro-R and the pro-S deuterium atoms of deuterated 
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aspartates are retained at C-2 of the isolated 3-nitropropanoic acid 
(1) giving resonances at 2.96 ppm and 3.04 ppm in the spectrum of the 
methyl valine amide. Thus stereospecific hydrogen loss and 
subsequent gain is precluded. If 3-nitroacrylic acid (6) is involved 
as a biosynthetic precursor it may be produced by loss of hydrogen 
either in a specific or a random fashion but the subsequent hydrogen 
addition to give (1) must be non-stereospecific process to give a 
mixture of 2 pro-R and 2 pro-S deute rated 3-nitropropanoic acid (1). 
If a saturated intermediate is involved then the retention of 
deuterium from C-2 deuterated L-aspartic acid at C-3 of 
3-nitropropanoic acid (1) implies overall retention of 
stereochemistry at this position. It should be noted that while 
pyridoxal phosphate-mediated interconversion of amino acids and 
cc-keto acids can occur in vivo, this would also cause loss of 
deuterium from C-2 of L-aspartic acid which is clearly not evident in 
this case. 
One of the C-2 deuterium atoms in 3-nitropropanoic acid (1) from the 
perdeuterated aspartate feeding occurs in ca 50% lower abundance than 
the other (Figure 1.8). This observation is important to later 
arguments but, for the moment, it implies that the pro-R and pro-S 
hydrogen atoms at C-3 of L-aspartic acid, even when isotopically 
identical, are not completely equivalent in the biosynthesis of 
3-nitropropanoic acid (1). 
Feeding L-aspartic acids in which either the pro-R or pro-s hydrogen 
at C-3 are replaced by deuterium gives incorporation in both cases. 
This result suggests that any hydrogen loss through the intermediacy 
of an acrylate analogue must be non-stereospecific since either the 
-40- 
pro-R or the pro-S can be retained. Preparation of- the methyl valine 
amides of the isolated 3-nitropropanoic acid (1) from each r..-aspartic 
acid feeding shows that a different hydrogen is retained in each 
case. For the pro-R 2  H case, a single resonance at 2.94 ppm (Figure 
1.9) was observed in the chiral amide while in the 3-nitropropanoic 
acid (1) derived from feeding pro-S 2 H aspartic acid the 
corresponding peak is at 304 ppm (Figure 1.9). This is consistent 
with the results from the perdeuterated aspartic acid feeding in 
which resonances were observed at 2.96 and 3.04 ppm. There is a 
small peak in the pro R-2 H feeding at 3.04 ppm corresponding to the 
other isomer which may occur as a result of post-biosynthetic cycling 
of the 3-nitropropanoic acid (1), in a non-stereospecific fashion, 
with 3-nitroacrylic acid (6). It is not possible to determine, by 
inspection, if the deuterium is being retained at C-2 of 
3-nitropropanoic acid (1) with retention of configuration or 
inversion. 
Gani and Young have shown 33 that, in the camphanoyl amide of 
-alanine, the pro-it hydrogen adjacent to the amide occurred at 
higher chemical shift than the pro-S hydrogen. Brown and Parker, in 
a study of stereospecific deuteration35 , found that the S-methyl 
mandelate esters of L-deuterated carboxylic acids showed chiral 
distinction with the pro-R hydrogen at higher chemical shift than the 
pro-S. In the case of the methyl valine amide of 3-nitropropanoic 
acid the deuterium derived from pro-it deuterated L-aspartic acid 
occurs at a higher chemical shift than that from pro-S thus while 
retention is implied, it remains unproven. The retention of 
stereospecificity at C-3 of 3-nitropropanoic acid (1) mentioned above 
however, and the non-intermediacy of the acrylate implies retention 
of configuration at C-2. 
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In the time course experiment, deuterium incorporation from (25, 
3R)-[3-2 H]-L-aspartic acid (15) was observed after 72 and 96 hours 
(Figure 1.10). The corresponding methyl valine amide for 96 hours 
gave two peaks in the 2 H nmr which corresponded to the resonances of 
the products from pro-B deuterated and pro-S deuterated L-aspartic 
acid feedings. Since the "reductase" enzyme is known to be active at 
this time and not at 72 hours (vide infra) this suggests that 
post-biosynthetic randomisation of the stereochemistry at C-2 of 
3-nitropropanoic acid (1) is occurring. There are two possible 
explanations for this observation. In the conversion to 
3-nitroacrylic acid (6), one hydrogen is lost. If the loss is 
stereospecific then this hydrogen must be the pro-B hydrogen from 
L-aspartic acid (such a stereospecific loss may be due to an isotope 
effect). The addition of hydride from NADPH, to form 
3-nitropropanoic acid (1) occurs with inversion of configuration so 
the pro-R derived site is now deuterated. This will lead to a 
population of pro-B and pro-S deuterated 3-nitropropanoic acids (1) 
and hence two peaks in the methyl valine amides. A second 
possibility is that the hydrogen loss and subsequent gain is a 
completely random process which leads to a population of pro-R and 
pro-S deuterated 3-nitropropanoic acids (1) of approximately equal 
amounts. However, the nmr suggests that more of the pro-R derived 
deuterium is present than the pro-S and this implies that 
randomisation does not occur and consequently that inversion is the 
preferred mechanism. 
The carboxyl resonance in the ' 3 C mar spectrum of 3-nitropropanoic 
acid (1) derived from feeding DL- [4 ---13 C, 3- 
2 112 1-aspartic acid (18) 
has already been shown to be shifted by 0.009 ppm - indicative of a 
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single deuterium loss. This implies that if any (1-' 3 C, 
2- 2  H 2  1-3-nitropropanoic acid is present, then it is in insufficient 
amounts to be detected by the 0-isotopic shift effect on C-i. The 
FAD ins of the isolated 3-nitropropanoic acid (1) shows significant 
ions at iiv'z 118, 119, 120, 121 and 122. Non-labelled 
3-nitropropanoic acid (1) gives ions at.Wz 118, 119 and 120 due to 
M-1, M and Mi-i respectively. The relative ratios are as shown in 
Table 1.2. From the intensities of the ions in the reference 
spectrum, it is possible to determine the contribution of each of the 
labelled 3-nitropropanoic acids to each of the ions observed. These 
results are detailed in Table 1.2. .A small contribution due to 
E1_13 C, 2- H2 1-3-nitropropanoic acid is apparent. 
Table 1.2 FABms of 3-nitropropanoic acid (1) and 3-nitropropanoic 
acid from (4-' 3 C, 3-2 H2 ]-L-aspartic acid feeding. 
Label in (1) 	 ion (nVz) 
118 	119 	120 	121 	122 
EM-i] 13 	2 CO3 H0 	33254 
EM) ' 3 CO3 2 H0 	 8812 
EM-i-li 13 CO3 ii 	 546 
EM-i] 13 CO3 2 H 	 7038 
[M] 13 CO3 2 H0 	 145 
[ni-i] 13 CO3 2 H0 	 9 
13 	2 En-li C, H1 	 359 
EM] ' 3 C, 2 H1 	 9.5 
EM+ii '3C, 2ii 
EN-li '3C, 2  H 2 	 457 
EM] 
13 C, 2  H 2 	 121 
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1.5.5 Conclusions 
It has been shown that feeding L-aspartic acid (2) containing 
deuterium in either the pro-R or pro-S positions at C-3 leads to 
stereospecific incorporation at C-2 of 3-nitropropanoic acid (1). 
The experiment with perdeuterated L-aspartic acid, where both 2 
pro-it and 2 pro-S deuterons appear in the product effectively 
precludes the possibility that an acrylate intermediate is involved 
since, in this case, the àverall reaction would be required to be 
non-stereospecific and this is at variance with the results from the 
stereospecifically labelled aspartic acid experiments. This implies 
that a saturated intermediate is involved. The most plausible 
mechanism would involve complete oxidation of the amino functionality 
of L-aspartic acid (2) followed by decarboxylation with retention of 
configuration at C-2 of the resulting 3-nitropropanoic acid (1). 
The occurrence of an ion in the FAB ins of 3-nitropropanoic acid (1) 
derived from feeding [4_13  C, 3_2  H2 ]-DL-aspartic acid which contains a 
' 3 C label and two deuterium atoms is further confirmation of the 
pathway. This result implies that L-aspartic acid (2) is 
incorporated into 3-nitropropanoic acid (1) with retention of the C-H 
bonds at C-3 of L-aspartic acid (C-2 of 3-nitropropanoic acid). 
I 	Subsequent loss of deuterium may occur as a result of 
post-biosynthetic cycling (vide infra) which produces [1-'3C, 2_ 2  Hi
and [l-' 3.C, 2-2 H0 1-3-nitropropanoic acid. This implies that the 
post-biosynthetic cycling does not occur with retention of 
configuration and that either inversion or scrambling occurs with 
ultimately, complete loss of deuterium from 3-nitropropanoic acid 
(1). 
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while an isotope effect cannot be excluded, the inequality of the 
peaks in the perdeuterated L-aspartic acid (2) feeding would imply 
that, in an isotopically identical situation, there is a degree of 
specificity exhibited in the post biosynthetic cycling with the pro-it 
deuterium lost preferentially. 
Finally, the isolation of 3-nitropropanoic acid (1) from cultures of 
P. atrovenetum at different times after innoculation and feeding with 
(2S, 3R)-[3-2 H]--L-aspartic acid (15) and the examination of the 
corresponding methyl valine amides sheds light upon the 
stereochemistry of the proposed post-biosynthetic cycling of 
3-nitropropanoic acid (1) with the 3-nitroacrylic acid (6). When 
isolated soon after feeding the 3-nitropropanoic acid (1) contains 
deuterium stereospecifically at C-2. When 3-nitropropanoic acid (1) 
is isolated 96 hours after incubation then two peaks are observed in 
the 2 H nmr spectrum of the methyl valine amides corresponding to 
deuteration at the pro-R and the pro-S positions. This suggests that 
"reductase" activity is not present early in the growth cycle of P. 
atrovenetum and the enzyme is only formed late in the growth cycle. 
Furthermore, either the post-biosynthetic cycling randomises the 
label or that inversion occurs during the cycling. If the latter is 
the case then the pro-R hydrogen from L-aspartic acid is retained 
during hydrogen loss. These results are summarised in figure 1.11. 
The greater peak size of the pro-it derived resonance implies that 
scrambling (which could only produce, at best, a 50:50 mixture) 
cannot be occurring and that inversion is the likely mechanism. 
-47- 
1.6 Post-biosynthetic cycling 
Post-biosynthetic cycling of 3-nitropropanoic acid (1) via the 
acrylate (6) will necessarily result in loss of hydrogen at C-2 and 
C-3. The earlier evidence for the incorporation of 3-nitroacrylic 
acid (6) suggests that a concerted pathway with loss of H from C-3 
may be involved in the decarboxylation of L-asparatic acid (2) to 
give 3-nitropropanoic acid (1). An alternative, suggested by the 
incorporation experiments from stereospecifically deuterated 
L-aspartic acid, is that (1) and (6) are in post-biosynthetic 
equilibrium in the cell. 
The occurrence of (l-' 3 C, 2-2 H1-3-nitropropanoic acid in the presence 
of normally biosynthesised 3-nitropropanoic acid (1) can be 
determined by the secondary isotope effect induced in the C-i niur 
signal of the carboxyl by deuterium labelling 3 bonds away 42 . 
1.6.1 Synthesis and feedin 
The synthesis of [1-' 3 C, 2-2 H2 1-3-nitropropanoic acid (7) was carried 
out by insertion of the 13 C label fairly early in the synthetic 
sequence. While such methods are generally, not preferred, attempts 
to insert a label at a later stage were unsuccessful. 
Tosylation of 2-nitroethanol was carried out successfully in 
tetrahydrofuran/triethylamine to give the tosyl derivative (21) after 
an initial failure using pyridine as solvent. It was found, however, 
that substitution of the tosyl group by cyanide in dimethyl formamide 
and 18-crown-6 was only accomplished in low yield (<10%) and this was 
unacceptable. The substitution reaction failed completely in 
dimethyl sulphoxide45 both - at room temperature and at 110 ° C. Direct 
preparation of 3-nitropropionitrile from 2-nitroethanol using 
triphenylphosphine, potassium cyanide and a phase transfer catalyst 46 
was also unsuccessful. 
A second approach to the synthesis was made via 
1-(N,N-dimethyl)-amino--2-nitroethene (22). The enamine (22) was 
readily formed by reaction of nitromethane with dimethylformamide 
dimethylacetal in dimethylfonuamide. Attempts to add 
iodoacetonitrile 47 or bromoacetic acid to nitromethane in a 
base-mediated condensation gave only starting material. 
Hydrolysis of 3-bromopropionitrile (8) with hydrochloric acid gave 
3-bromopropanoic acid (9) which was isolated in good yield. This 
compound could, in turn, be nitrated with sodium nitrite in 
dimethylsulphoxide to give (1) in about 50% yield. The conditions 
and time for the nitration had to'be carefully controlled, stirring 
at room temperature for 2 hours being found to produce the optimum 
yields. Longer periods of time or higher temperatures gave mixtures 
of products. These reactions were repeated with the incorporation of 
a deuterium label at C-3. 3-Bromopropionitrile (8) was hydrolysed 
with deuterium bromide to afford the corresponding acid which was 
then treated with sodium nitrite in dimethylsulphoxide as described 
above to afford the deuterated 3-nitropropanoic acid (10). This 
material was taken up in aqueous sodium carbonate buffer (pH 10) and 
stirred at room temperature overnight in order to exchange any 
deuterium incorporated at C-3 of the final product. Examination by 
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nmr and mass spectrometry showed that only C-2 was deuterated. The 
'H nmr spectrum showed a small triplet at 4.45 ppm and a large 
singlet corresponding to hydrogens at C-3 whilst the resonance for 
those at 0-2 was a small triplet at 2.65 ppm whose integral suggested 
90% deuteration. It should be noted, however, that although fast 
atom bombardment ( FAa) mass spectrometry with a glycerol matrix gives 
a peak due to [2-2 H2 ]-3-nitropropanoic acid (10) initially, (121, Ff) 
the deuterium atoms gradually exchange with hydrogen atoms in the 
glycerol while the sample is on the probe (nvz 119, if). After a 
period of 30 minutes, virtually no deuterium is left in the sample. 
Since 3-bromopropionitrile (8) could be effectively converted to 
[2-2 H2 ]-3-nitropropanoic acid (10) by this route, the remaining 
problem was the preparation of [1- 13 C]-3--bromopropionitrile. 
Reaction of dibromoethane with sodium cyanide in dimethylsuiphoxide 
gave the dinitrile rather than the mononitrile under a range of 
conditions. 
An alternative method which retained the strategy of nitration as the 
final step in the synthetic procedure was the hydrolysis of 
3-hydroxypropionitrile (11) with deuterium bromide giving deuterated 
3-bromopropanoic acid (9) which could be nitrated as outlined 
previously. 3-Hydroxypropionitrile (11) was prepared from sodium 
cyanide and 2-chloroethanol. This reaction was most successful 
(>60%) in the presence of phase transfer catalyst (18-crown-6) and 
at 80-90° ' ° . Heating of the product with hydrobromic acid 
afforded 3-bromopropanoic acid (9) in reasonable yield. This 
reaction sequence was carried out using [' 3 C] sodium cyanide to give 
[ 1-13 c1 -3-hydroxypropionitrile (24) which was refluxed with deuterium 
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bromide to give [1-' 3 C, 2-2 H2 1-3-bromopropanoic acid (12). Nitration 
with sodium nitrite afforded E1-' 3 C, 2-2 H2 1-3-nitropropanoic acid (7) 
(Figure 1.12). The ' 3 C and deuterium incorporation was verified by 
mass spectrometry (nvz 122,r(, 121,M-F). 
P. atrovenetum (ATCC 13351) was assayed for "reductase" activity at 
various times after inoculation as described by Shaw" . Activity was 
found to be present in mycelium harvested between 96 and 120 hours. 
Dark grown mycelium and cultures grown in shake flasks did not 
contain any active enzyme. - It has subsequently been noted" that 
cultures of P. atroventum secrete an enzyme capable of oxidising 
3-nitropropanoic acid (1) to 3-carboxyacetiijy6'i\ The mechanism 
proposed for this oxidation involves isomerisation to the aci-nitro 
compound and such a transformation is clearly not possible with 
3-nitroacrylic acid (6). 
[1- C, 2_2  H2 1-3-Nitropropanoic acid (7) was fed to growing cultures 
of P. atrovenetum 24 hours after innoculation and incubation 
continued for a further 76 hours. 3-Nitropropanoic acid (1) was 
isolated and the product analysed by 13 C nmr. 
1.6.2. Results 
The ' 3 C nmr of the isolated 3-nitropropanoic acid (1) gave two 
resonances due to the -,ca rboxyl group with a difference of 0.0123 ppm 
(Fig 1.13(a)). The sample was spiked with synthetic [l-' 3 C, 2-2 H2 ] - 
3-nitropropanoic acid (7). In this case, the carboxyl resonance in 
the 13 C nmr spectrum consisted of three components with chemical 
shift differences of 0.012 and 0.016ppm (Fig 1.13(b)). 
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The FAB mass spectrum of the isolated 3-nitropropanoic acid (1) shows 
peaks at nvz 119 (Mi and 118[i4-1[ and 121 and 120. The latter two 
are due to (N- I and [N-lr ions of singly deuterated, ' 3 C-labelled 
3-nitropropanoic acid (1). There is also a very small peak at nVz 
122 which corresponds to the uncycled dideuterated compound (Fig. 
1.14) at ca. 5% over background. 
1.6.3 conclusions 
The ' 3 c nmr spectrum of the carboxyl resonance of the isolated 
3-nitropropanoic acid indicates a mixture of C-2 monodeuterated and 
non-deuterated material. This implies that at least one deuterium is 
lost from the C-2 position of the fed metabolite. The nmr and ins 
data from this experiment implies that (1) and (6) are rapidly 
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1.7 3-Nitroacrylic acid reductase 
while in the above experiments post-biosynthetic cycling of 
3-nitropropanoic acid (1) and 3-nitroacrylic acid (6) appears to 
occur the reaction has been claimed by thaw to be non-reversible 24 
when isolated enzyme is used. It was therefore important to prepare 
3-nitroacrylic acid (6) and to incubate this material with the 
isolated enzyme in deuterated water in order to determine if any 
specificity is inherent in the reaction. Also in view of the in vivo 
result the claimed irreversibility of the reaction in vitro was also 
worth reinvestigation. 
1.7.1 Synthesis, enzyme isolation and results 
3-Nitroacrylic acid (6) was synthesised as described by Shaw" and 
the purified product stored under nitrogen at 0 ° C until required. 
The reductase enzyme was isolated and assayed according to the 
procedure outlined by Shaw24 . A time course study of the fungi 
showed that the reductase was present between 84 and 110 hours after 
inoculation. The crude ammonium sulphate-precipated enzyme (40%-65% 
saturation) was used since attempts to purify the enzyme further 
using DEAE Sephadex resulted in loss of activity. 
The enzyme was incubated with the acrylate (6) and NADPH at pH 7.3 
over a period of 2 hours and monitored spectrophotometrically at 231 
24 	Examination of the product isolated by ether extraction after nm 
this time showed it to be identical with an authentic sample of 
3-nitropropanoic acid (1). When the incubation was carried out in 
deuterated water, deuterium incorporation was detected only at C-3 as 
assessed by 'H and 2 }T nmr. (4.76 ppm,CHDN02). 
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In agreement with Shaw's results incubation of 3-nitropropanoic acid 
with the crude enzyme preparation in deuterated water and NAt) or NADP 
failed to show any incorporation of deuterium. This result is 
summarised in Figure 1.15. 
1.7.2 conclusions 
The results described above confirm that, tinder a range of 
conditions, the reaction catalysed by "3-nitroacrylic acid reductase" 
is irreversible in vitro. Furthermore, it appears that hydrogen 
incorporation at C-2 and C-3 occurs regiospecifically with the former 
presumably derived from NN)Pn and the latter from the water (Fig 
1.16). There is, however, no information about the stereospecificity 
of the addition in this experiment. The regiospecificity of the 
reaction implies that the enzyme is not succinate dehydrogenase and 
this confirms the study by Shaw 24 in which succinic acid was found 
not to be a substrate. A likely mechanism would involve abstraction 
of a proton from the medium at C-3 followed by hydride attack from 
NADPH at C-2 or, possibly, if attack in a Michael fashion at C-2 
follbwed by If quenching of the intermediate stabilised carbanion. 
1.8 3-Nitropropanoic acid biosynthesis - conclusions 
This study has demonstrated that 3-nitrosuccinic acid (5) is an 
intermediate in the biosynthesis of 3-nitropropanoic acid (1) from 
L-aspartic acid (2). A range of biosynthetic pathways which require 
a dehydroamino acid intermediate are thereby eliminated. The first 
step in the biosynthesis has been shown to be oxidation of the amine 
functionality (possibly via N-hydroxy-L-aspartic acid) to give 
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3-nitrosuccinic acid (5) with retention of stereochemistry followed 
by decarboxylation. Retention of a single deuterium in 
3-nitropropanoic acid (1) from administration of f 
3_2 H2 ]-L.-aspartic acid (18) initially suggests that loss of the 
carboxyl group is a concerted process with loss of H from C-3. 
Further investigation by ins however suggests that a non-acrylate 
pathway is operating. 
Feeding of deuterated L-aspartic acids (14,15,19) has shown that an 
unsaturated acrylate cannot be a biosynthetic intermediate. 
Deute ration of both the pro-R and the pro-S hydrogens at C-3 
independently in L-aspartic acid gives 3-nitropropanoic acid (1) 
stereospecifically labelled at C-2 thus implying that, if 
desaturation/resaturation is part of the pathway then the process 
must be stereospecific. This result is precisely opposed to the 
observation that, on feeding perdeuterated L-aspartic acid (19), the 
label at C-2 of 3-nitropropanoic acid (1) is present in both the 
pro-R and the pro-S positions thus implying scrambling of the label 
in a desaturation/resaturation process. It is clear from these 
results, therefore, that 3-nitroacrylic acid (6) cannot be a 
biosynthetic intermediate and is thus involved only in post 
biosynthetic cycling. 
An indirect confirmation comes from a time course feeding of (2S,3R) 
- E3_2H] - aspartic acid (15). When 3-nitropropanoic acid (1) is 	 2 
isolated from the culture before it has begun to produce the 
"reductase" (72 hours), the deuterium is located stereospecifically 
at C-2. Investigation of the metabolite produced after feeding (25, 
2 3R)-[3-H1-L-aspartic acid (15) to a culture which is producing 
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reductase (96 hours) shows deuterium incorporation at both the pro-R 
and pro-S positions at C-2 implying post-biosynthetic cycling and 
scrambling of the label at C-2. This may result if the 
post-biosynthetic cycling is a non-stereospecific process or if it 
occurs with inversion. 
while conclusive proof of retention of stereochemistry in the 
conversion of L.-aspartic acid (2) into 3-nitropropanoic acid (1) has 
not been presented, clearly the process is stereospecific and occurs 
via 3-nitrosuccinic acid (7) in which stereochemistry is retained. 
Studies on other systems by Gani and young  33 and Brown and Parker 35 
suggest by comparison of 2 H nmr data that the overall process may 
involve retention of configuration at C-2. 
In the post-biosynthetic cycling with 2 pro-R deuterated material the 
2-pro-R hydrogen from 3-nitropropanoic acid (1) appears to be lost 
preferentially. The 3-nitropropanoic acid (1) isolated after cycling 
has occurred has deuterium in both the 2 pro-R and 2 pro-S positions 
suggesting that inversion or scrambling has occurred. Random 
scrambling of the label would give, at best, a 50:50 mixture of 2 
pro-R and 2 pro-S deuterated material and the 2 pro-S deuterated 
material could never predominate. Since the 2  H nmr spectrum of the 
methyl valine amides shows that the 2 pro-S deuterium species 
predominates then the cycling must occur with inversion. The same 
effect could occur, however, as a result of an isotope effect with 
the C-2 H bond preferentially retained. This would still only result 
in, at best, a 50:50 mixture of the R and S deuterated acid. 
ago 
1.9 Future work 
While these results have served to delineate a substantial amount of 
detail about the biosynthesis of 3-nitropropanoic acid (1) from 
L-aspartic acid (2), a number of factors remain to be investigated. 
While conservation of stereochemistry rather than inversion seems 
likely, this remains to be proven conclusively. Oxidation of 
stereochemically deuterated -alanines of known conformation may 
provide a means of confirming the stereochemistry of the product. 
Administering [1-' 3 C, 2-2 H2 1-3-nitropropanoic acid to the culture and 
isolation of [1- 13 C, 2_2H  1-3-nitropropanoic acid suggests that 
3-nitropropanoic acid (1) and 3-nitroacrylic acid (7) are cycled in 
vivo. The isolated reductase enzyme shows specificity in its 
catalytic activity but the stereochemistry of the process is unclear. 
The stereochemistry of the cycling process can be investigated by 
feeding 3 pro-S deuterated L-aspartic acid in a time course 
experiment and determining the stereochemistry at C-2 of 
3-nitropropanoic acid (1) after cycling. If scrambling is occurring 
then both pro-R and pro-S hydrogens will be labelled while if 
inversion occurs then only the original uncycled material will 
contain deuterium. This will also serve to confirm any putative 
isotope effect in the recycling process. The second half of the 
cycling process can be investigated in vitro by incubating the 
reductase enzyme with 3-nitroacrylic acid (6) and NPDP2 H and finding 
if the isolated 3-nitropropanoic acid (1) is stereochemically 
deuterated at C-2 by preparation of the corresponding methyl valine 
amides as before. 
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The nature of any other intermediates remains unclear. While 
acrylate-type compounds have been eliminated N-hydroxy--t.-aspartic 
acid remains a potential biosynthetic precursor. The instability of 
this compound militates against synthesis and feeding as a means of 
determining if it is an intermediate in the biosynthetic pathway 






The biosynthesis and physiological role of thiamine (30 ), has been 
extensively studied and reviewed5052 ; Thiamine (30) was isolated in 
1926 from 100 kilograms of rice bran and subsequently 
synthesised54 ' 55 . It exists in vivo largely as its diphosphate (3l)(Figj.2) 
(thiamine pyrophosphate, cocarboxylase) in which form it is the 
cofactor for decarboxylation of pyruvic acid 56 . In addition, in 
animal tissue, small amounts of free thiamine, thiamine monophosphate 
and thiamine triphosphate are also found 5 ' - 
2.1.1. Chemistry and Physiology 
The chemistry and physiology of thiamine (30) have been extensively 
studied 5052 ' 57 , indeed early work on this vitamin was based upon 
isolation of an anti-beriberi factor from rice. tJgai demonstrated 
that benzoin formation from benzaldehyde can be catalysed by 
thiamine 58 ' 59 (30) and subsequent studies showed that it could 
catalyse the decarboxylation of pyruvate non-enzyrnically. 
Thiamine pyrophosphate (31) can carry out three types of reaction, 
non-oxidative decarboxylation of a-keto acids, oxidative 
decarboxylation of ct-keto acids and formation of u-ketols (acyloins). 
The mechanism of the reactions of thiamine (30) is a consequence of 
the characteristics of the two ring systems and, in particular, the 
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thiazole ring. Initik progress in this area resulted from Breslow's 
Fig. 2M 
discovery" that H-2/6f Ehe thiazolium ring would readily exchange 
into deuterium in deuterated water. This suggests that the reactivity 
of thiamine (30) occurs as a result of reaction at a c-2 car banioñ 
The mechanism shown in Fig 2.1 was postulated 1 . This was 
subsequently substantiated by the observation that several 
2ct-hydroxyalkylthiainine pyrophosphates function, as expected, as 
intermediates when added to suitable enzyme preparations62 ,63• 
The mechanism of nucleophilic substitution on thiamine (30) has been 
extensively studied - in particular the reaction with aqueous 
sulphite ion64 . Thiamine (30) also reacts readily with nucleophiles 
such as aniline in the presence of an enzyme, thiaxninase I to give 
66 
the pyrimidyl aniline analogue 
65, 	(32). An analogous mechanism to 
that proposed for bisuiphite cleavage of thiamine has been suggested, 
viz. nucleophilic addition across the 1,6 bond of the pyrimi.dine ring 
creating a dihydropyrimidine intermediate which can then be 
substituted at the benzylic methylene with elimination of the 
thiazole followed by addition of bisulphite (or some other 
nucleophile) and reversal of the 1,6 addition giving a substituted 
pyrimidine (Figure 2.2). Hutter and Slama 67 have recently tested 
this mechanism by preparing a -chloropyrimidine which, they 
postulate, forms an enzyme-substrate complex then eliminates chloride 
thus remaining irreversibly bound to the enzyme as an inhibitor of 
activity. It appears, therefore, that thiaminase 1 reacts with 
thiamine after first forming a 1,6-pyrimidyl enzyme intermediate 
rather than any other mechanism which would have a strict requirement 
for the 4-amino functionality in the ring68 or may lead to hydrogen 
exchange at the benzylic methylene. The importance of this 
observation will be discussed in greater detail below. 
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The biosynthesis of thiamine (30) has been the subject of significant 
scientific endeavour since its discovery and structural elucidation. 
Work has been reviewed frequently with reviews by Brown and 
Williamson", Leder5 ' and Young 52 being the most recent. This 
present work is concerned with the biosynthesis of the pyrimidine 
ring of thiamine (30) in yeast (Saccharcmyces cerevisiae) therefore 
studies carried out in prokaryotes (in particular, Escherichia coli) 
will be referred to only briefly and where they shed light or provide 
contrast to the biosynthesis in yeast. The biosynthesis of the 
thiazole moiety in yeast will be dealt with since it has some bearing 
on studies of the pyrimidine pathway. 
In the thiazole ring in prokaryotes, the nitrogen atom and the 
adjacent carbon are derived from tyrosine 69,70  with the remaining 
five carbon unit coming from pyruvate" and a triose 72 . The sulphur 
atom comes from cysteine 73 ' 74 . In eukaryotes, the thiazole ring is 
derived from glycine and a 2-pentulose 75 (Figure 2.3). As a result 
of labelled glycerol and glucose feeding experiments, White and 
Spenser 75  proposed that incorporation could occur by the oxidative 
pentose phosphate pathway via D-ribulose-5-phosphate or by the 
non-oxidative pentose phosphate pathway by way of 
xylulose-5-phosphate. The proportions of the label from specifically 
labelled glucose found in the product thiazole are dependent upon 
which of the two pathways predominate. This result is relevant to 
their later studies on the biosynthesis of the pyrimidine ring of 
thiamine. 
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In the biosynthesis of the pyrimi.dine moiety, a different set of 
precursors 1i: involved in prokaryotes as compared with eukaryotes. 
In procarytes, the pyrimidine moiety and purines share a common 
biosynthetic precursor i.e. 5 1 -aminoimidazoleribonucleotide (5'-AIR). 
Formate is therefore incorporated into C-2 of the ring. 
In yeast, however, incorporation of formate is at C-4 although a 
minor pathway has been suggested which involves C-2 incorporation' 6. 
In a detailed study of the yeast pathway by Grue Sorensen et al. 
which made use of specifically [ ' 4 C]-labelled glucose, glycerol and 
formate the biosynthetic pathway shown in fig 2.4 was elucidated 7 6 . 
Two different routes were postulated to operate - one in which C-4 is 
formate derived, C-2 is from C-2 or 0-3 of glucose, C-V is from C-i 
or 0-2 of glucose and C-S' is derived from 0-6 of glucose. The 
proportions of C-i and C-2 incorporated and the site of incorporation 
are dependent upon the relative proportions of the oxidative and 
non-oxidative pathways which operate (as seen inthe thiazole 
experiments earlier) and convert glucose to either 
xylulose-6-phosphate or to ribulose-6-phosphate. These results were 
confirmed using labelled glycerol. In the minor pathway C-2 was 
derived from formate, C-2' was from some unknown source and C-4 and 
C-S derived from C-i or C-2 of glucose with the proportions dependent 
upon the oxidative and non-oxidative pathways as described above. 
All the other carbon atoms and the nitrogens in this pathway are from 
some unknown source. On the basis of these experiments, Grue 
Sorensen et al. 76 suggested that the biosynthetic breakdown of each 
pathway implicated similar intermediates. In each case a C 2 unit 
derived from C-i, C-2 of a pentose unit is linked, via the C-2 of the 
pentose, to two nitrogen atoms one of which, in turn, is attached to 
a formate-derived carbon atom (figure 2.5). 
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Both pathways may, therefore, have the same biosynthetic precursor 
unit. A 5-aminoimidazole unit was proposed as a possible precursor 
which could be cleaved in either of two ways in order to give the 
appropriate partial structure which could then be elaborated to give 
thiamine (30). Further work by the same group 77  on the biosynthesis 
of purines in yeast showed that purines and thiamine (30) do not 
share a common precursor. The carbon skeleton of the purines of 
Saccharomyces cerevisiae were shown to arise from bicarbonate, 
formate and glycine and therefore a common precursor does not exist 
for purines and the pyrimidine ring of thiamine in yeast. 
Other studies78 have shown that N-3 and N-4 in both yeast and E. coli 
are derived from glutamine. Tazuya et a1 79 have recently shown 
however that administered histidine dilutes the incorporation of 
[' 5 r4]-ammonium chloride in yeast. These workers suggested, 
analogously to the situation in prokaryotes, that an imidazole ring 
(that of histidine rather than 5'-AIR) may be a precursor of both 
carbon and nitrogen atoms of the pyrimidine moiety. 
It is clear, therefore, that many of the details of the biosynthesis 
of the pyrimidine moiety of thiamine (30) remain unknown and 
therefore warrant detailed investigation. It is clearly important to 
determine the nature of any intermediates which lie between the 
pentose unit and the pyrimidine ring. Since, in the major proposed 
pathway, C-4 is derived from formate, the amino functionality (C-4 1 ) 
could be introduced after or prior to pyrimidine ring formation. A 
putative precursor in the former case, analogous to the purine 
atnination pathway, would be the desamino pyrimidine. 
while such an investigation might be carried out using a 
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radiolabelled precursor, ease of handling and simplicity of assay 
would suggest that the corresponding deuterated or (' 3 C)-labelled 
compound may offer advantages. In order to make use of such a 
precursor it is important to determine if the product thiamine (30), 
which is produced in very small amounts, can be assayed accurately 
using mass spectrometric techniques. 
This study is, therefore, designed firstly to develop a reliable 
method for determining stable isotope incorporation from labelled 
precursors into the pyrimidine moiety of thiamine in Saccharomyces 
cerevisiae. The method developed necessarily requires that 
incorporation will be monitored by mass spectral examination of 
either the intact thiamine (using Fast Atom Bombardment - FAR) or of 
a suitable volatile derivative (using Electron Impact (El) or 
Chemical Ionisation (CI). 
The technique developed can then be applied to a study of the 
intermediacy of a 4-desandno pyrimidine in the biosynthesis. Initial 
results from Tazuya et al 78 suggest that glutamine is a precursor 
and, under these circumstances, amination could be a post-cyclisation 
event. If, on the other hand, the imidazole ring of histidine is a 
direct precursor", then the 4-amino functionality is likely to be 
present in this precursor and post-cyclisation amination will not 
occur. 
2.1.3. Analysis and mass spectrometry 
While administering stable isotope precursors combined with mass 
spectrometry of the biosynthetic product have a number of advantages 
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over radiolabelled investigations - direct analysis of the product 
with little modification necessary, simplicity of precursor synthesis 
and product isolation - a number of disadvantages are also inherent 
in the technique. The sensitivity of mass spectrometry is 
considerably less than that of radionucleotide detection. The 
molecule must be presented in a form suitable for analysis. While 
soft ionisation techniques such as Fast Atom Bombardment (FAR) have 
greatly increased the range of molecules which can be detected and 
successfully analysed by ms, a problem nonetheless remains in certain 
cases. It should be noted that, while pyridinium cations have been 
shown to be amenable to analysis by FAR ms 80 , thiamine itself has 
never been investigated using this technique. 
The detailed analysis of thiamine (30) derived from . a labelled 
precursor by mass spectrometry is, in principle, simpler than the 
complex degradation and assay procedures required by radioisotope 
incorporation experiments. It is necessary, however, to separate the 
desired compound from other components and, while protocols for 
dealing with very small amounts of thiamine (30) in, for example, 
foodstuffs exist, the final separation generally makes use of high 
performance liquid chromatography (hplc) 81 . The use of ms linked to 
hplc is still at a fairly primitive stage and, although it has 
tremendous potential for the detailed analysis of vitamins and other 
micronutrients82 , the method of choice is gas chromatography mass 
spectrometry (gc/ms). This technique requires that the thiamine (30) 
be presented in a volatile form. 
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2.2. Assay of tMamine 
2.2.1 Introduction 
Since most studies of the biosynthesis of thiamine (30) have made use 
of radioisotopes, the standard methods of cleavage adopted have 
concentrated upon separation of the individual carbon atoms. In a 
very few cases 1514  and 13 C labelling has been carried out and these 
have made use of suitable volatile thiol derivatives. In particular, 
de Moll and Shive°3 investigated the origin of the sulphur in the 
thiazole part of thiamine by gc/ms using E 34 S]-sulphate and 
L-[sulphane-34 S]-thiocystine as labelled, non-radioactive precursors. 
White used ' 3 C and 2  labelled sugars 71  and 1514  labelled L-tyrosine 
to investigate the biosynthesis of the thiazole ring which was 
cleaved from thiamine using bisuiphite then taken up in 
triflouroacetic anhydride/methylene chloride prior to g.c/ms 
analysis. While this cleavage gives a volatile thiazole derivative, 
the pyrimidine part of the molecule forms an involatile sulphonate 84 
which is clearly unsuitable for gc/ms analysis. 
Direct analysis of the pyrimidine part of thiamine has been carried 
out by reaction of thiamine in a sealed tube with a suitable 
alkylthiol85 ' 86 . Thiamine is particularly susceptible to 
nucleophilic attack with concomitant liberation of substituted 
pyrimidine, however the reaction with alkylthiols requires high 
temperature and pressure. An alternative hydrolysis reaction is 
catalysed by the enzyme, thiaminase I, (thiamine: base 
2-methyl-4-aminopyrintidine-5-metheny1 transferase E.C. 2.5.1 . 2)65 
66 ' 67 which has been isolated and characterised. 
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Our strategy was, therefore, to determine, firstly, if thiamine can 
be assayed directly by FAB ms. If this technique is unsuitable then 
ins linked to gc becomes the method of choice, for which a suitable 
volatile pyrimidine derivative would be required. 
2.2.2. Direct ma 
The analysis of thiamine (30) and thiamine pyrophosphate (31) was 
carried out using FAB-ms The samples were taken up in water and 
examined in a glycerol matrix under negative and positive ionisation 
conditions. In neither case could a molecular ion or the pyrimidine 
part of the molecule be detected under negative conditions. Under 
positive FAB, however, the molecular ion was seen for both compounds 
together with a fragment at 123 due to the pyrimidine part of the 
thiamine molecule. The fragmentation could be followed with peaks at 
110 and 93 corresponding to loss of CH  and NH 2 , however detailed 
fragmentation was lost in background. It would appear, therefore, 
that while direct analysis of thiamine (30) and thiamine 
pyrophosphate (31) is possible there are, nonetheless, difficulties 
in obtaining detailed spectra of the pyrimidine moiety in FAB mode. 
In addition, small levels of incorporation of isotopes would be very 
difficult to detect given the high level of background noise in the 
spectrum. 	 - 
Both thiamine (30) and thiamine pyrophosphate (31) can be detected by 
electron impact (El )ms This technique was used to elucidate the 
fragmentation pathway of thiamine using daughter ion analysis. This 
gave the breakdown pathway shown in fig 2.6. Of particular interest 
is the loss of CH3 CN from the substituted pyrimidine moiety. This 
-76- 
Mass spectral fragmentation of Thiamine (El) 
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can occur by one of two pathways as shown thus unambiguous assignment 
of all the fragments is not possible. The detection limit for 
thiamine and thiamine pyrophosphate by El-ms was rather poor with ca 
10 pg of material required in order to obtain a suitable spectrum. 
This is more than the total amount of thiamine produced in a 50 cm 3 . 
culture of Saccharomyces cerevisiae. In addition to minimise 
background interference, thiamine (30) has to be in a purified form 
for ins analysis. The best protocol involved thiamine (30) (or the 
pyrophosphate (31)) being absorbed onto an ion exchange column then 
eluted with aqueous buffers. A more efficient and effective strategy 
is based upon preparation of a suitably volatile thiamine (30) 
derivative which can then be examined directly by gc/ms 
2.2.3 Isolation and Cleavage of thiamine from yeast. 
Saccharomyces cerevisiae was grown on a supplemented vitamin-free 
medium as described in the experimental section and found, by hplc, 
to produce ca 2-3pg of thiamine (30) per 50cm 3 of culture after 24 
hours growth. Considerable losses were noted if purification by ion 
exchange was attempted. A protocol was developed for isolation of 
- 	thiamine (30) based upon methods of White and Spencer 
87  and is shown 
in scheme 2.1. Attempts to reproduce the work of White and others 8 ' 
in which thiamine (30) is cleaved with an alkylthiol then analysed 
directly by gc,kis were unsuccessful. Reaction of thiamine (30) with 
ethanethiol in a sealed tube at elevated temperature produced a range 
of volatile products in which the peaks due to the pyrimidine thiol 
(33), while discernible, were almost swamped by those of other 
compounds and fragments. Various conditions and thiols were 
attempted with little success. 
WAS 
Thiamine isolation from Saccharomyces cerevisiae 
2 xSOcm3  cultures of S.cerevisiae 
Repeat (xl) 




Supernatant 	 Yeast 
Freeze dry 
Add sodium acetate 
buffer (1cm 3, pH 6.5) 
Add taka diastase 
Incubate 30° overnight 
Thiamine extract () 
Scheme 2.1 
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The breakdown of thiamine (30) can be catalysed by the addition of 
sodium metabisulphite 84 . In a model reaction 0.1 mole equivalent of 
sodium metabisulphite was reacted with thiamine (30) and aniline in 
60% aqueous ethanol and the mixture heated under reflux. The 
isolated product was found, from ms, to be the required aniline 
pyrimidine compound 88 (fig. 2.7). The gc/ms characteristics of the 
compound were investigated and conditions developed under which it 
could be purified and analysed (see experimental section). The 
thiamine extract from yeast in 60% aqueous ethanol was treated with 
0.2 pg of sodium metabisulphite and excess aniline then heated as 
described previously. A control experiment was also carried out in 
which a similar sample of pure thiamine was treated in an identical 
manner to the yeast-derived sample. In neither case was any material 
corresponding to the aniline derivative (32) detected by ins 
Repetition of the experiment under a range of conditions (different 
incubation times, temperatures, sealed tube reactions) also failed to 
give any of the required compound. The difficulties apparent in this 
approach led to consideration of an alternative procedure based on 
the enzymatic hydrolysis of thiamine. 
Thiaminase I was isolated from Bacillus thiaminolyticus as described 
by Wittliff and Airth66  . The bacterlumwas grown on nutrient agar 
slants and then transferred to nutrient broth and grown in shake 
flasks for 20 hours. An aliquot was then transferred to the defined 
medium of Douthit and A1rth89 and shaken for a further 20 hours. The 
enzyme activity was assayed by monitoring production of the aniline 
derivative (32) spectrophotometrically89 as described below. 
Initially the enzyme was active against both thiamine (30) and 
thiamine pyrophosphate (31), however, the activity against the latter 
5:115 
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substrate was found to diminish fairly rapidly with storage at -25° 
in buffer (Table 2.1). Activity diminished even more rapidly when 
the enzyme was stored at 0 0 thus the loss in activity was not solely 
a result of the freezing of the protein. The crude enzyme mixture 
may contain a labile pyrophosphatase as well as thiaminase I. 
Alternately thiaminase I may exist in two forms; the more stable of 
which uses thiamine (30) as substrate while the less stable can also 
(or only) cleave the pyrophosphate (31). 
Thiamine pyrophosphate (31) present was hydrolysed prior to 
incubation, incubations were monitored spectrophotometrically, and 
enzyme was discarded after one month and fresh stocks reisolated. 
The purification procedure developed included dialysis of the 
ammonium sulphate precipitated protein at 0 0 overnight. This led to 
a large variation in the activity of the freshly isolated protein. 
Attempts to purify the enzyme by Sephadex column chromatography as 
described by Wittliff and Airth66 gave only inactive fractions. The 
crude precipitated protein was therefore desalted by concentration in 
an Zmicon filter then made up to the original volume with distilled 
water. This procedure minimised the amount of time the enzyme was 
held at 00 and gave enzyme of consistently higher activity than that 
obtained after dialysis. These findings confirm those of Hutter and 
Slama6 ' who also found prolonged exposure to dialysis conditions led 
to enzyme inactivation. 
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Table 2.1 Activity of thiajuinase I with thiamine and thiamine 
pyrophosphate as substrates. 
Activity* 










* Activity at id taken as 1.00. 
Crude thiamine isolate was incubated with thiaminase I and aniline 
and the formation of the pyrimidine aniline product monitored 
spectrop4otometrically66 . The aniline-pyrimidine adduct (32) was 
extracted into ethyl acetate. Drying the ethyl acetate extract with 
magnesium sulphate led to complete loss of the pyrimidine/aniline 
compound (32) therefore sodium sulphate was used, the solution 
filtered and the filtrate concentrated by removing the ethyl acetate 
in a stream of nitrogen. The residue was taken up in 20pl of ethyl 
acetate and half of the volume applied to the gc/ms. Direct injection 
into the ms spectrometer gave El spectra corresponding to the 
pyrimidine moiety and the thiazole ring, however when a BP-5 packed 
column was used, the pyrimidine/aniline compound appeared to be 
preferentially adsorbed. Capillary column gc4ns enabled the required 
product to be separated. when the incubation was repeated using 
similar amounts of pure thiamine (30) under identical conditions the 
same gc/ms profile was observed. The isolation and analysis protocol 
outlined in scheme 2.2 was therefore adopted. 
Isolation of the pyrimidine- aniline adduct of thiamine 
Thiamine extract 0 	- 
Boil 10mm 
Adjust to pH 51 
Add thiaminase I 
Add aniline (14p1) 
Incubate overnight 
Pyrimidine -aniline adduct © 
, j  Acidify. extract with ether Repeat (x2) 
Ethereal extract 	 Aqueous extract 4 t with  
Ethylacetate extract 	 Aqueous extract 
Dry (Na2SO4) 
• 	 • 	 - Evaporate in stream of N. 
Take up in 20p1 ethyl acetate 
Product for gc./m.s. 
Scheme 2.2 
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2.3 Biosynthetic studies 
2.3.1 Introduction 
Having developed a method for the analysis of microgram amounts of 
thiamine from S. cerevisiae, the biosynthesis of the pyridimine 
moiety could then be studied. The stage in the biosynthesis at which 
aiuination at C-4 occurs was investigated by preparation and 
administration of normal and deuterated 2-methyl-4-hydroxy-
5-hydroxymethyl pyrimidine (34). This compound was chosen by analogy 
with the purine biosynthetic pathway where inosine monophosphate is 
aminated to give adenosine monophosphate or via xanthosine 
monophosphate to give guanosine monophosphate 90 . In both cases, a 
hydroxyl functionality is present at the point of amination. The 
question being addressed, therefore, is whether a cyclised pyrimidine 
(analogous to inosine monophosphate) is aminated or if the amine 
functionality is present prior to cyclisation as is the case for the 
pyrimidine moiety in prokaryotes. 
The synthesis and incorporation of normal (35) and deuterated 
2-methyl-4-amino- 5-hydroxymethyl pyrimidine (36) must be carried out 
in order that it may be used as a standard. If the deuterated amino 
compound (36) - which is a known precursor - is not incorporated to 
an extent sufficient to permit examination by ms then there would be 
little point in attempting to study the incorporation of the 
_- 
BJ-2--methy1-4-hydroxy-5-hydroxymethylpyriipjdijj( 34). If this 
were the case, the corresponding ' 4 C or tritiated compound would have 
to be used. 
The most convenient position to incorporate a label was considered to 
be at C-5' by preparation of a suitable derivative which could be 
reduced using a deuterated reducing agent such as sodium 
borodeuteride or lithium aluminium deuteride. 
The chemistry of 4-hydroxypyrimidines has been extensively 
reviewed91 . They can exist in a keto or an enol form (lactinvlactam 
isomerisation) and this clearly has a significant effect on the 
chemistry both of the ring itself and on any substituents attached to 
i 92 t . In normal pyrimidines, the 2, 4 and 6 positions of the ring 
are electron deficient. Substitution with any group which is 
electron releasing (eg. hydroxyl) will give the pyrimidine a more 
aromatic character. The chemistry of 2, 4 and 6 hydroxylated 
pyrimidines is similar giving, for example, principally N-substituted 
products in alkylation reactions. This is a direct consequence of 
keto-enol tautomerism and the favouring of the keto form. In 
addition, it has been reported that 4-hydroxypyrimidines'; can 
associate in solution because of hydrogen bonding 93 and this may have 
an effect upon reactions at the 5-position. 
2.3.2 Synthesis of 2-methyl-4-amino-5-hydroxyiuethy1 pyrimidine 
Acetamidine hydrochloride was treated with sodium ethoxide to 
generate the free base then reacted with ethoxymethylene 
malonitrile94 (38) to afford immediately 2-methyl-4-aminopyrimidine-
5-carbonitrile (39) as a dense precipitate which was recrystallised 
from ethanol. This product was converted to the corresponding 
aldehyde (40) by treatment with Raney nickel in formic acid". The 
aldehyde had identical tic characteristics to the nitrile in 
chlorofonty'methanol (4:1) but was identified on tic by spraying with 
MM 
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Z4_dinitropheny1hydiaihe. The crude aldehyde was reduced using 
sodium borohydride to afford the corresponding 5-hydroxymethyl 
compound (35) which was characterised by nnir and ins. The aldehyde 
could also be reduced with sodium borodeuteride to afford the 
monodeuterated product (36) (scheme 2.3). The extent of deuteration 
was determined by 'H nmr spectroscopy and found to be ca 90% single 
deuteration at the C-S" position. 
2.3.3 Synthesis of 2-methyl-4-hydroxy-5-hydroxymethyl pyrimidine (34) 
The first attempt to prepare deuterated 2-methyl-4-hydroxy. 
'LroEethyfpyrinndinè' (37) made use of the corresponding 
5-ethyl ester (41) which can be - prepared easily from acetarnidine and 
thethylethoxymethyfénemáläfe 6 This gave 
(41) in reasonable 
yield. Attempts to reduce the ester using sodium borohydride under a 
variety of conditions (eg. with polyethylene glyco1 97 , with methanol 
and tert-butanol98 , with excess borohydride99 , in the presence of 
calcium chloride' 00 , diglyme with lithium bromide' ° ') gave only 
starting material. Direct reduction with lithium aluminium hydride 
in tetrahydrofuran' °2 afforded 
however the yield was low (< 20%) therefore alternative methods were 
investigated. 
ethyl 2-methyl-4-ch1oropyrimidine-5-carylate(42) 
Attempted preparation of' 	
- 	reaction with 
thionyl chloride gave no isolable product. The hydroxy group could 
be readily substituted with a chloro group by reaction with 
phosphorus oxychloride' °3 . It was found to be important to keep the 
reaction at ice temperature during quenching of excess reagent and 
work up otherwise hydrolysis to give the non-chlorinated product 
occurred. Ethyl 2-methyl-4-chloropyrimidine-5- carboxylate (42) was 
unstable and thus was used rapidly after minimal clean up. 
Reaction of (42) with sodium methoxide in methanol' °4 gave ethyl 
2-methyl--4- methoxypyrimidine-5--.carboxylate (43) which could be 
readily reduced with sodium borohydride in the presence of methanol 
and t-butanol98 to afford the corresponding 5-hydroxymethyl compound 
(44). The mono deuterated compound (45) could be prepared by 
reaction with sodium borodeuteride under identical conditions. 
Unfortunately attempts to regenerate the 4-hydroxy analogue (37) by 
heating with trifluoroacetic acid or with hydrochloric acid (6N) gave 
only starting material and this route was abandoned. 
Cyanoethoxymethylene acetate' 05  (46) was reacted with acetamidine 
hydrochloride to afford 2-methyl.-4-hydroxypyrimidine-5-
carbonitrile94 (47) however attempts to reduce this compound to the 
corresponding aldehyde (48) using Raney nickel gave only starting 
material. 
Treatment of 2-methyl-4-amino-5-EroxymeE ipyrfiiddiEë (35) with 
hot hydrochloric acid gave the corresponding 4-hydroxy compound (34) 
in good yield. The same reaction carried out with the [51_2fl] 
analogue (36) showed retention of the deuterium in reaction times up 
to 30 minutes (80% retention by ms) however longer reaction times led 
to exchange. This method was, therefore, used to prepare 
2-methyl-4-hydroxy-5_hydroxymethylpyrjjji (34) and 
(51_2 HI-2-methyl-4- hydroxy-5-$ to 	thylyrfiiãI 	(37). 
Hydrolysis of the 4-amino aldehyde (40) to the corresponding 
4-hydroxy aldehyde (48) using 6N hydrochloric acid was carried out 
but the yield was poor (00%). 
Scheme 2-4 
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The mass spectral analysis of 2-methyl-4-amino--5-hydroxymethy1 
pyrimidine (35) gives the expected fragmentation pattern (scheme 2.4) 
with loss of OH followed by ring cleavage or loss of the benzylic 
Cu2 . 
In the case of the corresponding 4-hydroxy compounds (34) and (37), 
fragmentation involves loss of H 2  0 (scheme 2.5) giving an [M-OH] at 
123. In the deuterated analogue (37) fragments 123 [N-oD1 and 124 
[M-OH) are observed clearly. A most characteristic fragment occurs 
as a result of loss of CHO. The accepted mechanism for such a loss 
in phenolic compounds ' ° 6 involves elimination of oxygen together with 
its adjacent ring carbon atom. Substantial hydrogen scrambling 
occurs with CHO loss and this is confirmed in the case of the hydroxy 
pyrimidine by loss of deuterium from C-S' (scheme 2.5) which may 
occur by a similar mechanism to thatshown. Further fragmentation 
then occurs as expected. Such fragmentation and the loss of 
deuterium suggests that the keto form is preferred. 
2.3.4. Results 
Protiated and deuterated 2-methyl-4-amino-5-hydroxymethyl pyrimidine 
(35) (36)and 2-methyl-4-hydroxy-5-hydroxymethyl pyrimidine (34),(37) 
were fed to growing cultures of Saccharomyces cerevisiae. The 
isolated thiamine (30) was incubated as before, in the presence of 
aniline, with freshly prepared thiaminase I and the crude ethyl 
acetate extract examined by capillary gc,4ns. 
Peaks due to the molecular ion at 214 and a major fragment at 122 
were examined for deuterium incorporation. The background figure for 
the N + 1 peak in the unlabelled feeding trial is 4.5% for 215 and 
1.8% for 123 (Fig.2.8(a)). The product from feeding the labelled 
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these peaks respectively (Fig. 2.8(b)) corresponding to net 
incorporation of 8% and 7.3%. Feeding the corresponding 5-deutero 
4-hydroxy compound (37), at the same level gave no net incorporation 
(Figure 2.8(c)). 
When the level of administered [5'-2H1-2-methyl-4-hydroxy.-5-- 
d7rthy1pyine (37) is increased, an inhibitory effect on 
the growth of the yeast is observed. At 8 mg/50cm3 of culture, 
normal growth is observed, however at 25 mg/50cm 3 of culture, growth, 
as assessed by optical density of cells, is reduced by 60% while at 
50mg/50cm3 of culture, virtually no growth occurs. 
2.3.5. Discussion 
These results suggest that 2-methyl-4-hydroxy-5.ãrothy1rijjdine 
'(34), while a yeast growth inhibitor, is not a precursor 
of the pyrimidine moiety of thiamine. This implies that the 4-amino 
group is not incorporated subsequent to pyrimidine ring formation. 
The lack of incorporation would also suggest that the enzymes which 
are involved in the biosynthesis of thiamine have a relatively high 
substrate specificity the 4-hydroxy compound is not incorporated to 
form an oxythiamine analogue of thiamine (30) as might be expected if 
the substrate specificity were fairly low. However, it should be 
noted that oxythiamine has been shown to be toxic 107  and it may be 
formed in amounts too small to detect while being sufficient to 
prevent yeast growth. The oxythiasnine analogue has not been tested 
as a substrate for thiaminase I and may not be cleaved although the 
postulated mechanism does not require a 4-amino functionality. 
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Spenser et al. have already noted 77  that, in contrast to prokaryotes, 
the ring skeleton of the pyrimidine in thiamine (30) and the purines 
in yeast do not have a common precursor. Since the purines have been 
shown to have a common biogenesis in eukaryotes and prokaryotes, 
(from bicarbonate, formate and glycine), it necessarily follows that 
the carbon skeleton of the pyrimidine moiety of thiamine and that of 
purines in yeast are not linked. A unit which contains all three 
nitrogens already would appear to be favoured by this result. The 
attachment of a nitrogen to the formate-derived carbon at C-4 is 
clearly an early biosynthetic step occurring prior to pyrimidine ring 
formation. 
2.3.6. conclusions 
A method has been developed which can be used to study the 
biosynthesis of thiamine (30) at the microgram level using gcns and 
stable isotopically labelled precusors. Such a method has certain 
advantages over radiochemical methods including the ease of precursor 
preparation and the direct analysis of the product thiamine without 
the necessity of complex degradation and analysis of breakdown 
products. While this method is considerably less sensitive than 
using radiolabelled biosynthetic intermediates, when late precursors 
are being studied and where good incorporation would be expected, the 
levels of labelled material are adequate. From the background 
observed in this present .series, an incorporation of the order of 6% 
is required in order to be easily detected over background using 
gc/ms. 
The method developed has'been used to investigate the possible 
intermediacy of 2-methyl-4-hydroxy-15 	(34) in 
mum 
the biosynthesis of the pyrimidine moiety of thiamine. The 
corresponding 4-amino compound (35) is clearly incorporated, as 
expected. The apparent non-incorporation of the 4-hydroxy compound 
(34) eliminates it as a precursor of the '4-alninopyrimjthn1 and, 
hence, of thiamine (30). The result implies that post-ring ainination 
does not take place and that the 6 atom skeleton proposed by Spenser 
et al. 76  involving an amino functionality on the formate-derived 
carbon atom or a histidine precursor 79 may be correct. 
2-Methyl-4-hydroxy-5-hydroxymethylpyrimidine (34) is, however, a 
potent inhibitor of growth of yeast ' ° 8 . The precise nature of this 
inhibition is unclear however, the 4 1 -amino group of the pyrimidine 
ring is essential to thiamine pyrophosphate coenzyme activity and the 
4-hydroxy analogue of thiamine has been shown to be totally inactive 
as a coenzyme 109 . If the biosynthetic pathway is capable of 
incorporating 2-methyl-4-hydroxy-hãro 	thpiinidinth (34) to 
make the corresponding 4-hydroxy thiamine analogue, then this may 
account for the observed inhibition of growth although this analogue 
was not detected in the incubate. The 4-hydroxy analogue of thiamine 
causes a 50% decrease in the activity of pyruvate decarboxylase after 
simultaneous incubation of the enzyme with thiamine pyrophosphate and 
110 the analogue 	. 	 ' (34): 
may thus be incorporated into 4-hydroxythiataine and then act as an 
inhibitor of cell growth as a consequence of its effect on 
thiamine-dependent enzymes or on the biosynthesis of thiamine itself. 
Below the level necessary for inhibition, it appears not to be 
substantially incorporated although a failure to detect it may be due 
to the failure of thianunase I to cleave the '4-hydroxythiamxne 
analogue or to the low levels formed. 
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A more detailed investigation of the biological effect of 
2-methyl-4-hydroxy-5-hydroxymethy]4yriinidii -i& (34) is clearly 
warranted, as is a study of the biosynthetic pathway between the 
pentose unit and the complete pyrimidine ring of thiamine (30). 
Ims 
Chapter 3 
3. studies in the Genetic Manipulation of Biosynthetic Pathways 
Modifying the activity of restriction enzymes - a preliminary study. 
3.1 Introduction 
Biosynthetic pathways are composed of individual steps mediated by 
one or more enzymes. The detailed study of the individual steps (and 
hence the intermediates) involved in the biosynthesis of a particular 
product is crucial to understanding the mechanism and the factors 
affecting the production of the biosynthetic target molecule. Many 
studies have been carried out using mutants which contain blocks in 
the biosynthetic pathway and hence accumulate particular 
intermediates" 0 . Such an approach is relatively tedious and, 
essentially, random. 
In many cases the enzymes for any particular biosynthetic step in a 
pathway are strictly controlled. The sequence of amino acids in the 
enzyme are coded for by groups of three bases (codons) in ribonucleic 
acid (Wa) which in turn are read directly from the corresponding 
deoxyribonucleic acid (DNA). control of the expression of the gene 
for a particular enzyme generally takes place at the DNA level. Most 
of the DNA in a cell is accumulated in the nucleus however, small, 
autonomously replicating circular pieces of DNA (plasmids) exist in 
cells. Plasmids can be replicated many times over in the cell, they 
are also passed on to daughter cells and the protein they code for is 
produced by the cell using the normal cellular apparatus. 
Furthermore, the production of this protein is not generally subject 
to the control factors which govern normal chromosomal cellular 
protein production thus it can be overproduced and subsequently 
111-1.1.3 isolated 	- 
It is clearly implicit in the above that the simple introduction of a 
piece of DNA into a cell will not result in transcription and 
translation to give the protein which is coded for by the DNA. The 
DNA which codes for a particular protein (enzyme) in a biosynthetic 
pathway must be located and isolated. The isolation process is 
carried out using enzymes which recognise and cleave DNA at specific 
sites (Type II restriction enzymes). A great number of these 
restriction enzymes with different site specificities have been 
isolated' 13 . A plasmid* is then opened up using the same restriction 
enzyme(s) and the piece of isolated DNA inserted and ligated, thus 
reclosing the plasmid. The ends of the insert and the plasmid must 
be compatible to ensure maximum incorporation (ligation) and this 
means that they ought to be cut with the same restriction enzymes. 
From the point of view of the plasmid, this is easily accomplished by 
preparing a suitable strong promoter with a series of restriction 
sites following it. There is however rib guarantee that a unique 
restriction site occurs at the beginning of the gene to be inserted. 
In such cases, more complex manipulation using linkers must be 
carried out. The extra piece of DNA which is introduced into the 
plasmid must be placed under the control of a suitable mechanism (a 
promoter) which directs the cellular machinery to produce large 
* Note: A plasmid is an autonomous, self-replicating piece of closed 
circular DNA which carries the piece of DNA of interest into the cell 
and then infiltrates the cellular machinery so that the protein coded 
for is produced. Multiple copies of plasmi.ds can occur in any one 
cell thus leading to overexpression. 
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amounts of the corresponding RNA otherwise no protein will be 
synthesised. The modified plasmid is introduced into the host cell 
and, if successful, is replicated and produces large amounts of the 
required enzyme which can be isolated and studied. 
This is a greatly simplified picture however. In the preliminary 
stage of the process the DNA sequence which codes for the protein of 
interest must be uniquely identified and then excised from the 
genomic DNA molecule. This latter procedure can involve a large 
number of manipulations since suitable restriction sites are rarely 
conveniently placed in natural sequences. 
It would thus, clearly be of value to be able to modify the activity 
of restriction enzymes so that particular sites can be favoured or 
disfavoured. There are a number of observations which suggest that 
this may be possible. In the case of a large piece of DNA derived 
from phage lambda (ca 43 k base pairs), the cleavage of the DNA at 
its known restriction sites by the enzymes EcoRI and Hind III is not 
a simple process. Some preference is shown for particular 
sites '14 ,:115• Additionally, a non-specific endonuclease which 
generally cleaves DNA at random, nonetheless shows preferences for 
particular base sequences'". A further group of site-specific 
restriction enzymes (notably Nar I,Nae I, Sac II and Xma III) show 
dramatic site preferences between recognition sites in the plasmid 
pBR322. No correlation with surrounding nucleotides has been 
observed and the reason for these differences remains unclear. If it 
is possible to further modify restriction enzyme specificity in a 
predictive and reproducible fashion in order to get cleavage at 
certain recognition sites only or, indeed, to alter slightly the 
recognition sites themselves, then alternative cloning strategies may 
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be possible with concomitant advantages in the study of natural 
product biosynthesis. The activity of certain restriction enzymes 
can be modified by the presence of organic solvents or in high salt 
concentrations' 17 ' 118 . Such "star" activity generally leads however 
to a loss in specificity and greatly increased frequency of cleavage. 
One possibility is to constrain either the cleavage sites in the DNA 
or the activity of the enzyme such that certain sites are disfavoured 
compared with others thereby increasing the specificity of the 
enzyme. 
Enzymes have frequently been used in an immobilised form and, more 
recently, in low water 	 A favoured method of creating low 
water systems is to dissolve the enzyme in a very small amount of 
water and then to distribute this aqueous solution into an apolar 
organic solvent (generally an alkane) in which a surfactant (eg 
sodium dioctyl suiphosuccinate (ADT)) has been dissolved. The 
surfactant serves to protect the enzyme from the organic solvent and 
causes the formation of very small water droplets in which the enzyme 
is encapsulated (fig 3.1). These droplets comprise a 
thermodynamically stable system which is optically transparent is of 
low viscosity and is termed a reversed 	 The water 
droplets are generally of the order of 2-20nm. in diameter and the 
interfacial area is very large (tens of in 2 per cm3 ). These systems 
have been used to "solitilise" enzymes in organic solvents, to enable 
organic substrates to come into contact with enzymes and, on 
occasion, to improve enzyme stability and efficiency. In addition, 
novel enzyme activity has been noted in certain cases' 22 . 
Despite the small size of reverse micelles (typically of the order of 
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cells' 25 have been taken up in reverse micelle systems and found to 
function normally. The precise nature of the system in these cases 
remains unclear, however it seems likely that conformational 
restraints on both the enzyme and the nucleic acid exist. 
These conformational restraints on large molecules may lead to a 
modification in the substrate specificity of the entrapped enzyme or 
changes in the availability of the substrate. In the case of 
restriction enzymes and nucleic acids, this may lead to unusual 
fragments due to changes in the recognition site or in partial 
disfavouring of certain sites due to the folding of the DNA molecule 
in the reverse micelle system. In this study we examined the action 
of a series of type II restriction endonucleases on DNA in reverse 
micelles to see if enzyme activity is retained in these systems and, 
if so, then whether modification of site specificity is exercised. 
3.2 Results 
3.2.1 Cleavage of plasmid pIJC 8 
The plasmid pUC 8 is a member of the family of pUC plasmids developed 
by Messing et al' 26 . It is derived from pBR322 - the first unnatural 
plasmid vector constructed with specific defined characteristics. 
The pUC series contain the replication origin and ampicillin 
resistance gene of pBR322 with a portion of the p-galactosidase (lac 
Z') gene of E. coli. The value of pUC plasmids resides in the number 
of unique restriction sites within the lac gene. When the plasmid is 
transformed into a suitable strain of E. coli, blue colonies are 
produced on plates which contain a specific indicator. The cells 
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with the plasmid are also resistant to ampicillin. The insertion of 
foreign DNA by ligation into one (or more) of the unique restriction 
sites in the lac gene usually inactivates the gene and hence results 
in colourless colonies which retain ampicillin resistance. This 
insertional inactivation is a very powerful technique for rapidly 
monitoring the integration of a plasmid containing a desired insert 
113,127 into cells 	- 
The agarose gel electrophoresis of the fragments from the cleavage of 
the plasmid pUC8 with a range of restriction enzymes in both aqueous 
buffer and in sodium dioctylsulphosuccinate (AOT) (Fig. 3.2) reverse 
micelle systems is shown in Fig. 3.3. The puC 8 plasmid has single 
restriction sites from Barn HI, Hind III and Eco RI and three sites 
for the enzyme Hae II (Fig. 3.4). Both Lam HI and Eco RI give 
principally a single linear fragment from the range of partially 
supercoiled and fully supercoiled DNA. Supercoiled, nicked, 
(partially supercoiled) and circular plasmid DNA migrate at different 
rates through the agarose gel hence the series of bands obtained in 
the non-restricted sample. Cleavage with EcoRI under normal 
conditions, gives a major linear fragment of ca 2.7k. base pairs and 
some bands due to partially relaxed (nicked) DNA. In the reverse 
micelle system a single fragment of linear DNA is observed for both 
enzymes together with other nicked fragments observed in the natural, 
unrestricted nucleic acid. 
Restriction with Hind III should, as above, give a single linear 
fragment of 2.73k base pairs and this is observed in the aqueous 
buffer system. In the reverse micelle, however, no cleavage is 
observed and a pattern identical to that of unrestricted plasmid is 
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The cleavage of pUC 8 with Rae II gives 3 fragments as shown in fig 
3.3. In both the aqueous buffer and the reverse micelle systems the 
expected fragment sizes are observed although, in the latter, 
fragments symptomatic of incomplete cleavage are also found. 
3.2.2. cleavage of lambda and lambda blo 1 
Lambda bio 1 is a double stranded linear DNA with a molecular weight 
of the order of 31.5 x 10 6 Daltons and 12 base pair single stranded 
cohesive ends128 . It contains two genes of the biotin operon (bio A 
and bio B) (Fig. 3.5). Lambda bio 1 was prepared in Edinburgh in the 
course of other work and the availability of this material and 
accurate mapping of the restriction sites in the DMA sequence made it 
a convenient model for our studies. The restriction map of lambda 
bio 1 is shown in figure 3.5. 
Treatment with Hind III in aqueous buffer gave the expected fragments 
(Table 3.1). when this was repeated in 50 mm surfactant, once again, 
fragments of the expected sizes were seen after electrophoreseis. At 
100mM, surfactant concentration, however, cleavage at a single site 
only appears to occur. 
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Table 3.1 	cleavage of lambda bio 1 DNA with Hind III 
Aqueous buffer 	Reverse micelle (50mM) 	Reverse micelle (100 mm) 
(k.base pairs) 	(k.base pairs) 	 (k.base pairs) 
	
23.1 	 23.1 	 23 
2.0 	 2.0 	 25 
2.3 	 2.3 
7.8 	 7.8 
0.5 	 0.5 
0.1 	 0.1 
6.6 	 6.6 
4.3 	 4.3 
Cleavage with Eco RI, Hae II and Barn HI at 100mM surfactant 
concentration and in aqueous buffer gave the expected fragment sizes 
only. 
Cleavage of normal lambda DNA with Hind III in 100 mM surfactant gave 
fragments at about 24k base pairs, 4.3k base pairs and 2.0k base 
pairs rather than the expected fragments. The effect of pH upon the 
efficiency of cleavage was monitored using Hind III and lambda bio 1 
at pH 7 and pH 9. No cleavage was observed at p11 9, however the 
expected fragments were found at pH 7 in the reverse micelle. The 
incubations were carried out at 50mM surfactant concentration. 
3.2.3 cleavage and annealing of lambda Hind III 
The specificity of the restriction enzymes was further tested in the 
-111- 
reverse micelle environment by incubating lambda nra, which had 
already been exhaustively digested with Hind III, with Eco RI and Barn 
Hi. Incubation in the reverse micelle appeared to promote reversible 
annealing of the cohesive ends and to circumvent this samples were 
heated to 65° C prior to gel electrophoresis. In both 50mM and 100mM 
xo'r, incubation with both enzymes gave only fragments of an identical 
size to those observed in a double digest in aqueous buffer. It would 
appear, therefore, that with smaller pieces of DNA, all the 
restriction sites for Eco RI and Barn Hl are available for cleavage. 
3.3 Measurement of reverse micelle size 
The size of samples of nucleic acid in reverse micelles was measured 
by photon correlation spectroscopy (PCS). This technique relies upon 
the scattering of a beam of light by a dilute micellar solution. The 
scattering intensity increases with increasing size and concentration 
of particles and with refractive index differences between the solvent 
and the dispersed phase. The diffusion of particles in and out of a 
small volume (ca 0.1 mm 3 ) can be measured and give information that 
can be used to relate fluctuations in scattered light intensity to the 
diffusion coefficient and hence to the hydrodynamic radius of the 
particles. The output is transformed into an exponential decay curve 
which is analysed to obtain the radius. An optimal sampling time for 
particles of a specific size exists and thus, in a bimodal system, two 
(or more) runs with different sampling times are necessary in order to 
obtain realistic data. In the case of nucleic acids in reverse 
micelles, the nucleic acid-containing micelles were considerably 
larger than those which contain water only, therefore multiple scans 
were necessary. 
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The reverse micelles which contained only water and surfactant were 
found to be of the expected sizes with diameters of the order of 10 
run. When reverse micelles which contain lambda were examined, 
diameters of the order of 250-300 rim were routinely observed. When 
samples containing puC 8 or small fragments (<9k base pairs) were 
examined, results were variable but rapid aggregation appeared to 
occur and the size of the particles in solution outstripped the range 
of the instrument. 
3.4 Discussion 
3.4.1 Restriction of WC 8 
The plasthic pUC 8 is a small (2.7k base pairs) circular piece of DNA 
which exists in both supercoiled and relaxed forms. Repeated freezing 
and thawing and the action of certain enzymes results in nicks in one 
of the chains giving rise to various relaxed and semi-coiled forms of 
DNA. Plasmid DNA in vivo is negatively supercoiled and, because of 
its small, compact nature, migrates more quickly in agarose gel 
electrophoresis than more relaxed forms. The rate of migration of DNA 
is thus a measure of the degree of supercoiling as well as the size. 
Under normal conditions, plasmid DNA will exist in a number of forms 
varying between completely supercoiled and totally relaxed. This, in 
turn, gives rise to a series of bands when the sample is examined by 
agarose gel electrophoresis. In addition, ethidium bromide 
intercalates into DNA and generates positive superhelical turns. 
Clearly, once the DNA strands are cut through completely by the action 
of a restriction indonuclease a linear piece of DNA results and 
supercoiling cannot occur. 
-113- 
The identical size of the cleavage product from incubation of puc 8 
with Eco RI and Barn Hi in reverse micelles shows that cleavage at 
extra sites - as sometimes occurs in the presence of high salt 
concentrations and organic solvents - is not a feature of the action 
of restriction enzymes under these conditions. The efficiency of 
cleavage is, however, reduced in the reverse micelle system and 
complete digestion does not occur. However, while cleavage at more 
than one site appears not to occur, the precise site of restriction is 
unknown and these results in themselves do not indicate that site 
specificity is retained in this system. The failure of Hind III to 
cleave pUC 8 in the reverse micelle suggests either that the enzyme is 
particularly susceptible to the reverse micelle environment or that 
the plasmid is folded in such a way that the recognition site for Hind 
III is not readily available. Given the proximity of the Hind III 
recognition site to the Eco RI and the Barn Hl recognition sites (fig. 
3.4), the latter explanation would appear to be less likely. 
All three restriction enzymes require Mg 2+  and the exchange with Na 
in the reverse micelle system may reduce drastically the amount of 
Mg 
2+ available and thus substantially diminish the activity. This 
may. account for the prolonged (ca 12 hours) incubation times required 
to achieve comparable cleavage to the aqueous system. 
The restriction of pUC 8 with an enzyme which cuts at more than one 
site (Hae II), to produce the expected range of fragments together 
with partial cleavage products does however indicate that restriction 
is occurring at the same recognition sites in the reverse micelle 
system as in aqueous buffer. The major fragment (1.934k base pairs) 
and a linear whole piece are clearly present however, there is also 
some indication of a fragment of between 2.73 k base pairs (linear) 
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and 1.934 k base pairs. This piece of DNA may arise as a result of 
incomplete cleavage at either of the three sites in conjunction with 
complete cleavage at one other (Fig. 3.5). No fragment of 0.787 k 
base pairs was detected suggesting that complete restriction at site C 
is not occurring. These results, therefore imply that restriction 
occurs readily at site B giving the linear whole fragment. Further 
restriction at sites A and C does occur but at different rates thus 
giving rise to fragments of 2.304k base pairs and 2.351 k base pairs 
(which would be indistinguishable on the gel) and, where both are cut, 
a fragment of 1.934 k base pairs corresponding to the major fragment 
in the normal aqueous buffer incubations. Both of the small fragments 
(0.417 and 0.370 k base pairs) are also observed. 
The results from the single restriction site enzymes and using Hae II 
suggest that the specificity of restriction enzymes remains high in a 
reverse micelle environment. Clearly Hind III is either more 
sensitive to the reverse micelle system or its restriction site is not 
readily available. This latter option is supported by the results 
from Rae II digestions. Clearly all three sites in the plasmid are 
not equal and, while this may be due to some greater degree of 
specificity invoked by the environment, the net effect is that of 
preferential cleavage at certain of the sites. It is noteworthy that 
the base sequence surrounding the Rae II sites A and B are similar 
while that of site C has a higher level of thymidine residues. 
3.4.2 Restriction of lambda bio 1 
The cleavage of lanla bio 1 in aqueous buffer gave fragments of the 
expected sizes. The same experiment carried out with Eco Ri and Barn 
Hi again gave the expected fragements at 100Mm surfactant 
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concentrations. when this incubation was carried out with Hind III, 
only two fragments of approximately equal sizes were observed. This 
would suggest that Hind III restriction is occurring at one of three 
possible sites in a reproducible fashion, when the cleavage was 
repeated using normal lambda without the biotin insert incomplete 
cleavage was also evident although different fragments were observed 
on this occasion. When the Hind III experiment with lambda bio 1 was 
repeated at 50 mm surfactant concentration, the expected restriction 
pattern was seen. These results suggest that the amount of surfactant 
present has a direct effect on the specificity of cleavage. The 
micelle size and the amount of free water is dependant upon the ratio 
of water to surfactant with less free water being present at higher 
surfactant concentrations. From the point of view of the Hind III 
experiments, this lack of free water may cause conformational 
restraints upon the DNA thus only allowing a relatively small number 
of sites might near the centre of the lambda bio 1 to be exposed. 
Initial cleavage at one of these sites will not lead to dissociation 
and subsequent cleavage at other sites because the DNA is held so 
tightly in the reverse micelle environment. In the case of normal 
phage lambda, the absence of the biotin insert would appear to expose 
other sites, in particular, that at 4300 base pairs. 
The cleavage of lambda bio 1 using the other restriction enzymes (Eco 
Ri and Barn Hi) are difficult to justify in terms of the above 
analysis. All three restriction enzymes have restriction sites in the 
similar domains and thus should all be subject to the same 
difficulties of enzymes-DNA interactions as Hind III in carrying out 
the cleavage. It is possible that the environment has having an 
effect upon the enzyme itself (as suggested earlier by the experiments 
with puC 8). The noticable difference observed between lambda and 
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lambda bio 1 hydrolysis would suggest that a relatively small 
alteration in the composition of the DNA substrate has a considerable 
effect on the cleavage. Hind III is a relatively large enzyme (m.w. 
80,000 Da) compared with Eco RI (2 x 37,000 Da) this may have an 
effect upon the amount of free water available and hence on the 
cleavage at different sites. The lowered availability of ng2 in the 
reverse micelle system may also be more crucial to Hind III than to 
the other enzymes. 
Certain restriction enzymes are particularly susceptible to the 
presence of high salt concentrations (which can occur in impure MYF 
reverse micelle systems) or organic solvents. In enzymes such as Eco 
RI and Hind III this can induce "star" activity in which some 
specificity is lost and restriction occurs at sites other than the 
generally recognised restriction sites. Clearly this is not happening 
in this case. 
The rate of cleavage at different sites in lambda DNA can vary as much 
as 14 fold with Hind III and Eco R1 115 , however even such differences 
in rate do not explain why only a single site is apparently cleaved at 
100 RIM surfactant concentration.with Hind III and no abnormal effect 
is noted with Eco El. Other enzymes (in particular Nar I, Nae I, Sac 
II and Xma In) exhibit even greater site specificity with fifty-fold 
and greater differences observed between certain sites in lãnda. 
Conformational restraints upon the DNA or the enzyme (or both) would 
appear to be a likely explanation for the results observed. It 
remains possible, however, that local bass sequences may cause certain 
sites to be considerably less accessible than others and that the 




This study was designed to find out if DNA could be cleaved in a 
specific and reproducible fashion using restriction enzymes in reverse 
micelles and to examine whether the site-specificity of restriction 
was altered under these conditions. In most cases, cleavage produces 
identical fragments both in small, plasmid DNA and in large modified 
lambda DNA. The exception occurs with the enzyme Hind III which has 
very low activity in the reverse micelle enviroment with plasmid DNA 
and cleaves at a single site only in lambda bio 1 DNA. This may 
simply be due to the low activity of the enzyme per se, however this 
would not explain the reproducible nature of the cleavage in the 
multiple site modified lambda. Furthermore, in normal phage lambda 
without the biotin genes insert, the cleavage is, once again, abnormal 
but in a different manner to that observed for the modified lambda. 
It is more likely therefore, that the principal cause of the 
differences observed is inherent in the DNA rather than the enzyme. 
Since many of the overall cleavage domains are similar for the 
different restriction enzyme sites, a more localised effect would 
appear to be indicated. The nature of the restriction sites 
themselves is not sufficiently different to explain the results thus 
it may be some reflection of the neighbouring base sequences. The 
exchange of ?1g2 with Na in the reverse micelle system with 
concomitant lowered availability of Mg 2 may be more important to some 
enzymes than to others. The size of the restriction enzyme, the 
amount of water it requires to order around itself and the nature of 
the active site may be of particular importance. 
While the specificity of the enzymes appears to be maintained in 
reverse micelles it remains to be proven that the site of recognition 
-118- 
and cleavage is precisely identical in aqueous and reverse micelle 
systems and further work involving, perhaps, sequencing of the termini 
of fragments is necessary to confirm this observation. 
Further studies are also necessary to determine if there is an optimal 
surfactant/water ratio for a range of restriction enzymes and if the 
sites of cleavage can be predicted. Also of interest may be the 
cleavage of DNA using "non-specific" endonucleases such as 
deoxyribonuclease I (E.C. 3.1.21.1). While this enzyme is used for 
general DNA assays, it does exhibit some substrate specificity' 6 and 
it may be possible to tailor this specificity to certain types of 
sequences, eg CG-rich regions which are associated with particular 
parts of the gene. Certain sequences of nucleotides are conserved in, 
for example, the Shine-Dalgarno (S-D) sequence which occurs prior to 
the bacterial start codon for a gene. Careful manipulation of the 
enzyme and the conditions of incubation may lead to greater, 




Starting materials from commercial sources were used without further 
purification unless otherwise indicated. Solvents were either Analar 
grade or redistilled prior to use with the exception of ethyl acetate, 
chloroform, petroleum ether and diethyl ether which were laboratory 
grade. Organic extracts were dried with anhydrous magnesium sulphate 
or anhydrous sodium sulphate prior to evaporation. Comparison of 
synthesised material with commercially available samples or with 
literature values (m.pt., ms, nmr etc.) was carried out whenever 
possible. Melting points are uncorrected. 'H nmr spectra were 
obtained on a Bruker spectrometer operating at 80.13 ?4.Hz. or on a 
Bruker WH200 operating at 200.13 MHz. ' 3 C Nmr ipectra were obtained 
on the latter instrument at 50.32 M.Hz. 2  H and 5 N nmr spectra were 
obtained at 40 and 36.5 M.Hz respectively. Mass spectra were obtained 
routinely on a Kratos 74530 or MS60!ass spectrometer operating in CI, 
fleil 	indicatedthiTheMmsng 	 p 
El 
	
L or FAB mode.A  Capillary gc4ns was carried out using -an BPI - 
capillary column (12.5m x 0.33mm i.d.) connected to a Kratos 74560 mass 
spectrometer. Photon correlation spectroscopy was carried out on a 
Malvern 7026 spectrometer at the Institute of Food Research, Norwich, 
by Alan Mackie. 
Plasmid and lambda DNA was obtained either from a connuercial source or 
from Dr • N. Murray, Department of Molecular Biology, University of 
Edinburgh. Restriction enzymes were obtained from commercial sources. 
Cultures of Penicillium atrovenetum and Saccharauyces cerevisiae (M'CC 
29403) were obtained from the Commonwealth Mycological Institute, Kew 
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Gardens. The former was maintained on Czapek Dox slants and 
subcultured as little as possible since this was found to result in 
the loss of 3-nitropropanoic acid synthesising capacity. The yeast 
was maintained on agar slants and subcultured every 4-6 weeks. Fresh 
slants were used for each experiment. 
Penicillium atrovenetum was grown on modified Raulin Thom medium as 
described by Shaw20 . Saccharomyces cerevisiae was grown on Difco 
vitamin free medium supplemented with pantothenic acid, biotin and 
myo-inositol 7 - 5-. The -isolation- of--thiaminase L was carried out from 
Bacillus thiaminolyticus which was grown in the defined medium of 
Douthit and Airth89 . 	 - 
"A sample of the amino acid (19, 200mg) in water (1 
cm3 ) was neutralised to pH 7.6 (NaOH, 414) then cooled 
in ice and treated with acetic anhydride (140pl). The 
pH was adjusted to >5 (NaOH, 4W) and the mixture was 
treated again with acetic anhydride (140pl) and the pH 
adjusted to >5 (NaOH, 4W). The mixture was stirred 
for 30 mm. then applied to an ion exchange column (1R 1 
120(H), 20 Mesh, 2 x 30 cm). The eluate was freeze 
dried to afford the acetate as an oil. A sample of 
the acetate was treated with diazomethane in methanol 
then evaporated to dryness in vacuo to afford the 
acetylated dimethylester. & (80MHz, CDC1 3 ), 6.74 
p.p.m. (1H, br.d., 3=7.8Hz, NH), 4.76 p.p.m. (1H, d, 
3=8.4Hz, CH (anómeric).), 3.67 p.p.m. (3H, S, CO 2 cH3 ), 
3.60 p.p.m. (3H, D, 3=3.9Hz, 13 cD2 cH3 ), 2.68 p.p.m. 
(0.3H, cHDs-cH2 ), 1.96 p.p.m. (3H, S. NHCOCH3 ). 
Apparent deuteration ca. 85%. ins (El) Wz, 206 (?t, 
13 c d2 ), 205 (r4, 13 C, d1 ), 204 (M 	13 C, d1 ). 
Apparent_deuteration ca. 60% d 2 , 20% d1 , 20% 
-121- 
( 4- ' 3 C13-2 H2 12-2 n1-DL-1½.spartic acid (19): Diethylacetamide malonate 
(21.7g, 0.1 moles) and formaldehyde (4.0%, 8.2 cm 3 ) were added to a 
solution of dimethylamine (15 en?, 0.1 moles.) in glacial acetic acid 
(15 cm ) at 0°C. The reaction mixture was left at room temperature 
for 30 minutes, made alkaline by addition of sodium hydroxide solution 
(20%) and the Mannich base crystallised out (27.4g). This produce was 
dissolved in ethanol (60 cm3 ) and treated with methyl iodide to give 
the corresponding methiodide. The methiodide (4.2g. 10 m.moles) was 
dissolved in water and added to a solution of (' 3 CI-sodium cyanide 
(0.6g, 12 m.moles) in water (20 en?) and the mixture heated under 
reflux for 16 h. The reaction mixture was evaporated to dryness in 
vacuo then treated with 2  H (20% in 2 112 0) for 18 h. The reaction was 
evaporated to dryness in vacuo, the residue dissolved in methanol and 
the sodium iodide removed by filtration. Addition of pyridine in two 
stages gave [4-' 3 C, 3 2 H2 , 2-2 H]-Dtr-aspartic acid (19) (0.97g, 73%). 
1-(4-methyltoluenesulphonyl)-3-nitro-ethane (21): A solution of 
2-nitroethanol (4.75g, 0.052 moles) in dry, redistilled 
tetrahydrofuran (25cm3 ) was cooled in an ice bath then treated with 
triethylamine (2cm3 ) and 4-toluenesulphonyl chloride (10.5g, 0.55 
moles) and the mixture allowed to reach room temperature and stirred 
overnight. The reaction mixture was filtered, applied to a column of 
- 	 silica (Kieselgel 60-230 Mesh) and eluted successively with hexane, 
hexane/ethyl acetate (60:40), ethyl acetate, methanol and ethanol. 
The alcoholic fractions were combined and evaporated under reduced 
pressure to afford an oil which slowly solidified. The crude material 
was recrystallised from chloroform/ethanol to afford a purified 
product (5.24g, 47%) <_(80 MHz, CDC13 ), 7.20ppn (211, d, 3 - 8Hz, 
m.pt. 122-124°d 
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aromatic), 6.72ppm (211, d, .3 = 8Hz, aromatic), 3.52ppm (3H, 5, 013 ), 
3.05ppm (2H, t, 3 	6Hz CU2 NO2 ), 2.60ppm (2H, t, .3 c 6Hz, 012 OTs) ms 
(El) nVz, 213 [M1. 
1-N,N-dimethylamino-2-nitroethene (22) Nitromethane (5g. 0.1 moles) in 
dry dimethyl formami.de (100 Ca?) was treated with N,N-dimethyl 
fonnamide dimethylacetal (11.1g. 0.12 moles) and pyrrolidine (0.04g. 
0.6m.moles). The mixture was heated to 70-80 ° C for 3h by which time 
the initially pale yellow solution had turned deep red. Dimethyl 
formamide was removed by distillation in vacuo with the temperature 
kept below 40° C. The residual red oil was triturated with isopropanol 
to afford an orange solid which was recrystallised from ethanol to 
give pure i-N,N-dimethylamino-2-nit roe thene (22, 6.1g. 54%) m.pt. 
92-4°C 6 (8014Hz, CDC1 3 ), 7.80 ppm (1H, d, J = 8Hz, GIN02 ), 6.15ppm 
(1H, d, .3 = 8Hz, CH-N (CR3 ) 2 ), 2.85 ppm (313, 5, N-CE3 ), 2.55ppm (311, 
S, N-Cl3 ) ins (El) nVz, 116 EM']., 71 EM-NO2 ), 58 EM-GINO2 ). C4 H, 0N202 
requires C, 41.4%; H, 8.6%, N, 24.1%. Found C, 41.9%; H, 8.3%; N, 
23.8%. 
, 32; 1-3-Bromopropanoic acid (23): 3-Bromopropionitriie (0.2g 
l.Sm.moles) was treated with deuterium bromide (37% in 2;.o 4 cm? 
and the mixture refluxed for 3h then allowed to cool, diluted with 
2  H2 (5cm3 ) and extracted with diethyl ether (10cm3 x 3). The 
ethereal extracts were combined, dried and evaporated under reduced 
pressure to afford an oil with identical tic characteristics to an 
authentic sample of 3-bronopropanoic acid' 29 (23, 0.22g) ins n/z 156 
[M'j, 110 (M-0O2 H]. 
[2_2; 1-3--Nitropropanoic acid (10): Crude [2- 2 H, 
3_2 112  1-3-bromopropanoic acid (22) (0.2g. 1.3m.moles) from the above 
-123- 
reaction was added to a suspension of sodium nitrite (0.16g, 
2.3m.moles) in dry dimethylformamide (3cm3 ) at 0° C. The mixture was 
allowed to reach room temperature and stand for 3h. then diluted with 
water (5cm3 ), acidified (6 N hydrochloric acid, 1cm 3 ), dried and 
evaporated under reduced pressure to afford a brown 6i1 which was 
purified by sublimation (60-65° , 0.1mm) to give------------- - 
m.pt.63-64°C, lit ,63-65° 
[2-2 H2.]-3-nitropropanoic acid (10, 0.08g, 50%) which was identified by 
tic 	 comparison with an authentic sample. 6 (80 14Hz, 
(cD3)2CO) 4.45 ppm (211, t, 3=7.5Hz, d, 3=6Hz, cH2 NO2 ), 2.65ppm (0.2H, 
t, 3=7.5Hz, cH2 CO2 H). 
3-Hydroxypropionitrile (11): (a) A solution of sodium cyanide (0.31g, 
6.3m.moles) in water (5cm3 ) was treated dropwise with 2-chloroethanoi 
(0.6g, 7.4m.moles), and the mixture stirred at 45 ° C for lh. The 
reaction mixture was heated to 550 C and stirred for a further 3h., 
allowed to cool to room temperature, treated with citric acid (10%, 
San3 ) and extracted with ethyl acetate (10cm3 x 2). The organic 
layers were combined, dried and evaporated under reduced pressure to 
afford an oil (0.26g) which appeared, from 'H nmr, to contain only 
about 20% of the desired product. Prolonged heating gave a mixture of 
products. 
(b) A mixture of sodium cyanide (1.55g,. 31.5 m.moles) and 18-crown-6 
(0.159, 0.55m.moles) was treated with 2-chloroethanol (3.0g. 
37.0m.moles) and water (10cm3 ) and the reaction stirred at 80-90 ° C for 
3h. The mixture was allowed to cool to room temperature, treated with 
citric acid solution (10%, 25cm3 ) and extracted with ethyl acetate 
(50cm3 x 3). The organic fractions were combined, dried and the 
solvent removed by evaporation under reduced pressure, giving a crude 
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product (2.8g) which was distilled under reduced pressure to afford 
pure 3-hydroxypropionitrile (11, 1.64g, 63%). B.pt. 74-76 ° C/lm, lit 
130 107-109° C/12mm. 6 (80MHz, CDC1 3 ), 3.85ppm (2H, t, 3=6Hz, cH2 -OH) 
2.80ppm (211, t, 3=6Hz, cH2 cN). ir v 3350cnf' (OH stretch), 2250cn1' (C 
N stretch). 
3-Bromopropanoic acid (9): (a) 3-Hydroxypropionitrile (11) (0.3g. 
4.2m.moles) in hydrobromic acid (40%, 5cm 3 ) was refluxed for 2 hours. 
The reaction mixture was then allowed to cool to room temperature and 
extracted with ethyl acetate (5cm 3 x 3). The organic fractions were 
combined, dried and evaporated to dryness to afford a crude product 
which was crystallised from aqueous ethanol to give (9) (0.32g. 62%) 
m.pt. 62-63° C, lit 129  62.5 - 63.5° C. 6 (60MHz, cD3 cN) 2.5ppm (2H, 
t, 3 = 6Hz, CH2 Br), 1.7ppm (2H, t, 3=6Hz, CH 2 0O2 H) which was identical 
to an authentic sample. 
(b) 3-Bromopropionitrile (8) (0.1g, 0.75m.moles) in hydrochloric acid 
(20%, 3cm3 ) was refluxed for 3h. then allowed to cool to room 
temperature and extracted with ether (5cm 3 x3). The ethereal extracts 
were combined, dried and evaporated to dryness in vacuo to afford the 
product as an oil which solidified overnight (0.06g). 
Recrystallisation from aqueous ethanol gave pure 3-bromopropanoic acid 
(9, 0.045g, 40%) which had identical tic, m.pt. and nmr 
characteristics to an authentic sample. 
3-Nitropropanoic acid (1): 3-Dromopropanoic acid (9) (0.77g, 5manoles) 
in dry dimethylsulphoxide 410cm3 ) was treated with sodium nitrite 
(0.55g, 8m.moles) and the mixture stirred at room temperature for 
1.5h. The reaction mixture was then poured into ice ,water (10cm3) 
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acidified to pH 1-2 with 6N hydrochloric acid and extracted with ether 
(10cm3 x 3). The ethereal extracts were combined, dried and the 
solvent removed by evaporation in vacuo to afford a mixture of 
starting material and the desired product. The crude mixture was 
sublimed at 60-65°/0.lmm and the crystalline sublimate recrystallised 
from chloroform to afford 3-nitropropanoic acid (1, 0.15g, 25%) which 
was identified by comparison (m.pt, ms, tic, nmr) with an authentic 
sample. M.pt. 62-64 ° C lit 131  63-65° C. 6 (80MHZ, CD3 CN),4.45ppm (2H, 
t, 3=7Hz, CH NO 2 ), 2.65ppm (2H, t, 3 = 7Hz, cH 2 CO2 H) ms (FAB -Ye) n/z 
119 (M) - , 118 (N-H) - . 
[ 1-'3 c1 -3-Hydroxypropionitrile (24): A mixture of [' 3 CJ-sodium cyanide 
(0.1g. 2.0 m.moles), 2-chloroethanol (0.25 cc 3 ) and 18-crown-6 (0.03g. 
0.11pmoles) was stirred at 90°C for 3h. The cooled reaction mix was 
absorbed on dry silica (2g) and eluted with ethyl acetate (2 cm 3 x 5). 
The organic eluate was evaporated under reduced pressure to afford the 
crude product as an oil (0.08 g). The product had identical tic 
characteristics to an authentic sample of 3-hydroxypropionitrile (11) 
and was used without further purification. 
[l-' 3 c)-(2-2 ; , 3-2 H2 1-3-Bromo-propanoic acid (12): [1- 13 C1-3-
Hydroxypropionitrile (0.1569, 2.0 m.moles) in deuterobromic acid (40%, 
3.0 cm?) was refluxed for 2 hours. The reaction was allowed to cool 
to room temperature, diluted with 2 ;•O (3.0 cm?) and extracted with 
ether (10 c? x 3). The ethereal extracts were combined, dried and 
the solvent removed by evaporation under reduced pressure to afford a 
brown oil which solidified upon agitation and cooling (0.12 g). This 
crude product had identical tic characteristics to an authentic sample 
of 3-bromopropanoic acid and was used without further, purification. 
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[1-' 3 C,2-2 H2 ]-3-Nitropropanoic acid (7): crude bromopropanoic acid 
(12) from the above reaction (O.lg) was added to a suspension of 
sodium nitrite (0.075g) in dry dimethylsuiphoxide (5 cm 3 ) and the 
mixture stirred at room temperature for 1.5h. The reaction mixture 
was then diluted with water (10cm3 ), acidified to pH 1-2 with 
hydrochloric acid (6N) and extracted with ether (15 cm3 x 5). The 
ethereal extracts were combined, dried and evaporated to dryness in 
vacuo to afford the crude product (35 mg) which was recrystallised 
from chloroform to give [1- 13 C, 2-2 H2 1-3-nitropropanoic acid (7, 
t'4 , 63-6  
0.025g, 28%) m.pt. 62-3°C 	 (8014Hz, (CD3  ) 2 C0) 4.45 ppm 
(211, br, CH2 NO2 ). ins (FAB -i-ye) nVz 122 [IC], 121 [M-lf. 
3-.Nninopropanoic acid (4): (a) 3-Nitropropanoic acid (1) (15 mg, 0.125 
m.moles) was added to tin powder (80mg) in hydrochloric acid (35%, 3 
en?) and the mixture refluxed for 2 hours. The cooled reaction 
mixture was evaporated to dryness in vacuo to afford a solid residue 
which was washed repeatedly with ether to leave a colourless solid (4 
mg) with identical tic and nmr characteristics to authentic 
3-aininopropanoic acid (4). 
(b) A stirred solution of 3-nitropropanoic 
acid (1) (0.06g, 0.5 iu.moles) in dry methanol (3 cii?) was treated with 
palladium on charcoal (10%, 0.1g) and the suspension added to 
anhydrous ammonium formate (0.14g, 2.3 m.moles). The reaction was 
stirred at room temperature for 20 min then filtered through celite 
and evaporated to dryness under reduced pressure to afford a 
colourless crystalline solid (0.058g) which was identified by 
comparison (m.pt., tic, 'H nmr) with an authentic sample of 
3-aminopropanoic acid (4). 
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3-Nitropropanoic acid methylmandelate ester (25): (a) A stirred 
solution of 3-nitropropanoic acid (1) (0.12g. 1 m.mole) in 
dichioromethane (5 cm3 ) was treated with 2-dimethyl aminopyridine (5 
mg 0.04 m.moies), S-(+)--methyl mandelate (0.25g. 1.5 m.moles) and 
1,3-dicyciohexylcarbodiimide (0.15g, 0.73 m.moles) at 0°C. The 
reaction mixture was stirred at 0°C for 5 mm. then allowed to warm to 
room temperature and stirred for a further 3h. The reactIon mixture 
was then filtered and the solvent removed by evaporation in vacuo to 
afford an oil (0.21g) which appeared, from tic and nmr to consist of 
starting material. 
3-Nitropropanoic acid (1) (0.055g, 0.46 m.moles) in dry 
tetrahydrofuran (3 cm 3 ) was treated with 
1-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoimne (0.14g, 0.57 m.moles) 
and S-(+)-methylmandelate (0.08g, 0.48 m.moles). The reaction mixture 
was stirred at room temperature for 5 d after which time examination 
by tic indicated that only starting material was present. 
3-Nitropropanoic acid (1) (0.1g, 0.8 m.moles) was treated with 
triflouroacetic anhydride (0.18g, 0.8 m.moies) and the mixture shaken 
for 2 mm. then intermittently over 1 h. R-(--)-Methyl mandelate 
(0.2g, 0.85 m.moles) was added and the reaction mixture left standing 
at room temperature overnight. The reaction mixture was then cooled 
to 0°C, neutralised (pH 7-9) with potassium hydroxide (3N) and 
extracted with ethyl acetate (5 cm? x 3). The organic fractions were 
combined, dried and evaporated to dryness in vacuo to afford an oil. 
The crude material was purified by preparative tic using 
chlorofowethanol (95:5) as the mobile phase to afford 
3-nitropropanoic acid methyl mandelate ester (25, 0.,08g, 37%) m;pt. 
-128- 
120-122°C 6(80MHz, C 6 ;) 7.00 ppm (SH, aromatic), 5.50 ppm (1H, 5, 
CH-CO 2 C113 ), 3.90 (111, m (AA'B2 ), C112 NO2 ), 3.70 ppm (111, m (AA'B2 ) 
GiNO2 ), 3.40 ppm (311, 5, CO2 CH3 ) 2.45 ppm (2H, t, 3=10Hz, CH2 CO2 R). 
ms (CI) ITVZ,  267 (PiJ. 
3-Nitropropanoic acid methyl valine amide (26): 3-Nitropropanoic acid 
(1) (0.2 g, 1.7 ra.moles) in dry tetrahydrofuran (5 cm3 ) was treated 
with L.-valine methyl ester (0.33g, 2.0 m.moles) generated from the 
corresponding hydrochloride by shaking an ethyl acetate suspension 
with saturated sodium bicarbonate. 1,3-Dicyclohexylcarbodiimide 
(0.2g, 1.0 m.moles) was added and the reaction mixture stirred at room 
temperature for 2 h. The filtered reaction mixture was evaporated in 
vacuo to afford an oil which was purified by flash chromatography 
using chloroforenethanol as the mobile phase, giving an oil which 
slowly crystallised. Crystallisation from ethyl acetate/hexane gave 
3-nitropropanoic acid methyl valine amide (26, 0.208g, 53%) m.pt. 
42-44°C. 6(200M Hz, CDC13 ) 6.25 ppm (in, d, 3=9Hz, NH), 4.70 ppm, (311, 
m (AA'B) CH2 NO2 ).4.60 ppm (in, dd, 3=10Hz, 5Hz, CH-NH), 3.75 ppm (311, 
s, CO2 CI), 2.86 ppm (211, m, (AA'B), CH2 CO2 H), 2.14 ppm (111, in, 
0.92 ppm (3H, d, 3=5.5 Hz, CH), 0.89 ppm (311, 6, 3=5.5 Hz, 
CH) ins (El) Wi, 232 [14k ], 172 [M-0O2 CH3 J, 125 [1727NO2 ]. Exact mass 
measurement gives 232.1069 corresponding to C9 111 6 N2 O. 
[2_2 11,3-2 11]-Fumaric acid (27): Dimethylacetylene dicarboxylate (2.1 
g, 14.8 m.moles) in tetrahydrofuran (10 ca?, preshaken with 0.5 cm 3 
deuterated water) was cooled to 0°C then treated dropwise with 
triphenylphosphine (3.9 9, 15. m.mles) in dry tetrahydrofuran (4 cm?). 
The initially colourless solution turned deep red and was allowed to 
warm to room temperature over 30 mm. then refluxed for 3h. The 
reaction mixture was then allowed to cool to room temperature, dried 
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and evaporated to dryness in vacuo to afford an orange solid which was 
purified by sublimation to give [2- 2 H, 3-2 H)-dimethylfumarate (28, 
0.78g) m.pt. 90-92°C ins (El) 134 (M1, 115 {M-OCH 3 I. A sample of 
this product (0.5 g, 0.34 m.nioles) was treated with aqueous sodium 
hydroxide (10 cm 3,  12%) and the reaction mixture stirred at room 
temperature for 72 h. The reaction was cooled in ice, acidified (pH 
1-2) with hydrochloric acid (6N) and the product isolated by 
filtration and crystallised from aqueous ethanol [2_211, 3-'HI-fumaric 
acid (26, 0.4g, 36%) m.pt. 298-300°C lit40 299-300°C ins (El) nvz 118 
[?4], 100 [M-H2 0]. 
[2S-2 H,3S-2 H]-L--Aspartic Acid (14): [2- 2 H, 3-2 H]-Fumaric acid (27) 
(0.4g, 3.5 m.moles) in water (5 cm3 ) was treated with magnesium 
sulphate heptahydrate (0.08g. 0.3 m.moles) and ThIZMAI base (0.11g) 
then a solution of ammonium chloride (0.38g, 7.0 m.moles) in water (5 
cm3 ) was added. The mixture was made up to 20 cm  with water, 
adjusted to pH 8.0-8.5 by addition of aqueous sodium hydroxide (2N) 
then treated with aspartase (4 units) and the mixture incubated at 
30°C for 10 d. The incubate was then immersed in boiling water for 30 
mm., cooled and treated with cupric sulphate heptahydrate (0.85g, 3.5 
m.moles) and the blue precipitate isolated by filtration. The solid 
was suspended in water (10 a?) and treated with hydrogen sulphide for 
3-4 mm. The black precipitate was removed by filtration through 
celite and the filtrate treated with ethanol (20 cm3 ) and stored at 
0°C for 4d over which time [2S- 2 H, 3R-2 H]--L-aspartic acid (14) 
crystallised out and was isolated by centrifugation (0.11g, 24%) 6(80 
11Hz, Na OD/D20) 2.65pjn (s, 3R-H) ms (FAD 1-ye) 136 ro,/z (MJ, 
90[M-cO2 H]+ , 72(-NH2 ] 1 . 	 $ 
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[3R-2 H]-L--aspartic acid (15): Fumaric acid (0.8g, 6.9 m.moles) was 
added to a mixture of magnesium sulphate heptahydrate (0.15g, 0.6 
m.moles) and ThIZMA. base (01.11g) in deuterated water (10 cm 3 ). The 
mixture was heated at 80°C for 10 mm. then allowed to cool to room 
temperature. The same procedure was carried out for a solution of 
ammonium chloride (0.74g. 15 m.moles) in deuterated water (5 cm?). 
Both solutions were evaporated to dryness in vacuo and the former 
dissolved in deuterated water (15 cm 3 )and added to a solution of the 
latter in deuterated water (10 cm 3 ). The combined mixture was 
adjusted to pH 8.1 with sodium deuteroxide (214) then incubated with 
aspartase (2 units) at 30°C for lOd. After this time the reaction 
mixture was treated in an identical fashion to that described above 
with cupric sulphate heptahydrate (1.9g. 7.0 m.moles) and 
[3S-2 H]-L-aspartic acid isolated as colourless crystals (15, 0.26g, 
28%). msVz (FAB +ve), 135 (1€], 89_[M-CO2 H], 71[-M2] + 
SH (80. MHz, NaOD/02 0), 2735 p. p iIJ 
d., 3=8 Hz, GiD), 3.55 p.p.m. (1H, d, 3=8 Hz, CH-NH 2 ).\ 
troacrylic acid (6) : Fuming sulphuric acid (12.3g, 90%, 0.15 
moles) was added dropwise to a stirred solution of fuming nitric acid 
(lO.Og, 90%, 0.15 moles) at 0°C. The reaction mixture was stirred 
vigorously at 0°C while chlorosulphonic acid (17.0g, 0.14 moles) was 
added slowly over 2-3h and the evolved nitryl chloride was collected 
in an acetone/CO2 trap. Nitryl chloride was allowed to warm and 
bubbled into stirred glacial acrylic acid (6.4g, 0.09 moles) at 0°C. 
The reaction mixture was stirred at 0°C for lh and then stored at 0°C 
until required. 
A sample of 2-chloro-3-nitropropanoic acid prepared above (0.7g. 4.6 
m.moles) in dry ether (50cm3 ) was treated slowly with anhydrous sodium 
acetate (0.439, 5.2 m.moles) and the reaction mixture,heated under 
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reflux for lh. The solution was then allowed to cool to room 
temperature and reduced by evaporation in vacuo to afford an oil 
which was purified by flash chromatography on silica using redistilled 
chloroform as eluant. The purified product was crystallised from 
redistilled chloroform to afford 3-nitroacrylic acid (6) as off-white 
crystals (0.08g. 15%) m.pt. 135-136°C lit 132 134-136°C. 8(80MHz, 
CD3 CN) 7.25 ppm (111, d, .1 - 12Hz CHNO 2 ), 6.55 ppm (XH, d, a - 12Hz, 
CHCO2 H) ins ni/z (FAa -ye) 117 IMV, 116 [M-H]. 
3-Bromopropionitrile (8): Dibromoethane (0.71g, 5 m.moles) in dry 
dimethyl sulphoxide (20 cm?) was treated with sodium cyanide (0.30 g, 
4.8 m.molés) and the mixture stirred at 110°C for lh. After this time 
the reaction was allowed to cool to room temperature, quenched with 
citric acid solution (15%, 20 cii?) and extracted with ethyl acetate 
(20 cm  x 3). The organic layers were combined, dried and evaporated 
in vacuo to afford an oil which was identified by comparison (tic, 
ir, ms) with an authentic sample of succinonitrile. 
[2_2; J-3--Nitroproparioic acid (10): 3-Hydroxy propionitrile (11) 
(0.2g, 2.8 m.moles) in deuterium bromide (40%, 5 cii?) was refluxed for 
2h. The reaction mixture was allowed to cool to room temperature, 
diluted with deuterated water and extracted with ether (10 cm  x 3). 
The ethereal extracts were combined, dried and evaporated to dryness 
in vacuo to afford an oil which solidified overnight and was identical 
(tic) to an authentic sample of 3-bromopropanoic acid (9). 
Crude 3-broiuopropanoic acid (9) prepared above was dissolved in dry 
dimethylsulphoxide (10 cm3 ) and treated with sodium nitrite (0.3g). 
The reaction mixture was stirred at room temperature for 1.5h then 
diluted with water, acidified with hydrochloric acid (2N) and 
extracted with ether (10cm 3 x 5). The ethereal extracts were 
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combined, dried and evaporated to dryness under reduced pressure to 
afford an oil which was taken up in buffer (15 cm?, p1110) and stirred 
at room temperature overnight. The reaction mixture was acidified 
with hydrochloric acid (2N) and extracted with ether (10 cm? x 5). 
The ethereal extracts were combined, dried and evaporated to dryness 
in vacuo to afford an off-white crystalline solid which was 
recrystallised from chloroform to afford (2-2 1ç1-3-nitropropanoic acid 
(10, 0.05g, 15%) which was identified by comparison (tic, m.pt.) with 
an authentic sample. 6(80M.Hz, CD 3 CN), 4.65 pn (211, br.m., CH2 NO2 ) 
ins nVz (FAB, -ye) 121 [if], 120 [M.-ffl. 
13-2 H2 ]-3-Nitropropanoic acid (28): 3-Nitropropanoic acid (1, 0.05g. 
0.42 m.moles) in deuterated water (2 cm3 ) was treated with anhydrous 
sodium carbonate (0.03g, 0.28 m.moles) and the mixture allowed to 
stand at room temperature. After 24 h the reaction mixture was 
acidified (deuterium chloride, 35%) to pH 1-2 and extracted with ether 
(5 cii? x 3). The ethereal extracts were combined, dried and 
evaporated to dryness under reduced pressure to afford 
[3-2 ;]-3-nitropropanoic acid (28, 0.04g). The identity of the 
product was confirmed by comparison (tic, m.pt) with an authentic 
sample. The 'H nmr indicated that ca 70% exchange had occurred at C-3 
with no exchange at C-2 6(80MHz, CDC1 3 ) 4.4 ppn (0.611, t, 3 8 Hz, 
01 
2 N0 ) 
[2_2 H2 1-3-arninopropanoic acid (29): [22; 1-3-Nitropropanoic acid 
(0.02g, 0.17 m.moles) in methanol (3 cii?) was treated with anhydrous 
ammonium formate (0.035g, 0.55 mawles) and 10% palladium on charcoal 
(0.02g) and the mixture stirred at room temperature for 30 mm. The 
reaction mixture was then filtered through celite and evaporated to 
I. 
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dryness in vacuo to afford a colourless solid (0.02g). Examination by 
nmr and ins showed this sample to be identical with an authentic 
sample of 3-aminopropanoic acid (4) with no deuterium incorporation. 
N-Camphanoyl-3-aminopropanoic acid (16): (a) 3-Aminopropanoic acid 
(0.09g, 1 m.mole) in dichloromethane (5 cm 3 ) was treated with 
triethylamine (0.14g, 1.5 m.nioles) and (-)-camphanyl chloride (0.23g, 
1.1 m.moles) at 0°C and the reaction mixture stirred for 3h. Further 
camphanyl chloride (0.12g, 0.5 m.moles) was added and the reaction 
mixture stirred at room temperature overnight however tic examination 
after this time showed that no reaction had occurred, ins (FAB, we) 
n/z 198 [7(]-camphanic acid, 153 [i'i-co2 n]. 
(-)-Camphanyl chloride 
(0.27g, 1.2 m.moles) in toluene (1 cm 3 ) was treated with a solution of 
3-aminopropanoic acid (0.08g, 0.9 m.moles) in aqueous sodium hydroxide 
(0.5 cit?, 2N plus 0.75 cm3 , 3N) and the mixture stirred at room 
temperature overnight. The reaction mixture was washed with 
chloroform, the aqueous layer acidified (p13 1-2) with 614 hydrochloric 
acid and then extracted with chloroform (2 cm3 x 3). The chloroform 
extracts were combined, dried and evaporated to dryness under reduced 
pressure to afford an off white solid which consisted of starting 
material and camphanic acid only. 
Freshly sublimed 
(-)-camphanyl chloride (0.09g. 0.45 m.moles) in toluene (0.2 cm3 ) was 
treated with a solution of 3-aminopropanoic acid (0. 0254g, 0.3 
m.moles) in aqueous sodium hydroxide (0.17cm3 , 2N plus 0.17cm3 , 314) 
and the mixture stirred vigorously for 3 h. The reaction mixture was 
extracted with chloroform 2 cr1? X 3) and the aqueous portion acidified 
(pH 1-2) with 614 hydrochloric acid then extracted with chloroform (5 
I 
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cii? x 3). The organic phase was dried and evaporated to dryness under 
reduced pressure to afford an oil which slowly solidified (0.085g). 
The crude material was recrystallised from chlorofonnv40-60 0 petroleum 
ether to afford N-camphanoyl-3-aminopropanoic acid (16) (0.055g. 65%) 
m.pt 129-131°C lit 33 128_1300. 6(80MHZ, cDCl 3 ) 7.0 ppm (1H, br.s, 
COOH) 3.5 ppm (211, m, CJçNHCO), 2.7 ppm (2H, t, 3 - 6 Hz, CH2 CO2 H), 
1.8 pp (211, m, camphamyl 0) 1.7 ppm (211, in, camphanyl 	1.1 (611, 
S, camphanyl 2 x Cr13 ), 0.8 ppm (3H, s,camphanyl CH) ins (El) nt/z 269 
W1. 
N-Camphonyl-3-aminopropanoic acid methyl valine amide (17): 
N-Camphonyl-3- aminopropanoic acid (0.050g, 0.18 m.ntoles) from the 
above reaction in dry tetral-iydrofuran (2 cii?) was treated with 1, 
3-dicyclohexylcarbodiimide (0.05g, 0.24 m.moles) and added to methyl 
valine (0.05g, 0.3 m.moles) in dry ethyl acetate (4 cm3 ). The mixture 
was stirred at room temperature overnight then filtered and evaporated 
to dryness in vacuo to afford a crude product which was purified by 
flash column chromatography on silica gel (Kieselgel H type 60) using 
chloroform as the mobile phase. The purified product was 
recrystallised from chlorofonnv40°-60 0 petroleum ether to give 
N-camphonyl-3-aninopropanoic acid methyl valine amide (17, 0.04g, 56%) 
-a- 
rn.pt.142-144°C\6(8OriHz, CDC1 3 ), 7.0 ppm (H, d, .1-10Hz, NHCO Camphanyl), 6.25 
ppm (1H, brs, NH-methyl valine), 4.5 ppm (1H, dd, 3 = 6Hz, CH2 Moo) , 
2.4 ppm (2H, m, CH2 CONH), 1.8 ppm (211, m, cançhonyl CH2 ), 1.7 ppm (2H, 
M, camphonyl 	1.1 ppm (6H, s, 2 xCI), 0.8 ppm (3H, 5, caniphonyl 
C1). ins (El) nVz382 [1€]. 
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Feeding experiments 
11-13 C,2-2 H2 1-3Nitropropanoic acid (7). Penicillium atrovenetum was 
cultured on Czapek Dox slopes and then grown in modified Raulin Thom 
medium (50 cm3 x 2) in static culture. Growth was maintained in the 
light at 30°C for, 24 h. and the culture then treated with (1-' 3 C, 
2_2; 1-3-nitropropanoic acid (7) (10 mg per flask) and the incubation 
continued for a further 72 h. the mycelium was removed by filtration, 
the medium acidified with conc. hydrochloric acid (ca pH 1-2) and 
extracted with ether (100 cm3 x 5). The ethereal fractions were 
combined, dried and evaporated in vacuo to give a yellow crystalline 
solid which was recrystallised from chloroform to afford 
3-nitropropanoic acid (1, 80 mg). 6 400 MHz, (CDC1 3 ) carboxyl region 
only 173.334 ppm, 172.716 ppm. ins (FM -ye) nvz 122 (small), 121, 120. 
Deuterated aspartic acids 
Modified Raulin Thom medium (50 cm 3 x 2) was inoculated with 
Penicillium atrovenetum from Czapek Dox slopes and the culture 
incubated under static conditions at 30°C for 42 h. then pulse fed 
with the deuterated L-aspartic acid in distilled water at 42, 48 and 
54 h. after innoculation (total 20 mg). The flasks were worked up as 
described above 96h. after the initial inoculation and 
3-nitropropanoic acid isolated and recrystaflised from chloroform. 
In the time course experiments, flasks were worked up 72 and 96h. 
after inoculation and the 3-nitropropanoic acid isolated as described 
above. The product was examined by 2 H nmr spectroscopy (see table in 
results and discussion). 
-136- 
3-Nitropropanoic acid methyl valine amides: 3-Nitropropanoic acid (1) 
isolated from the Penicillii.im atrovenetum was treated with 
1,3-dicyclohexylcarbodiiuij.de (1.1 mol. equiv) and with methyl valine 
(1.1 mol. equiv.) in dry THF/ethyl acetate (1:1) and the reaction 
mixture stirred at room temperature overnight. After this time the 
reaction mixture was filtered and the solvent removed in vacuo to 
afford the crude product which was purified by flash column 
chromatography using chloroform/methanol as the mobile phase. The 
product was identified by comparison (tic) with an authentic sample 
prepared previously. 
5 xqJ-Nitrosuccinj.c acid (5): Modified Raulin Thom medium (50 cm 3 x 2) 
was inoculated with Penicillium atrovenetum a described above. The 
cultures were treated with [ 15N]-nitrosuccinic acid (20 mg) after 42, 
48 and 54h. and the 3-nitropropanoic acid (1) isolated after 96h. as 
described above. The recrystaflised sample was identified by 
comparison (tic) with authentic 3-nitropropanoic acid. 
Isolation of 3-Nitropropanoic acid reductase 
The method of Shaw24 was used, with the exception that cultures were 
grown in a static state in the light since dark-grown cultures failed 
to produce reductase activity in crude extracts. 
The crude mycelium from cultures grown in modified Raulin Thom medium 
(2 x 50 cm3 per extraction) were harvested at various time intervals. 
Crude extracts were prepared from the frozen mycelium by grinding and 
extracting the mycelium at 0°C in phosphate buffer (pH 7.2). The cell 
debris was removed by centrifugation at 0-4°C (3,000 g, 20 mm.) and 
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the crude extract assayed for enzyme activity (see below). Activity 
was found in extracts from mycelium harvested between 84 and 110 
hours. 
Extracts which possessed activity were combined and treated with solid 
ammonium sulphate (24.2g/100 cm3 ) to 40% saturation then centrifuged 
(20,000g, 20 mm.) and the supernatant retained. Treatment with 
additional ammonium sulphate (18.8aJ100 cm 3 ) to 65% saturation and 
centrifugation (20,000g, 20 rain.) gave a pellet of protein which was 
resuspended in phosphate buffer (0.05M) then dialysed at 2-4°C 
overnight. By this method, from 2g of mycelium, sufficient enzyme was 
isolated to hydrolyse 1 pmole of N1DPH per mm. The partially 
purified enzyme extract was stored frozen at -15°C until used. 
Assay of 3-nitropropanoic acid reductase. 
The assay procedure followed was essentially that of Shaw24 . The 
assay mixture contained potassium phosphate (pH 5, 100 pmoles) NPIDPH 
(0.3 pmoles), 3-nitroacrylic acid (3.0 p moles), enzyme extract (0.3 
cm3 equivalent to 0.075 g of wet mycelium) made up to a final volume 
of 1.5 cne with water. The oxidation of WIDPH was monitored 
spectrophotometrically at 340 rm. 
Incubations with 3-nitropropanoic acid reductase. 
The enzyme was incubated with 3-nitroacrylic acid (6) in both water 
and. deuterated water in the presence of stoicheometric amounts of 
NADPH. The reaction was monitored spectrophotometrically and the 
3-nitropropanoic acid isolated by acidification (pH 17.2, 6W 
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hydrochloric acid) and extraction into ether. The ethereal extracts 
were dried and evaporated to dryness in vacuo and the product 
identified by comparison (tic) with an authentic sample of 
3-nitropropanoic acid. 
Ethyl 2-methyl--4-hydroxypyrimidine-5-carboxylate (41): Acetamidine 
hydrochloride (1.24g, 0.013 moles) was added to an ice cold solution 
of sodium (01. 30g, 0.013 moles) in ethanol (10cm3 ) and the mixture 
stirred at 0°C until the acetamidine had dissolved. The reaction 
mixture was filtered through celite, treated with 
diethylethoxymethylene malonate (2.84g, 0.13 moles) and stirred at 0 0  
for 3h. The reaction was then treated with a further aliquot of 
sodium (0.30g. 0.013 moles) in ethanol (10 cm3 ) and stirred at room 
temperature overnight. The ethanol was removed by evaporation in 
vacuo and the yellow residue suspended in water (20 cm3 ) washed with 
ether (10 cm? x 2) and the ether washings discarded. The aqueous 
portion was acidified with glacial acetic acid to pH 5-6 then 
extracted with ethyl acetate (20 cm3 x 3). The organic -fractions were 
combined, dried and evaporated to dryness in vacuo to afford the crude 
crystalline product which was recrystallised from acetone to afford 
ethyl 2-methyl-4-hydroxypyrimidine-5-carboxylate (41) 1.18g. (50%) 
m.pt. 190-192°C, lit96 191°C 6(8014Hz, cDc].3 ) 8.7 ppm (0.67 H, s, Cu 
aromatic), 7.25 ppm (0 .33H, 5, CH aromatic), 4.50 ppm (2H, q, 3 7Hz, 
CR2 ) 2.60 ppm 	s, aromatic Cu3 ), 1.35 ppm (311, t, 3 = 7Hz, CH 0' 
ms (El) nvz 182 [1?]. 
Ethyl 2-methyl-4-chloropyrimidine-5-carboxylate (42) 
(a) Ethyi.2-methyl-4-hydroxypyrimidine-5-carboxylate (41) prepared 
above (0.1g, 0.55 m.moles) was treated with phosphorous trichloride 
(0.25 cm3 ) then sealed in a tube and heated to 100°C for 30 mm. 
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Excess phosphorous trichloride was removed by evaporation under 
reduced pressure and the residue treated with ice water, neutralised 
with solid sodium carbonate and extracted with ethyl acetate (5 cm3 x 
3). The dried, evaporated organic fraction gave a white crystalline 
solid which was identical with starting material (tic). 
Ethyl 2-methyl-4-hydroxypyrimidine-5-carboxylate (41) (0.11g. 0.55 
m.moles) in chloroform (0.5 cm3 )was treated with thiony]. chloride 
(0.5 cm3 , 0.8g, 6 m.moles) and the reaction mixture heated under 
reflux for 2h. then cooled in ice, treated dropwise with ice water, 
neutralised with solid sodium carbonate and extracted with ethyl 
acetate (5 cii? x 3). The dried and evaporated organic fraction gave a 
brown oil which appeared, from tic, to contain a number of products. 
Ethyl .2-methyl-4-hydroxypyrimidine_5_carboxylate (41) (1.0g, 5.5 
m.moles) was treated with phosphorous oxychloride (8 cm3 , 13 g, 0.85 
moles) and heated to 78-80°C for 3h. Excess phosphorous oxychioride 
was removed by evaporation under reduced pressure and the residue 
cooled in ice and treated with ice water. The reaction mixture was 
then neutralised with sodium bicarbonate and extracted with chloroform 
(20 cm3 x 3). The organic fractions were combined, dried and 
evaporated to dryness under reduced pressure to afford the product as 
an oil which was purified by flash chromatography to give 
ethyl 2-methyl-4-chloro pyrimidine-5-carboxylate (42) 0.42g (38%). 
This product was unstable.in the presence of light and air and 
analytical data could not be obtained. Vacuum distillation led to 
decomposition. 6 (80 MHz, CDC1 3 ) 9.0 wn (1H, S, CU aromatic), 4.4 
ppn (2H, q, 3=7Hz, Cu2 ) ins (El), nvz 200 (Kt 1, 165 IM-ClJ. 
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Ethyl 2-methyl-4-methoxypyrimidine--5-carboxylate (43): 
Ethyl •.2-methyl-4-chloropyrimidine-5--carboxylate prepared above (42, 
0.1g. 0.5 m.moles) in methanol (5 cm ) was treated with sodium 
methoxide (0.03g, 0.06 m.moles) and the mixture stirred at room 
temperature for 4 h. The reaction mixture was then filtered and 
evaporated to dryness in vacuo and the residue treated with water (5 
cm3 ) then extracted with ethyl acetate (5 cm 3 x 3). The organic 
fractions were combined, dried and evaporated to dryness under reduced 
pressure to afford a mixture of the ethyl and methyl esters of 
2-methyl-4-methoxypyrimidine-5-carboxylate (43) (0.085g) m. pt. 100-101 
ref73 101-102 8(80MHz, CDC1 3 ) 9.4 ppm (1H, s, aromatic CH), 4.7 ppm 
(ill, q, J = 7Hz, CO2 CH2 ), 4.4 ppm (311, 5, OCR3 ), 4.2 ppm (1.911, s, 
CO2 CH3 ), 3.0 ppm, (311,s, aromatic CR3 ), 3.0 ppm, (311, s, aromatic 
1.65 ppm (1.511, t, J = 7Hz, CO2 CH2 CR3). Separation of the two 
esters by tic was not possible therefore the crude product was used 
without further purification. 
2-methyl-4-methoxy-5-hydroxymethylpyrimidine (44): The mixture of 
esters prepared above (0.1g) in t-butanol (3 ci?) was treated with 
sodium borohydride (0.03g, 0.8 m.moles) and heated to 80°C. Methanol 
(1.5 cm3 ) was added dropwise and the reaction mixture then refluxed 
for 3h. After this time the reaction mixture as allowed to cool to 
room temperature, acidified (pH 1-2, 2N hydrochloric acid), 
neutralised with saturated sodium bicarbonate and extracted with ethyl 
acetate (10 cii? x 3). The organic fractions were combined, dried and 
evaporated to dryness in vacuo to afford the crude product which was 
purified by flash column chromatography using chloroform/ethanol as 
eluant to give 2-methyl-4-methoxy-5-hydroxymethyl pyrimidine as a 
colourless crystalline solid (44, 0.04g), 8(8014Hz, C0ç1 3 ), 8.5 ppm 
(1H, s, CH aromatic), 5.3 ppm (1H, brs, OH), 4.65 ppm (2H, 5, CH2OH), 
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4.10 ppm (311, s, 0Q13 ), 2.9 ppm (311, s,CH3 ) ins (El), nvz 155 (Mi-11, 
140 (M-M3 1. 
HI -2-Nethyl-4-znethoxy-5-hydroxymethylpyrimidine (45) : The 
deuterated material was prepared in an identical fashion to the 
non-deuterated compound by reduction of the mixture of methyl and 
ethyl esters of 2-methyl-4-methoxypyrimidine-5-carboxylate (43) with 
sodium borodeuteride. The product was isolated as a colourless 
crystalline solid with identical tic characteristics to the 
non-deuterated compound. 8 (8011Hz, OX13 ) 8.50 ppm (1H, 5, CH 
aromatic) 4.65 ppm (111, 5 CEf 4 HOH), 4.10 pm (311, s, CQ, 2.90 ppm 
(311, s, CR3) ins (El) aVz 156 [MI-1], 141 [N-CR3 ]+ - 
2-methyl-4-hydroxy-5-hydroxymethylpyrimidine (34): 
(a) Ethyl-2-methyl-4- hydroxypyrimidine-5-carboxylate (41, 0.46g, 2.5 
m.moles) in dry tetrahydrofuran (50 cii?) was added to a suspension of 
lithium aluminium hydride (0.45 g, 12 m.moles) in dry tetrahydrofuran 
(20 cii?) and the mixture stirred at room temperature for lh. then 
refluxed for 45 mm. until a faint yellow colour was observed. The 
reaction mixture was cooled in ice, treated dropwise with water (0.5 
cii?) and the precipitate collected by filtration then added to 
phosphoric acid (d 1.71, 1.05 cm 3 ) in water (50 cm3 ). The reaction 
mixture was heated at 100°C for 30 mm. and the hot solution filtered, 
neutralised with aqueous sodium hydroxide (OA  M) and evaporated to 
dryness under reduced pressure to afford a colourless residue. This 
solid material was extracted with boiling ethanol (60 cm 3 x 3, 20 
rain.). The ethanolic extracts were combined and evaporated to dryness 
to afford a colourless solid which was recrystallised from dioxane to 
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give 2-methyl-4-hydroxy-5-hydroxymethylpyrinddine (34) 0.02g, (6%) 
m.pt. 213-215°C, lit... 212-213°C 6(8011Hz, d 6 -.DMSO), 7.80 ppm (1ff, 5, 
CH aromatic) 4.30 ppm (2H, 5, CH2 OH), 2.54 ppm (3ff, S, 	C1) ins 	(El) 
iiy'z 140 EM1, 123 (14-OH1, 82 
(floff_QJ3Qflf 
(b) 2-Methyl-4-amino-5-hydroxymethylpyrimidine (35, 0.2g, 1.4 m.noles) 
was taken up in hydrochloric acid (6N,m 5 cue) and the reaction 
mixture heated under refiux for Sh. then evaporated to dryness in 
vacuo. The colourless product was crystallised from ethanol/ethyl 
acetate to afford 2-methyl-4-hydrox7-5-hydroxymethylpyrimidine (34) 
0.16g (82%) which had identical characteristics (tic, m.pt, nmr) to an 
authentic sample prepared above. 
_2 H2 1-2-flethyl-4-hydroxy-5-hydroxynthylpyrimidine (37): The above 
reaction was repeated using lithium aluminium deuteride and the 
product isolated and recrystallised as before (37) 0.025g, (7%) m.pt. 
213-214°C 6(80MHz, d 6 DMSO) 7.80 ppm (1H, 5, CH aromatic), 4.30 ppm 
(0.5ff, 5, CIfHOH), 2.54 ppm (3ff, s,-CH) ins (El) m/z 142 [flJ 124 
(M-CM], 83 (M-H2 0-cH3 cN1 
Cyanoethoxymethylene acetate (46): Ethylcyanoacetate (28.25g, 0.25 
moles) triethylorthoformate (36g, 0.25 moles) and acetic anhydride 
(51g, 0.5 moles) were refluxed together for 1.5 h. then unreacted 
starting material distilled off at 160°C. The residual oil slowly 
solidified giving yellow crystals which were recrystallised from 
ethanol to afford cyanoethoxymethylene acetate (46) 13g (30%) m.pt. 
121-123°C lit .. 122-123°C 6(80MRz,cDC13 ) 7.9 ppm (111, s, CH), 4.25 
ppm (4ff, 2xq, 3 = 7Jz, Cff x 2), 1.3 ppm (6ff, 2xt, 3 = 7Hz, ac x 2). 
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2-Methyl-4-hydroxypyrimidine-5-carbonitrile (47): Acetamidine 
hydrochloride (6.7g, 0.07 m.moles) was added to a solution of sodium 
(1.7g. 0.07 m.moles) in ethanol (35 cm3 ) at 0°C. After shaking to 
dissolve the acetamidine, the mixture was filtered through celite and 
the clear filtrate treated with cyanoethoxymethylene acetate (5.6g, 
0.03 m.moles). The reaction mixture was stirred at room temperature 
for 2h. then stored at 0°C overnight and the orange/yellow crystals 
which formed were isolated by filtration, and recrystallised from 
ethanol to afford the intermediate dimer (49) 3.75g (28%) 8(80 MHz, 
CDC1 3 ) 7.8 ppm (1H, s, CH), 2.0 ppm (3H, 5, 013 ) 1.95 ppm (3H, 5, 
0). A sample of this product (1.5g, 7.7 m.moles) in ethanol (10 
cm3 ) was treated with hydrochloric acid (0.514, 15 cm and the 
solution heated to 100°C for 10 mm. then allowed to cool to room 
temperature overnight. The colourless crystals were isolated by 
filtration, washed with ice water and dried to afford 
2-methyl-4-hydroxypyrimidine -5-carbonitrile (47) 0.4g, (38%) m.pt. 
230-232°C lit 104  233-235°C 8(80MHZ, Cd 3 ) 8.7 ppm (iN, 5, CH 
aromatic), 2.75 ppm (3H, 5, CH 3)  ins nVz (El) 135 [7?], 107 [n.a)] 
2-methyl-4-aminopyrimidine-5-carbonitrij.e (39): Acetamidine 
hydrochloride (0.8g. 8.5 m.moles) was added to a solution of sodium 
(0.21g, 9.1 m.moles) in ethanol (4 cm3 ) at 0°C. The mixture was 
shaken to dissolve the acetamidine, filtered through celite and the 
clear filtrate treated with ethoxymethylene malonitrile (0.5g. 4.1 
m.moles). A dense precipitate formed immediately which was separated 
by filtration and crystallised from ethanol to afford 
2-methyl-4-aminopyrimidine--5-carbonitrile (39), 0.23g (42%) 6(80MHz, 
2 H2 0+2 HC1) 8.75 ppm (111, s, Cl! aromatic), 2.85 ppm (311, 5, 013 ) ins 
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(El) nVz 134 [?.1], 94 [n-a13 cNJ 
	
C6 H6 N4 requires C, 53.7%; H, 4.5%; 
N, 41.8%. Found C, 53.4%, H, 4.6%; N, 42.0%. 
2-Methyl-4-aminopyrixnidine-5-carbaldehyde. (40) t Raney nickel (0.25g) 
was activated by stirring with aqueous sodium hydroxide (2N, 6 cm 
for 30 min. then the aqueous portion decanted off and the residue 
washed with water (10 cm3 x 2). The active catalyst was added to the 
nitrile prepared above (39, 0.5g, 1.1 m.moles) in formic acid 
(98-100%, 2.5 cm3 ) and the mixture stirred at 80-100°C for 45 mm. 
The reaction mixture was then filtered through celite and the celite 
washed with ethanol/Water (3:2, 5 cm 3 x 2). The filtered reaction 
mixture and the washings were combined and the ethanol removed by 
evaporation in vacuo to leave an aqueous portion which was neutralised 
with sodium bicarbonate and extracted with ethyl acetate (10 cm3 x 4). 
The organic fractions were combined, dried and evaporated to dryness 
to afford the aldehyde as an off, white solid which was crystallised 
from ethanol to afford 2-methyl-4-aminopyrimidine-5-carbaldehyrje (40), 
0.075g m.pt. 192-194°C, lit133 , 195-196°C. 6 (80MHz, d 6 -DMSO) 9.8 ppm 
(1H, s, 010), 8.6 ppm (IN, s, CH aromatic), 2.4 ppm (311, s, C11) ins 
(Er) nVz, 137 [t4] 109 ffl-001. 
2-Methyl-4-amino-5-hydroxymethy]. pyrimidine (35) 
2-Methyl-4-aminopyrimidine-5-carbaidehyde (40, 0.5g, 3.7m. moles) in 
methanol (25cm3 ) was treated with sodium borohydride (0.2g. 5.3 
m.moles) and the reaction mixture stirred at room temperature for 30 
nun. The reaction was then treated with further sodium borohydride 
(0.1g, 2.6 m.moies), stirred at lOOm temperature for 30 minutes, then 
quenched with hydrochloric acid (2N, 3.2 cm 3 ). The solution was 
evaporated to dryness under reduced pressure and the çesidue extracted 
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with hot ethanol (10cm3  x 3). The ethanol extracts were combined and 
evaporated to dryness in vacuo to afford a colourless solid which was 
recrystallised from ethanol to afford 2-methyl--4--amino-5-
hydroxymethylpyrimidine (35) 0.48g (93%) m.pt. 198-200°C lit' 33 
193-194°C 6(80 M.Hz.,d6 DM80) 8.50 ppm(2H, br.s, NH2 ), 8.05ppn 
(111,s, Cu aromatic), 4.35ppm (2H,S,CH 2 ), 2.50ppm (3H,s,CIç) ins (El), 
nvz 139 U?], 122 (N-OH], 110 [M-MO). 
1 _2 
H1-2-Methyl-4-amino-5-hydroxymethylpyrjnhjdine (36) 
2-Methyl-4-aminopyrimidine-5-carbaldehyc3e (40, 0.1g, 0.7 m.xnoles) in 
methahol (8cm3 ) was treated with sodium borodeuteride (0.04g, 0.95 
m.moles) and the reaction mixture stirred at room temperature for 30 
minutes. The reaction was treated with further sodium borodeuterjde 
(0.02g. 0.48 m.moles) and stirred at room temperature for 30 minutes 
then quenched with hydrochloric acid (2N, 0.6 cn?) and evaporated to 
dryness in vacuo. The residue was extracted with hot ethanol (5cm 3 x 
3) and the ethanol extracts combined then evaporated to dryness under 
reduced pressure to give the crude product which was recrystallised 
from ethanol to afford [5'-'HI-2-methyl-4-amino-5-
lit 1, 	3i' 
hydroxymethylpyrimidine (36), 0.075g (76%). nt.pt. 196-1980c -16 (80MHZ, 
DM80 8.5ppm (2H, br.s, NH2 ), 8.05ppn (1H,s,CH aromatic), 4.35ppn 
(111, 5, CHD), 2.50ppm (3H, s,CH) ins (El) nvz, 140 (74) 110 (N 
-CHDOH), 82 [123 - 013 Cr4]. 
H J-2-Methyl-4-hydroxy-5-hydroxymethylpyrjnujdine (37): ,_2 H]-2- 
Methyl-4-amino-5-hydroxymethylpyrimidine (36) (0.3g, 2. 16m.moles) was 
added to hydrochloric acid (6N, Scn?) and the reaction mixture treated 
at 100 1c for 30 win. After this time the reaction was evaporated to 
dryness in vacuo and the residue recrystallised from ethanol/ethyl 
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acetate to afford [51- 2  H ]-2-methyl-4-hydroxy-5-hydroxymethylpyrjnudjne 
(37) 0.26g (77%) m.pt. 198-200°C 6(400 MHz, d 6 DMSO) 7.8 ppm (1H, s, 
CH aromatic) 4.20 ppm (1.1H, 5, CIfHOH), 2.50 ppm, (3H, s, dc) ins 
(El) nVz, 41 (MI, 124 [H-OH]. Heating for >45 mm. lead to 
substantial loss of deuterium as measured by ins 
2-Methyl-4-amino-5-methylanilinopyriznidine (32) (a) Thiamine (1, 
0. 5g, 1.48 m.moles) in ethanol/Water (3:2, 12cm3 ) was treated with 
aniline (0.14g, 1.50 m.moles) and sodium metabisulphite (0.0g, 0.15 
m.moles) and the mixture refluxed for 1 h. The cooled reaction 
mixture was acidified (6N hydrochloric acid), washed with ether, 
neutralised (4N sodium hydroxide) and extracted with ethyl acetate 
(20cm3 x3). The ethyl acetate fractions were combined, dried and 
evaporated to dryness under reduced pressure to afford an oil (0.15g) 
which was purified by preparative tic using chlorofozittnnethanol (9:1) 
as the mobile phase and recrystallised from ethanol to afford 
2-methyl-4-amino-5-methylanilinopyriinidine (32), 0.08g. m. pt. 
168-170°C, lit 88  167-169°C ins, (El), n/z 214 [J 122 [N - C 6 HNHJ 
(b) Thiamine (1, 6.01g, 0.03 m.moles) was incubated with thiaminase x 
in phosphate buffer (pH5, 2cm3 ) containing aniline (0.005g. 0.06 
m.moles) and the appearance of (32) followed spectrophotometrically at 
248 mu. After incubation overnight at 37°C, the mixture was 
acidified, (6 N hydrochloric acid) washed with ether, neutralised (2 N 
sodium hydroxide) and extracted with ethyl acetate (2cm x 3). The 
ethyl acetate fractions were combined, dried and the solvent removed 
by a stream of nitrogen. The residue was examined by capillary gc4ns 
and found to be identical to the authentic product prepared above. 
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2-Methyl-4-amino-5-methylsulphonatepyrimidine (50) 
Thiamine hydrochloride (1, 0.5g, 1.48 m.moles) in water (2cm3 ) was 
treated with sodium metabisuiphite (0.3g, 1.6 m.moles) and the 
solution heated in a boiling water bath for 10 minutes. The cooled 
reaction mixture was left standing at room temperature overnight and 
the white crystals which formed were isolated by filtration, washed 
with ice water and dried in vacuo to afford 2-methyl-4-amino-5.-. 
methylsuiphonatepyrimidine (50), 0.30g (98%). 
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Isolation of thianilnase I. 
Bacillus thiaminolyticus from nutrient agar slopes was grown initially 
in nutrient broth in a shake culture for 20 h at 35°C. An aliquot 
(5cm3 ) was then transferred to the 100cm3 of the defined medium of 
Douthit and Airth87  and the culture grown in shake culture at 37°C for 
a further 20h. The culture was then centrifuged (30,000 rpm, 15 mm.) 
at 0-4°C. The precipitate was discarded and the supernatant treated 
with ammonium sulphate (to 75% saturation, 516g l') at 0-4 ° °C. The 
precipitate which formed after 5-6h. was collected by centrifugation 
(30,000 rpm 20 mm), taken up in distilled water and desalted using an 
Amicon filter unit. Desalting by dialysis led to an extract of low 
activity. The enzyme was stored frozen in aliquots at -20°C. 
Assay of thiaminase I 
The assay procedure was essentially that of Douthit and Airth 7 . 
Sodium phosphate buffer (0.1m, pH 5.8) and aniline (11.5 x 10 4 M, 10 
p11100 cm3 ) was treated with thiamine (5 x 10 7M, l7mg/100cm3 ) or 
thiamine pyrophosphate (5 x 10 n, 23mg/ 100cm3 ) and an aliquot of the 
crude enzyme (0.2cm3 /2cm3 ) and the formation of the anilinopyrimidine 
product followed spectrophotometrically at 248nm. Activity against 
thiamine pyrophosphate was found to diminish more rapidly than 
activity against thiamine itself over a period of months (vide infra). 
Production of thiamine by Saccaromyces cervisiae 
The growth of the yeast in the thiamine-free medium was monitored 
using a haemocytometer. A short lag phase (2h) was followed by a 
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rapid growth phase lasting a further 7h. and this was followed by a 
static phase. After 20h. the incubate contained ca 3 x 10 
cells/cm'. Thiamine was isolated from the yeast cells after 20h. by 
boiling the centrifuged cells in 0.1 N hydrochloric acid (5cm3 ). They 
were centrifuged and extracted once again and the pH of the 
supernatant adjusted to ca 6.5. The supernantant was then incubated 
with takadiastase which also possesses phosphatase activity. A sample 
of the supernatant (5cm3 , 25%) was analysed for thiamine using hplc. 
Thiamine was converted to its thiochrome derivative by the addition of 
potassium ferricyanide (0.3M, 3cm3 ) in sodium hydroxide (3.75M). The 
mixture was then shaken vigorously for 2 mm. and left to stand in the 
dark for 10 Mn. after which time it was filtered through a millipore 
filter (0.45 pm) into a vial for hplc analysis. Standard solutions of 
known thiamine concentration were treated in an identical fashion. 
Ten microlitres from each sample was injected on a 25cm x 4.6mm p - 
Bondapak C18 column using water : methanol (7:3) as mobile phase and 
running at 2cm3,kdn. Peaks were detected using a Perkin-Elmer t.S-5 
luminescence spectrometer fitted with a 8pl flow cell with excitation 
at 365nm and emission at 435nm. Calibration curves were constructed 
by plotting peak heights against concentration. Using this method, 
the amount of thiamine per 50cm3 incubation was found to be ca 2.4pg. 
Capillary gcAtts analysis of thiamine as its aniline derivative 
The thiamine isolated from yeast cells as described above were treated 
with thiaminase I as described previously and the pyrimidine/aniline 
derivative (32) extracted into ethyl acetate then blown to dryness in 
a stream of nitrogen. The residue was taken up in ethyl acetate 
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(204) and a sample (54) injected onto a BPI fused silica capillary 
column (12.5m x 0.3m i.d.) The temperature programme used started at 
70°C and increased at 30 04ni.n. to 220°C then at 5 04nin to 280°C. The 
total ion current was monitored however it revealed little about the 
required product therefore ions of 214-215 (the M peak for the 
aniline derivative) and 122-123 (N-aniline) were also monitored. The 
column output was measured directly using a Kratos ms 80 RFA mass 
spectrometer operating in the El mode. Under these conditions, the 
aniline pyridine compound (32) had a retention time of 8mm. 
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Cleavage of nucleic acids in reverse micelles 
Samples were prepared in duplicate containing 1 p1 buffer (50 mm NaC1, 
100 mM Tris Cl pH 7.5, 100 mm MgCl2 , lO nfl dithiothreitol), enzyme (1 
pL ca lOu), DNA (1-2 p1, lpg) and then made up to 10 p1 with sterile 
distilled water. One sample was treated with a solution of sodium 
sulphosuccinate dioctyl ester (A(YT) in hplc grade hexane (100 mm or 50 
mM) and vortexed vigorously until visually clear while the other was 
vortexed. Both samples were then incubated at 37°C overnight. After 
incubation the samples were placed at -25°C for 2h or at -78°C for 30 
mm. then treated, while still cold, with water (10 p1) and loading 
buffer (2 4ul). Following centrifugation in an eppendorf centrifuge 
(15000 rpm, 5 mm.) the aqueous phase was removed and applied to a 1% 
aga rose gel containing 0.5 pg/cm3 ethidiunt bromide. Bands were 
visualised by ultraviolet illumination. 
In the annealing experiments, samples were incubated as described 
above with and without enzyme and the reversibility of the annealing 
process demonstrated by heating the sample to 65°C prior to gel 
electrophoresis. 
-152- 
Williams, M.C., Canadian J. Botany, 60, 1956, 1982. 
Turner, W.B., Fungal Metabolites, Academic Press, London, 1971, 
pp.303-304. 
Alston, T.A., Pharmacol. Therapy, 12, 1, 1981. 
Coles, C.J., Edmonson, D.E., Singer, T.P., J. Biol. them., 254, 5161, 
1979. 
Porter, D.J.J., Bright, H.J., J. Biol. them., 255, 4772, 1980. 
Hamilton, B.F., Gould, D.H., Aeta Neuropathol. (Bed), 72, 286, 1981. 
Carter, C.L., McChesney, W.J., Nature, 164, 575, 1949. 
Gorter, K., Bull. .Jard. Bot. Buitenz. Ser. XII, 3, 187, 1920. 
Carter, C.L., J. Soc. them. Ind. (London), 62, 238T, 1943. 
Candish, E., La Croix, L.3., Unrau, AM., Biochem., 8, 182, 1969. 
Raistrick, H., Stossl, A., Biochein. 3., 68, 647, 1958. 
Dextader, K.G., Alexander, N., Canadian J. Nicrobiol., 12, 807, 1966. 
-153- 
Hooper, A.B. in Microbiology ed. D. Schlessinger, Amer. Soc. 
Microbiol., Washington D.C., 1978, pp.229-304. 
Birch, A.3., McLaughlin, 3.3., Smith, H., Winter, 3., them, and id., 
26, 840, 1960. 
Gatenbeck, S., Forsgren, B., Acta. them. Scand., 18, 1750, 1964. 
Hylin, 3.W., Matsumoto, H., Arch. Biochem. Biophys., 93, 542, 1960. 
Baxter, R.L., Abbot, E.M., Greenwood, S.L., McFarlane, 1.3., J. them. 
Soc. them. Comm., 564, 1985. 
Burkenshaw, 3.11., Dryland, A.M.L., Biochem. 3., 93, 478, 1964. 
Gruner, 8.3., De Angelo, A.B., Shaw, P.D., Arch. Biochem. 
Biophys.,148, 107, 1972. 
Shaw, P.0., Wang, N., J. Bacteriol., 88, 1629, 1964. 
Shaw, P.D., McCloskey, 3.A., Biochem., 6, 2247, 1967. 
Baxter, Rd.., Greenwood, S.L., J. them. Soc. them. Comm., 175, 1986. 
O'Leary, M.H. in Transition states of biochemical processes, S. R.D. 
Gandour, R.L. Schowen, Plenum Press, New York, 1978, pp.288-290. 
Shaw,P.D., Biochem., 6, 2253, 1967. 
-154- 
Bycroft, B.W. and Wells, C.H. in Specialist Periodical Report; 
Amino-acids, peptides and proteins Vol. 8, ed. R.C. Sheppard, Royal 
Society of Chemistry, 1976, pp- 310-338 . 
Bycroft, B.W. in Specialist Periodical Report; Amino-acids, peptides 
and proteins Vol. 6, ed. R.C. Sheppard, Royal Society of Chemistry, 
1974, pp. 381-418 . 
Bentley, R., Molecular asymmetry in biology, Vol. II, Academic Press, 
New York, 1970, pp. 236-238 . 
Bentley, R., Molecular asymmetry in biology, Vol. II, Academic Press, 
New York, 1970, pp.238-240. 
Battersby, A.R., McDonald, E., Wurziger, H.K.W., James, K.J., J. 
Chem. Soc. them. Comm., 493, 1975. 
Herbert, LB., Mann, J., Tetrahedron Lett., 25, 4263, 1984. 
Reinheckel, H., Czech, H., Z. Chemie, 18, 214, 1978. 
Morris, G.A., in Topics in ' 3 C nmr spectroscopy vol. 4., ed. G.C. 
Levy, Wiley, New York, 1984, pp.179-196. 
Gani, D., Young, D.W., J. them. Soc., Perkin Trans. I, 1355, 1985. 
Baxter, ILL., Thompson, G.A., unpublished observation. 
-155- 
Brown, J.H., Parker, D., Tetrahedron Lett., 22, 2815, 1981. 
Ram, S., Ehrenkaufer, R.E., Tetrahedron Lett., 25, 3415, 1984. 
Dupont Durst, H., Tetrahedron Lett., , 2421, 1974. 
Bruice, T.C., Hegarty, A.F., Felton, 8.14., Donzel, A., Kundu, N.E., 
J. Amer. them. Soc., 92, 1370, 1976. 
Gunther, H., nmr spectroscopy. An introduction. J. Wiley, New York, 
1980, pp.182-184. 
Richards, EM., Tebby, J.C., Ward, R.S., Williams, D.H., J. Chem. 
Soc, C., 1542, 1969. 
Field, 5.3., Young, D.W., J. them. Soc. Perkin Trans. I, 2387, 1983. 
Feeney, 3., 'artington, P., Roberts, G.C.K., 3. Mag. Res., 13, 268, 
1974. 
Bell, R.A., than, C.L.., Sayer, B.G., J. them. Soc. them. Comm., 67, 
1972. 
l4aciel, G.E., Ellis, P.D., Hofer, D.C., J. Phys. them.; 2' 2160, 
1967. 
Cope, A.C., Melita, A.S., J. Amer. them. Soc., 86, 5626, 1964. 
46. 	Mizuno, A., Hamada, Y., Shioiri, T., Synthesis, 1007, 1980. 
-156-- 
Prostenik, LV., Butula, I., Angew. Chemie. mt. Edn., 21, 139, 1982. 
Dupont Durst, H., Zubrick, J.W., Kieczykowski, G.R., Tetrahedron 
Lett., 1777, 1974. 
Porter, D.J.T., Bright, J. Biol. them., 262, 14428, 1987. 
Brown, G.M., Williamson, 3.11., Adv. Enzymol., 53, 345, 1982. 
Leder, I.G., in Metabolic Pathways, Vol. 7, 3rd Edn., Ed. D.M. 
Greenberg, Academic Press, New York, 1975, pp.57-85. 
Young, D.W., Natural Prod. Rep., 3, 395, 1986. 
Jansen, B.C.P., Donath, W.F., them. Weekbl., 23, 201, 1926. 
Williams, R.R., dine, J.K., J. Amer. them. Soc., 58, 1504, 1936. 
Andersag, E., Westphal, K., Ber. Deut. them. Ges., B70, 2035, 1937. 
Lohmann, K., Schuster, P., Biochem. z., 12, 206, 1984. 
Hilvert, D., Breslow, R., Bioorg. them., 12, 206, 1984. 
tJgai, T., Tamaka, S., Dokawa, S., J. Pharm. Soc. .ipn., 63, 269, 1943. 
Ugai, T., Dokawa, T., Trubokawa, S., J. Pharm. Soc. Jpn., 64, 3, 
1944. 
-157- 
Breslow, R., J. Amer. Chem. Soc., 80, 3719, 1958. 
Breslow, R., Ann. New York Acad. Sci., 98, 445, 1962. 
Krampitz, L.D., Greull, G., Miller, C.S., Bicking, LB., Skeggs, 
H.R., Sprague, 7.M., J. Amer. them. Soc., 80, 5893, 1958. 
Deus, B., Ulirich, 3., Holzes, H. in Methods in enzymology, ed. D.B. 
McCormick, L.D. Wright, Vol. 18A, Academic Press, New York, 1970, 
p.259. 
Zoltewicz, .7.A., Kauffxnann, G.M., J. Amer. them. Soc., 99, 3134, 
1977. 
Fujita, A., Advances in Enzymology, 15, 389, 1954. 
Wittliff, 3.1.., Airth, R.L., Biochem., 7, 736, 1968. 
flutter, l.A., Slama, .7.T., Biochem., 26, 1969, 1987. 
bienhard, G.E., Biochem., 2, 3011, 1970. 
White, R.H., Rudolph, F.B., Biochim. Biophys. Acta., 542, 340, 1978. 
Estramareix, B., Therisod, M., Biochim. Biophys. Acta., 273, 275, 
1972. 
White, it!!., Biochem., 17, 3833, 1978. 
-158- 
White, R.H., Experientia, 36, 637, 1980. 
Estramarejx, B., Gaudry, D., Therisod, M., Biochimie, 59, 857, 1977. 
Bellion, E., Kirkley, D.H., Biochim. Biophys. Acta, 497, 323, 1977. 
White, R.L., Spenser, I.D., J. Amer. them. Soc., 104, 4934, 1982. 
Grue-Sorensen, G., White, R.L., Spenser, I.D., J. Amer. Chem. Soc., 
108, 146, 1986. 
Koziuk, T., Spenser, I.D., J. Amer. them. Soc., 109, 4698, 1987. 
Tazuya, K., Nomsaka, ii., Yamada, K., Kumaoka, H., Biochem. Int., 14, 
769, 1987. 
Tazuya, K., Monsaki, M., Yamada, K., Kumaoka, H., Biochem. Int., 16, 
955, 1988. 
De Angelis, F., Doddi, G., Ercolami, C., J. them. Soc. Perkin Trans. 
II, 633, 1987. 
Finglas, P.M., Faulks, R.M., Food them., 15, 37, 1984 
Covey, T.R., Lee, E.D., Bruins, A.P., Henior, J.D., Anal, them., 58, 
1451A, 1986. 
De foil, E., Shive, W., Biochem. Biophys. Res. Comm., 132, 217, 1985. 
-159- 
Zoltewicz, J.A., Kauffmann, G., Uray, G., Ann. New York Acad. Sc., 
378, 7, 1982. 
Bonvicino, G.E., Hennessy, D.J., J. Org . them., 24, 451, 1959. 
White, R.H., Rudolph, F.B., Biochent., 18, 2632, 1979. 
White, R.r..., Spenser, I.D., Biochem. i., 179, 315, 1979. 
?4ochida, K., Nakamura, T., Fujita, K., Bull Fac. Agric. Shirnane 
Univ., 18, 188, 1984. 
Douthit, H.A., Airth, R.L. Arch. Biochim. Biophys., 113, 331, 1966. 
Lehninger, Ad..., Biochemistry, 2nd Edn., Worth Publishers, New York, 
1975, pp.  731-733. 
Katritzky, A.R., Lagowski, .3.H., Advances in heterocyclic chemistry, 
Vol. 1., ed. Katritzky, A.R., Academic Press, New York, 1963, pp. 
386-370. 
Brown, D.J., The pyrimidines, J. Wiley and Sons, New York, 1962, 
Chapter XIII. 
Nishiwaki, T., Tetrahedron, 23, 2657, 1967. 
Nesbitt, P., Sykes, P., J. them. Soc., 3057, 1954. 
95. 	Staskun, B., Backeberg, O.G., J. Cheat; Soc., 58Q0, 1964. 
-160- 
Geissman, T.A., Schalter, M.J., Webb, I.D., Roberts, .J.D., J. Org . 
Chem., 11, 746, 1946. 
Santiello, J. Org. them., 46, 4584, 1981 
Soai, K., Oyamada, H., Ookawa, A., Synthetic Comm., 12, 463, 1982. 
Brown, H.C., J. Org . them., 28, 3261, 1963. 
Dohmori, R., Yoshimura, R., Shin-ichi, K., Tamaka, Y., Naito, T., 
Chem. ['harm. Bull., 18, 1908, 1970. 
Brown, H.C., Mead, E.J., Subba Rao, B.C., J. Amer. them. Soc., 77, 
6209, 1955. 
David, S., Estramareix, B., Hirshfeld, H., Sinay, P., Bull. Soc. 
thim. France, 936, 1964. 
Cline, •J.K., Williams, R.R., Finkelstein, J., J. Amer. them. Soc., 
59, 1052, 1937. 
Kitagawa, T., Mizukama, S., Hirai, E., them. ['harm. Bull., 22, 1239, 
1974. 
de Bellemont, M.E.G., Bull. Soc. thim. France, 25, 18, 1901. 
McCafferty, F.W., Interpretation of Mass Spectra, 3rd .Edn., 
University Science Books, California, .1980, pp.  193-194. 
-161- 
Fletcher, .3., Sax, 74., 1\irano, A., Chang, C-H., Ann. New York Acad. 
Sc., 378, 454, 1982. 
Cheng, C.H., Prog. Medicinal Chem., 6, 67, 1969. 
Schellenberger, A., Ann. New York Acad. Sci, 378, 51, 1982. 
Brown, S.A., in Biosynthesis, Vol. 1, Specialist periodical reports, 
Chemical Society, London, 1972, pp. 1-4. 
ill. Parish, 3.11., McPherson, N.J., Natural Prod. Rep., 4, 139, 1987. 
McPherson, M.3., Parish, 3.11., Natural Prod. Rep., 4, 205, 1987. 
Old, R.W., Primrose, .3.B., Principles of gene manipulation, 3rd edn., 
Blackwell Scientific Publications, Oxford, 1985. 
Thomas, 74., David, LW., J. fbi. Biol., 91, 315, 1975. 
Nath, K., Azzolina, B.A., in Gene amplification and analysis, ed. 
chirikjian, 3.G., Vol. 1, Elsevier, New York, 1981, p.113. 
Lewin, B., Genes xii, J. Wiley and Sons, New York, 1987, pp.551-555. 
Polisky, B., Greene, P., Garfin, D.E., McCarthy, 8.3., Goodman, H.M., 
Boyer, H.W., Proc. Natl. Acad. Sci, USA, 72, 3310, 1975. 
Nasri, 71., Thomas, D., Nucleic Acid Res., 14, 811, 1986. 
-162- 
Luisi, P.L., Angew. Chemie. mt. Edit, 24, 439, 1985. 
Mozhaev, V.V., Martinek, K., Enzyme Microb. Technol., 6, 50-59, 1984. 
Martinek, K., Berezin, I.V., Khmelnitski, Yu. L., Klyachko, N.L., 
Levashov, AN., Biocatalysis, 1, 9, 1987. 
Luthi, P., Luisi, P.L., J. Amer; them. Soc., 106, 7285, 1984. 
Wolf, R., Luisi, P.L., Biochem. Biophys. Res. Comm., 89, 209, 1979. 
irate, V.E., Luisi, P.L., Biochelu. Biophys. Res. Comm., 107, 538, 
1982. 
flaring, G., Luisi, P.L., Meussdoeffer, F., Biochem. Biophys. Res. 
Comm., 127, 911, 1985. 
Vieira, 3., Messing, 3., Gene, 19, 259, 1982. 
Maniatis, T., Fritsch, E.F., Sambrook, 3., Molecular cloning - a 
laboratory manual, Cold Spring Harbour, 1982, 'pp.11-13. 
Barker, D.F., Campbell, A.M., J. Bacterial., 143, 789, 1980. 
Kendall, E.C., McKenzie, B., Org. Syn. Coil. Vol I, 131. 
Kendall, E.C., McKenzie, B., Org. Syn. Coll. Vol I, 256. 
-163- 
Gresham, T.L., Jansen, J.E., Shaver, F.W., Frederick, M.R., Fedorek, 
F.T., Bankert, R.A., Gregory, J.T., Beears, W.L., J. Amer. Chem. 
Soc., 74, 1323, 1952. 
Schechter, H., Conrad, F., Daulton, A.L., Kaplan, R.B., J. Amer. 
Chem. Soc., 74, 3052, 1952. 
Price, D., May, E.L., Pickel, F.D., J. Amer. them. Soc., 62, 2818, 
1940. 




Identification of t.-Nitrosuccinate as an Intermediate in the Fungal Biosynthesis of 
3-Nitropropanoic Acid 
Robert L. Baxter,*a A. Bryan Hanley.' and Henry W.-S. Chanb 
a Department of Chemistry, University of Edinburgh, West Mains Road, Edinburgh EHS 3JJ, U.K. 
b AFRC Food Research institute, Coiney Lane, Norwich NG2 3RD, U.K. 
D,L.Diethyl [ 15 N)nitrosuccinate is efficiently incorporated into 3-nitropropanoic acid (1) by cells of 
Peniciliium 
atrovenetum; incorporation of i42.3.32H3IasPartate into (1) with retention of the C-2 deuterium of the amino acid 
allows assignment of the chirality of the intermediate. 
3Nitropropanoic acid (1) is a toxin produced by a number of 
fungi' and several plants of the family Fabaceae.2 The 
biosynthetic routes to this metabolite, although not charac-
terised in detail, appear to be markedly different in the two 
types of organism. 3  The fungal pathway is of especial interest 
since 3-nitropropanoic acid is implicated as a key intermediate 
in the nitrification pathway of Aspergillus and f-'enicillium 
strains. 4  Previous investigations with P. atrovenetum have 
shown that the amino nitrogen and carbons-2. -3 and -4 of the 
L-aspartate skeleton are incorporated as an intact unit 57 and 
that both oxygens of the nitro group are derived from 
dioxygen. 8  On this basis, three distinct routes from L-aspartate 
to (1) are possible in theory (Scheme 1). While route (a), via 
-alanine, can be discounted by the failure to incorporate label 
from 13.alanine into (1), 5  the alternative routes, involving 
decarboxylation either of N-hydroxyaspartate (2), or of 
nitrosuccinate (3), have proven difficult to test because of the 
instability of these compounds. 9  We have examined the 
incorporation of ' 5 N from D,L-diethyl [15N]nitrosuccinate into 
(1), reasoning that in vivo hydrolysis of the diester would be 
slow enough to liberate small quantities of the free acid within 
the cells and that subsequent incorporation of (3), while it 
would not preclude N-hydroxyaspartate as an earlier inter-
mediate, would show that complete oxidation of the amino 
group of aspartate to a nitro group precedes decarboxylation. 
Accordingly, D,c-diethyl [lsN]nitrosuccinate was prepared 
by treatment of diethyl bromosuccinate with Na' 5NO2 (94 
atom % 15N) in the presence of phloroglucinol'° and the 
diester was pulse fed to surface cultures of P. atrovenetum 
over a period of 36 h beginning 48 h after inoculation. The 
tH4ecoupled 15N DEPT n.m.r. spectrum of the isolated 
3-nitropropanoic acid in deuteniomethanol showed an intense 
signal at 3.4 p.p.m. (relative to MeNO2) corresponding to a 
14-fold increase of the 15N signal over natural abundance. The 
enrichment of the nitro nitrogen was also evident from the 
appearance of 15N satellites of both methylene,signals in the 
Ji nm.r. tpectrum of the metabolite (21N11 2.2 Hz, 31nu 3.7 
Hz) which corresponded in intensity to a 20 fold dilution of 
15N enrichment from the racemic diester. 
The stereochemistry of the intermediate nitrosuccinic acid 
was determined indirectly by examining the incorporation of 
deuterium from t[2,3,3.2H 3]aspartic acid (98 atom % 2H) 
into (1). The 2H n.m.r. spectrum of the enriched 3-nitropro-
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Figure 1. 55.3 MHz 2H N.m.r. spectrum of 3-nitropropanoic acid 
obtained from material biosynthetically enriched with 2l1 from 
L[2,3,3.2H3]aspartic acid, The spectrum was measured on a 1 M 
solution in acetone, spectral width 600 Hz, acquisition time 0.85 s, 
2000 transients. 
3-positions of the metabolite (Figure 1).t If inversion of the 
stereochemistry at the carbon derived from the C-2 of 
L-asparatate had occurred in the formationrof nitrosuccinic 
acid then no retention of deuterium of the 3-position of (1) 
would be expected. It follows that the stereochemistry at the 
t Partial toss of 211 derived from the 2-position of L_12.3,3- 2Hlasapar-
tate may arise through aspartate aminotransferase activity' or by 
chemical exchange at a later stage in the pathway. In a control 
experiment (data not shown) the intensity ratio of the 2}-j  signals for 
3-nitropropanoic acid isolated from a culture grown in medium 
containing 20% 21120 was Ca. 1: 1, indicating that no significant 
exchange of 2H at C-3 occurred during isolation of the metabolite. 
J. CHEM. SOC., CHEM. COMMUN., 1988 
C-2 of L-aspartate is probably retained in themetabolic 
oxidation of the amino acid to nitrosuccinic acid. 
On the basis of these results it appears evident that the 
biosynthetic pathway involves oxidation of L-aspartate to 
L-nitrosuccinate prior to decarboxylation [route (c) in Scheme 
I  and that the subsequent steps do not involve loss of the H-2 
of this intermediate. The mechanism and stereochemistry of 
the decarboxylation step are however unknown. 
A. B. H. was on secondment at the University of Edinburgh 
during the course of this work; we thank the A.F.R,C. for 
support. 
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Correlation of the Energies of 7t-Bonds between Carbon and Other Elements with 
E.S.R. Hyperfine Coupling Constants 
Christopher J. Rhodes 
School of Chemistry. Thames Polytechnic, Wellington St., Woolwich, London 5E18 6PF, U.K. 
A linear correlation is found between C=A it-bond energies in compounds of the type HC-AR (or HGEAR_ 1 ) and 
(3-proton hyperfine coupling constants for the corresponding radicals H 3C–AR (or H 2C=AR... 1 ): an empirical method 
is therefore available for either estimating n-bond energies from e.s.r. data or predicting hyperfine coupling 
constants from bond energy data. 
We have found that a linear correlation (r = 0.96) exists 
between C=A n-bond energies (estimated as the difference 
E(C=A) - E(C–A); A is an element) and the 0-proton 
hyperfine coupling constants in the corresponding radicals 
H 3C–AR (or 1-1 1C=AR_ 1 ). [We have taken the (3-proton 
couplings of methyl groups as the maximum, on the basis of a 
Bcos 20 dependence (i.e. as the value of B, since 0 = 0 for 
maximum coupling), in order to relate, them directly to 
couplings in radicals of the type l-1 1C=AR_ 1 , where the 
geometry forces 0 = 0.1 The data used in the correlation are 
collated in Table 1. 
Our qualitative interpretation of this is that as the formation 
of a n-bond requires overlap between a singly occupied C(2p) 
orbital and a singly occupied A(np) orbital, so part of the 
hyperfine coupling mechanism for (3-protons involves hyper- 
conjugation, which, in the cases considered here, requires 
overlap between a doubly occupied carbon-based group 
orbital of n-symmetry and a single occupied A(np) orbital: a 
relationship between these processes therefore appears 
reasonable. 'We attribute the intercept on the plot to the fact 
that our simple difference method does not separate the 
strengthening of the C–A a-bond due to the change in 
hybridisation between C(spt)–C(sp') and C(sp 2)=C(sp2), 
which will therefore be included in the derived n-bond 
energies. 
However, our main point is that this correlation may be 
used in a purely empirical way for predictive or interpretive 
purposes, by employing either equation (1) or (2), as 
illustrated by the following examples which relate to some 
areas of current interest. 
